University of Windsor

Scholarship at UWindsor
Electronic Theses and Dissertations

Theses, Dissertations, and Major Papers

8-3-2017

Computational Insights into the High-Fidelily Catalysis of
Aminoacyl-tRNA Synthetases
Mohamed M. Aboelnga
University of Windsor

Follow this and additional works at: https://scholar.uwindsor.ca/etd

Recommended Citation
Aboelnga, Mohamed M., "Computational Insights into the High-Fidelily Catalysis of Aminoacyl-tRNA
Synthetases" (2017). Electronic Theses and Dissertations. 6594.
https://scholar.uwindsor.ca/etd/6594

This online database contains the full-text of PhD dissertations and Masters’ theses of University of Windsor
students from 1954 forward. These documents are made available for personal study and research purposes only,
in accordance with the Canadian Copyright Act and the Creative Commons license—CC BY-NC-ND (Attribution,
Non-Commercial, No Derivative Works). Under this license, works must always be attributed to the copyright holder
(original author), cannot be used for any commercial purposes, and may not be altered. Any other use would
require the permission of the copyright holder. Students may inquire about withdrawing their dissertation and/or
thesis from this database. For additional inquiries, please contact the repository administrator via email
(scholarship@uwindsor.ca) or by telephone at 519-253-3000ext. 3208.

Computational Insights into the HighFidelity Catalysis of Aminoacyl-tRNA
Synthetases
By

Mohamed M. Aboelnga

A Dissertation
Submitted to the Faculty of Graduate Studies
Through the Department of Chemistry and Biochemistry
in Partial Fulfillment of the Requirements for
the Degree of Doctor of Philosophy at the
University of Windsor

Windsor, Ontario, Canada

© 2017 Mohamed Aboelnga

Computational Insights into The High-Fidelity Catalysis of AminoacyltRNA Synthetases
By
Mohamed Aboelnga

APPROVED BY:
_____________________________
P. Fernandes, External Examiner
University of Porto
_____________________________
S. Goodwin
School of Computer Science
______________________________
S. Ananvoranich
Department of Chemistry & Biochemistry
______________________________
J. Rawson
Department of Chemistry & Biochemistry
_____________________________
J. Gauld, Advisor
Department of Chemistry & Biochemistry

June 9, 2017

Declaration of Co-Authorship/Previous Publication
I.

Co-Authorship

I hereby declare that this dissertation incorporates material that is result of joint research
as follows:
Chapter 4: The primary contribution and data analysis were performed by myself and the
written manuscript was edited in collaboration with Dr. John J. Hayward under the
supervision of Prof. James W. Gauld.
Chapter 5: The primary contribution and data analysis were performed by myself and the
written manuscript was edited in collaboration with Dr. John J. Hayward under the
supervision of Prof. James W. Gauld.
Chapter 7: The primary contribution and data analysis were performed in collaboration with
Sarah Henshaw and Zaid Kaloti under the supervision of Prof. James W. Gauld.
Chapter 9: The primary contribution and data analysis were performed in collaboration with
Jacqueline Gemus under the supervision of Prof. James W. Gauld.
I am aware of the University of Windsor Senate Policy on Authorship and I certify that
I have properly acknowledged the contribution of other researchers to my thesis, and have
obtained written permission from each of the co-authors to include the above material in my
thesis.
I certify that, with the above qualification, this dissertation, and the research to which it
refers, is the product of my own work.

III

II.

Previous Publication

This thesis includes three original papers that have been previously published/submitted for
publication in peer reviewed journals, as follows:
Thesis chapter

Citation

Chapter 3

J. Phys. Chem. B 2017

Chapter 4

Phys. Chem. Chem. Phys. 2017

Chapter 5

ACS Catalysis 2017

Publication status
Accepted for publication
Submitted
Accepted for publication

I certify that I have obtained a written permission from the copyright owners to include
the above published materials in my thesis. I certify that the above material describes work
completed during my registration as a graduate student at the university of Windsor.

III.

General
I declare that, to the best of my knowledge, my dissertation does not infringe upon

anyone's copyright nor violate any proprietary rights and that any ideas, techniques,
quotations, or any other material from the work of other people included in my dissertation,
published or otherwise, are fully acknowledged in accordance with the standard referencing
practices.
I declare that this is a true copy of my dissertation, including any final revisions, as
approved by my dissertation committee and the Graduate Studies office, and that this
dissertation has not been submitted for a higher degree to any other University or Institution.

IV

Abstract
Obtaining insights into the catalytic function of enzymes is an important area of research
due to their widespread applications in the biotechnology and pharmaceutical industries.
Among these enzymes, the aminoacyl-tRNA synthetases (aaRSs) are known for their
remarkable fidelity in catalyzing the aminoacylation reactions of tRNA in protein
biosynthesis. Despite the exceptional execution of this critical function, mechanistic details
of the reactions catalyzed by aminoacyl-tRNA synthetases remain elusive demonstrating the
obvious need to explore their remarkable chemistry. During the PhD studies reported in this
thesis the mechanism of aminoacylation, pre-transfer editing and post-transfer editing
catalyzed by different aaRS have been established using multi-scale computational
enzymology.
In the first two chapters a detailed information about aaRS and the addressed questions
was given in addition to an overview of the used computational methodology currently used
to investigate the enzymatic mechanisms. The aminoacylation mechanism of threonine by
Threonyl-tRNA synthetases, glutamine by Glutaminyl-tRNA synthetases and glutamate by
Glutamyl-tRNA synthetases have been clearly unveiled in chapter 3 and 4. Also, valuable
information regarding the role of cofactors and active site residues has been obtained. While
investigating the post-transfer editing mechanisms, which proceed in a remote and distinct
active site, two different scenarios were experimentally suggested for two types of threonyltRNA synthetase species to correct the misacylation of the structurally related serine. We
explored these two mechanisms as in chapters 5 and 6. Moreover, the synthetic site in which
the aminoacylation reaction is catalyzed, is also responsible for a second type of proofreading
reaction called pre-transfer editing mechanism. In chapter 7, this latter mechanism has been

V

elucidated for both Seryl-tRNA synthetases and Isoleucyl-tRNA synthetases against their
non-cognate substrates cysteine and valine, respectively. In chapter 8, an assessment
QM/MM study using a variety of DFT functionals to represent the chemically active layer
in aminoacylation mechanism of the unnatural amino acid ß-Hydroxynorvaline as catalyzed
by Threonyl-tRNA synthetase has been carried out. Overall, it was found that substrateassisted mechanisms are a common pathway for these enzymes.
One important application of such information is to establish the criteria required for
any candidate to inhibit the catalytic functions of aaRS, which was applied in chapter 9 to
screen potential competitive inhibitors able to efficiently block the bacterial Threonyl-tRNA
synthetases.
The investigations reported herein should provide atomistic details into the fundamental
catalytic mechanisms of the ubiquitous and ancient aaRS enzymes. Consequently, they will
also help enable a much-needed deeper understanding of the underlying chemical principles
of catalysis in general.
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Chapter 1
1.1 Introduction
Numerous biochemical reactions take place in every cell in all living organisms. The
feasibility of such biochemical reactions might be kinetically challenging but enzymes are
catalyze these reactions through tremendous rate enhancements.1 While many strategies are
employed by enzymes, providing stabilization to the transition state lowering the energy
barrier is central to enzymatic catalysis.2-3 For instance, the phosphodiester bond, the
backbone linkage of DNA and RNA molecules, is exceedingly resistant to spontaneous
hydrolysis.4 The half-life scission time of its hydrolysis is estimated to be 30 million years,5
but in the presence of metallonucleases the hydrolysis rate is accelerated dramatically by a
factor of 1017.6 Understanding the incredible catalytic power of enzymes has been a goal of
chemical and biochemical research for the past century.7 Considerable progress has been
achieved; however, deeper insights into the source of the catalytic power of enzymes8 and
the roles of enzymes associated in different biological processes and diseases are still much
in demand. This, in turn, will open many novel routes into the development of many
biological and biotechnological applications.9-10

Aminoacylation

+

tRNA

aa

aaRS

Anti-Codon
3`

aa-tRNA

Anti-Codon
Codon
mRNA

5`

Figure 1.1. The cellular synthesis of an aminoacyl-tRNA and its role protein biosynthesis.
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The aminoacylation process catalyzed by the ubiquitous aminoacyl-tRNA synthetases
(aaRS) is a critical step in faithful translation of genetic information into proteins.11 High
accuracy in translation is essential for preserving cellular function.12 Additionally, aaRSs
have been associated with viral assembly, chlorophyll biosynthesis, oxidative stress response
and antibacterial therapy; however,

it is most known for its pivotal role in protein

biosynthesis.13-14 The family is split into two main classes according to distinct structural and
mechanistic elements.15
Specifically, aaRSs catalyze the attachment of an amino acid to its corresponding
transfer RNA (tRNA), the molecule responsible for providing amino acids to the elongating
polypeptide chain, in the form of aminoacyl-tRNAaa as shown in Figure 1.1. The enzyme
performs this role with outstanding specificity with an error rate of less than 1 in every 10
000 reactions.16 This accuracy is vitally important, as errors in aminoacylation can lead to a
variety of physiological and pathological problems including misfolded proteins, nonfunctional enzymes, cancer, and possibly cell death.17-18
AaRSs catalyze the aminoacylation reaction via a two-step process: activation and
acylation. In the activation step, the aaRS aligns its cognate amino acid together with
adenosine triphosphate (ATP) in an appropriate orientation for the carboxylate of the amino

acid to attack the α-phosphate of the ATP, leading to the formation of aminoacyl-AMP
accompanied by the release of the inorganic pyrophosphate. Subsequently, the acylation
reaction takes place where the aaRS catalyzes the aminoacyl transfer onto its cognate tRNA,
Scheme 1.1.19
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Scheme 1.1. General two-step aminoacylation mechanism of aaRS.
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As a result of the large sizes of the tRNA molecules, it has been found to be simple for
each aaRS to identify its cognate tRNA.20 However, due to significant structural similarity
between the amino acids, it is much more complicated for aaRSs to select their cognate amino
acids from a pool of structurally and chemically similar molecules.21 As a result, aaRSs have
evolved numerous strategies to ensure high fidelity in catalysis and accordingly faithful
translation of the genetic code.22 Through a size-base discrimination mechanism, the
aminoacylation site of an aaRS recognizes its cognate substrate and rejects non-cognate
ones.23 For example, cysteinyl-tRNA synthetase shows impressive fidelity in substrate
recognition and consequently, aminoacylation24 with 108 fold selectivity.23
Additionally, the majority of aaRSs possess an ability to edit mis-aminoacylation, either
in the aminoacylation site through pre-transfer editing or by using a separate catalytic editing
site through post-transfer editing, Figure 1.2.25 In the pre-transfer editing mechanism, the
aaRS hydrolyzes aminoacyl adenylate intermediate to regenerate the free non-cognate amino
acid which can then be cleared from the active site, Scheme 1.2.26 In addition, a selfcyclization mechanism has been suggested for the pre-transfer editing against homocysteine
and ornithine by Methionyl-tRNA synthetases and Lysyl-tRNA synthetases.27-28 Once the
wrong amino acid is misacylated to the tRNA a post-transfer editing process can operate,
during which the misacylated-tRNA is shuttled to a distal editing active site where the ester
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bond between the misacylated amino acid and tRNA is cleaved, Scheme 1.2.29
For instance, the aminoacylation site of threonyl-tRNA synthetases (ThrRS)
accommodates a unique Zn(II) metal ion which assists in the removal of the non-cognate
valine.30 However, this synthetic site is unable to fully distinguish between its cognate
substrate, threonine, and the structurally related noncognate serine.31 Rather, it acts under a
double-sieve model and employs a range of editing approaches to clear misacylated SeryltRNAThr, Figure 1.2.32

Aminoacylation Mechanism.

Editing Mechanism.

Figure 1.2. Surface representation of the double discrimination model in threonyl-tRNA
synthetase to ensure overall fidelity mechanism; the catalytic domain in blue where the
editing one is in grey colour.
Only yeast mitochondrial ThrRS lacks a separate editing site and thus appears to exploit
only pre-transfer editing within its aminoacylation site.33 However, ThrRS from any other
species is known to follow a double discrimination approach; that is, they exhibit both preand post-transfer editing.34 Notably, the post-transfer editing mechanism of ThrRS has been
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observed to be somewhat species specific; in the case of the N-terminus motif (archaeal)
ThrRS, the post-transfer editing process is thought to proceed via an RNA-mediated
hydrolysis pathway.35 Specifically, it is thought to be facilitated by the tRNA co-substrate’s
2´-/3´-OHAdo76 group. Interestingly, sequence analysis has demonstrated a substantial
sequence similarity between this motif in ThrRS and D-amino acid deacylases (DTD).36 The
latter is utilized by aaRSs to ensure the homochirality of the synthesized protein by removing
the misformed D-aa-tRNAaa37 but, unfortunately, the precise mechanistic role is unknown.38
Meanwhile, in E. coli species, the hydrolysis mechanism is a matter of much more
debate.39-40 It has been proposed that an editing site cysteine or histidine residue acts as a
mechanistic base to activate the nucleophilic water molecule.41-42 Interestingly, even by
employing a double discrimination mechanism, ThrRS can still have difficulties since the
unnatural amino acid β-hydroxynorvaline cannot readily be discriminated against and can
be incorporated into proteins.43 Other aaRS are thought to go even further and employ a
triple-sieve approach; for instance, distinguishing between serine and alanine by AlaRS is
one of the greatest molecular-recognition challenges in nature.42, 44
Scheme 1.2. Schematic drawing for the general editing mechanisms utilized by ThrRS.
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However, it has been recently suggested that this inaccuracy in translation is a “doubleedged sword”.45 Absolute accuracy is not always essential and indeed, several aaRSs have
been observed to tolerate moderate levels of misaminoacylation.46 In fact, this can be used
as a physiological stress response or allow some amino acids to be incorporated into proteins
even if their specific aaRS is lacking in certain species.47-48 For instance, it has been found
that only eukaryota and some bacteria species possess twenty aaRS, each responsible for a
specific, individual amino acid.49 Accordingly, indirect acylation pathways are required for
the transfer of amino acids in those species that do not possess all 20 aaRS.49 For example,
most prokaryota lack AsnRS and GlnRS enzymes; instead, non-discriminating glutamyl-RS
and aspartyl-RS can mis-aminoacylate tRNAGln and tRNAAsn with glutamate and aspartate
amino acids, respectively.50 These mischarged tRNAs are then converted to the desired GlntRNAGln and Asn-tRNAAsn by Glu-tRNAGln and Asp-tRNAAsn amidotransferases.51
The exact mechanisms of the aforementioned reactions remain quite poorly understood.
This is highly unfortunate given their tremendous potential impact on molecular recognition,
physiological and pathological processes, and catalysis. The outgrowing computer and
software capabilities made it possible for the state-of-the-art multiscale computational
chemistry to provide significant insights into these critical and far-reaching problems.52-53
Specifically, it can shed light on the exact contribution of each active site residue to catalysis
and thus precisely identify the catalytically active ones. This can provides the foundation
required for the development of targeted and effective therapeutic agents for the treatment
of the many disease states associated with these enzymes.54
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Chapter 2
2.1 Molecular Modeling of Enzymes
Elucidating the complete catalytic mechanism of an enzyme means establishing and
understanding all the factors that contribute to their remarkable ability to enhance the rate of
reactions and to act with great specificity. This often requires, for instance, identifying and
characterizing the structures, properties, and energy of all the intermediates and transition
states along a reaction cycle. Experimental investigations have made numerous great strides
and progress in the field enzymatic catalysis across many different aspects. Unfortunately,
however, many aspects of enzymatic catalysis, particularly at the atomistic or electronic level,
remain challenging or impossible to elucidate by current experimental techniques.1-2
Fortunately, the exponential growth of computational power has enabled the development
and application of computational chemistry methods to, for instance, ever increasingly large
and complex chemical problems. Indeed, computational enzymology, the use of such
methods to study enzymes, is now able to provide a tremendous wealth of accurate and
reliable insights into their structures, properties, energies, and catalytic mechanisms.3
Furthermore, such methods can be used to examine chemical systems from the atomistic to
macromolecular level. Thus, computational enzymology has established itself as both a
complementary and stand-alone approach to traditional experimental methods, and has
become a booming area of active research and development in the field of enzymology.
In this dissertation a range of computational methods have been applied to study a range
of enzymes. There have several great reviews in the literature on the field. Hence, within this
chapter only a brief introduction and summary of such methods and their application, as
relevant to the work herein, is provided.
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2.2 Molecular Dynamics Simulations
Computational enzymology studies often start with obtaining or deriving a suitable
chemical model from an experimentally derived high-resolution X-ray crystal structure.
However, such experimental structures are themselves not necessarily an exact
representation of the enzyme or complex in vitro being impacted by, for example, they are
static, non-solvated, may contain mutations, and are potentially subject to crystal packing
effects.
For example, it has long been recognized that, for instance, within cells enzymes are in
dynamic motion and can adopt a range of conformations over time that exist from a few
femtoseconds to several seconds. In contrast, the observed time scale for a catalytic reaction
can be on the order of a millisecond to microsecond scale.4 This inherent flexibility has been
found to be central to enzymatic catalysis, including their efficient substrate binding and
product release, and is represented through a multidimensional free-energy landscape.5
Indeed, for any enzyme to function properly, it is essential to balance between its inherent
flexibility and suitable stability to maintain its original coordinates.
Thus, unraveling enzymatic mechanisms at the atomistic level can require the use of
molecular dynamics (MD) simulation, which enable one to model the time-dependent change
of the atomic coordinates of the system under study.6 Specifically, the position of any atom
in the protein at any time can be monitored. Furthermore, they can allow one to model the
behaviour of a solvated system, as well as include the effects of temperature on conformation.
MD simulations use classic Newtonian mechanics to determine the movement behaviour of
a system under the pressure of the forces acting on it. Parametrized forcefields such as
Assisted Model Building with Energy Refinement (AMBER)7-8 or Chemistry at Harvard
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Macromolecular Mechanics (CHARMM)9 are used to compute the applied force on each
atom of the complex systems and then integrate over time.
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Figure 2.1. Flow diagram for a common strategy used to obtain a suitable chemical model
for subsequent QM/MM or QM-cluster calculations. The PDB ID for the starting X-ray
structure in this example is 1TKY.10

In response to the enzyme flexibility, atoms are in a continuous movement during time
and thus the applied forces are changing, thereby the latter need to be recalculated at each
time step. Eventually, MD simulations sample the generation of all plausible conformations
the enzyme can adopt in a certain time. The outcome of the MD simulations is a trajectory
which reveals the fluctuations of all atoms in the specified time frame over thousands of time
steps. Complete atomistic details of the atoms motion in the system under study can be
obtained through the analysis of the generated trajectories. It is also crucial to mention that,
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the length of the MD simulation should be adequate to allow the structural fluctuations to
reach a plateau indicating the equilibrium of the generated conformations from which a
snapshot can be chosen for the following QM/MM calculations, Figure 2.1. All the
conformations obtained before this equilibrium state are usually discarded and a
representative model is chosen from only the equilibrated ones. In complex biomolecular
systems such as lipids, membrane proteins and related systems where longer timescales ( ≥
µs) are needed for proper simulations; a coarse-grained model can be applied.11 This model
allows for a significant increase in the timescale of MD simulations by treating small groups
of atoms as single particles.12
In this thesis, the Molecular Operating Environment13 (MOE) was used to prepare all
the chemical models and the simulations themselves were performed using the NAMD
program.14 It is important to bear in mind that the X-ray crystal structures do not always
contain the cognate substrates; either an analogue or even no substrate (apoenzyme). In the
latter case, molecular docking is the tool we use to insert the substrate in the most favorable
binding mode inside the active site. Many docking protocols have been developed based on
the idea of inserting the substrate in all the possible orientations using molecular mechanics
(MM) method. Each generated complex is then energy minimized and the complex with the
lowest energy is the one predicted to exhibit the substrate bound in its most favorable position.
It is also well established that there is a central influence of the conformational
fluctuations of the enzyme on the calculated energy barriers for the studied mechanism.15-16
The active site residues change their positions regularly during the simulation and thereby
their catalytic contributions are varied from one conformation to another. Inaccurate
selection of the starting structure for any enzymatic study can lead to a proposal of the wrong
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reaction mechanism. Accordingly, it has been suggested to select multiple initial points from
the generated conformations of MD simulations for subsequent enzymatic study.16

2.2.1 Molecular Mechanics:
As we mentioned above, MD sampling is usually performed using molecular mechanics
(MM). In this empirical-based approach, the calculation ignores the electronic motion and
the energy is then calculated based on the nuclear positions only. Therefore, the chemical
system is described as spheres joined by springs. Specifically, the energy of this system is
derived as a function of its conformation and expressed as the sum of basic classic equations
that describe the valence terms (such as bond stretching, bond bending, bond torsion), van
der Waals energy, electrostatic interaction and cross terms (which describe the effects of the
motion of one molecule on the other). The constants used in the equation are parametrized
either from experimental data or through ab initio calculations. A set of equations with their
respective constants is called a force field. Among many available forcefields, the most
widely used for proteins and nucleic acids are the AMBER and CHARMM forcefields.8-9
This simplicity of the calculations allowed MM minimizations to be applicable to very big
chemical systems.
2.3 Quantum Mechanics and Quantum Mechanics/Molecular Mechanics.
A diverse range of computational tools are available and widely used in computational
enzymology. Two of the most common are the quantum mechanical (QM)-only, also known
as the QM-cluster method, and the Quantum Mechanics/Molecular Mechanics (QM/MM)
methodologies.17 Indeed, these approaches have become essential for exploring the structure
and the functions of biomolecules from the quite small to large multi-molecular species such
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as enzyme-substrate complexes. However, each approach has its challenges and strengths
and in the following sections we highlight at least some of these.

2.3.1 QM-only Approach:
Modeling enzymatic reactions using the QM-only method has been successfully applied
to the study of a range of chemical reactions and, in particular metalloenzymes.18-20 At the
moment, the QM-cluster method can only be used to treat chemical systems of 200 atoms or
less, thus it can not treat an entire enzyme. This is due to the fact that a single quantum
mechanical method is used to describe the entire chemical model. According to numerous
investigations on different metalloenzymes, the error of the QM-only approach is estimated
to be less than 5 kcal/mol.21
More specifically, a central foundational idea behind this approach is that for an
enzymatic system the active site residues that are catalytically essential in the mechanism or
responsible for productive binding of the substrate are excised out of the protein and treated
with a high level of theory.22 As a result of discarding the protein environment, two main
essential factors that influence the excised model are ignored: the steric effect employed by
the protein to maintain the geometry of the active site, which can lead to artificial and nonphysically relevant geometry changes, as well as long-range interactions and polarization
effects induced by the surrounding protein.23
Two common solutions are introduced to overcome these limitations. It is typical to freeze
one atom from each residue at its crystallographic or possibly MD minimized coordinate to
help maintain the structural integrity of the model in place.22 Also, it is presently common to
use a continuum medium with a dielectric constant to approximately represent the
electrostatic effects due to the surrounding protein. The latter can be included via the use of
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single point energy calculations on the optimized geometries. Different values for the
dielectric constant can be used based on the polarizability of the protein, but a value of 4 is
generally held to be the most representative of common protein environments.24
The number of atoms included in the QM-only chemical model and that are ideal to
accurately represent the real active site has been a matter of increasing debate.18-19, 25-26 But
it is now generally established that the accuracy of the QM-only protocol increases when a
large chemical model of 100-200 atoms is used.23 This has been concluded based on the
finding that the impact of changing the value of the dielectric constant is insignificant when
the model used is derived by truncation of the real system at some distance away from the
active site.27
Moreover, increasing the size of the QM model provides the system with two essential
properties; (i) suitable flexibility to adapt to any required geometry changes along the
chemical reaction, and (ii) a suitable compromise for treating the short- and long-range
interactions. Many assessment studies have demonstrated that a convergence in the obtained
potential energy surfaces of different chemical reactions can be achieved when chemical
models in the range of 150-200 atoms are used.25-26 However, before expanding the size of
the chemical model, special care should be taken to consider the consequences. In particular,
the calculation time will increase dramatically and, the larger the model, the higher the
chance to obtain various local minima during the optimization of the chemical pathway. In
addition, larger chemical models do not allow for the use of the higher and thus more accurate
and reliable computational methods.
It is also important to mention that several QM-only investigations have been performed
on different metalloenzymes to examine the choice of X-ray structure used to derive a
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chemical model on the reliability of the obtained energy barriers.28 Applying different
displacements on the fixed atoms was found to result in negligible changes in the kinetic
energies as long as the system is composed of more than 100 atoms.29 Overall, if the
resolution of the considered X-ray structures is reasonable, better than 2.0 Å, the starting
structure is not critical to the computed energies by the QM-only approach.
In practicality, the QM-only approach is found to be helpful to provide preliminary
insights into the catalytic mechanism. Because of the less expensive time cost, it can be used
to determine from a variety of proposed or potential mechanisms the one that is likely most
feasible. It can also be useful for benchmark investigations; that is, to determine the most
reliable QM method and basis set for reliably and accurately treating the chemical system
under study. However, one must also be aware of the inherent limitations associated with the
use of such models.

2.3.2 QM/MM Modeling
The QM/MM multilevel methodology inspired by the pioneering work of Warshel and
Levitt30, became the method of choice in studying enzymatic catalysis.17,

31-35

In this

approach, the entire enzyme is split into two main subsystems according to their importance
in the chemical reaction. The active site where the bond forming and bond breaking takes
place is the electronically active region and is treated by the QM level of theory (inner layer).
The criteria for choosing the size and the number of atoms in this region is the same as the
QM-only approach. In fact, it is generally accepted that different sizes leads to different
results and thus different models should be assessed to establish the consistency of the
obtained energy.36
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The remaining region of the protein is represented by an empirical MM method which
treated by a forcefield such as AMBER or CHARMM.37 The entire protein can be
represented but for the proteins that have many chains in its X-ray structure, the size of the
model depends on the location of the active site. In most of the cases, one monomer
containing the active site is a good representation for the entire protein. A large size of the
chemical model makes it computationally more expensive in addition to the complexity of
the generated conformations of the MM layer. The resulting error from the latter can be
diminished by either fixing the alpha carbon atom of the residues 8 Å away from the substrate
to its coordinates at the MM minimization or even fixing the remaining part of the protein
entirely.34
Also, the interaction between these two layers (QM__MM coupling) cannot be estimated
by just combining the energy between them. Special precautions should be considered when
selecting the boundary region. Two general approaches, additive and subtractive, are
currently considered for treating the coupling between these two layers.
2.3.2.1 Additive and Subtractive QM/MM schemes
Additive Scheme. In this scheme the QM/MM energies are calculated by adding the MM
energy of the low layer (EMM), the QM energy of the the active site region or high layer
(EQM), and the QM energy of the electrostatic interaction between the high (QM) and low
(MM) layers (EQM/MM, coupling), Figure 2.2.
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EQM/MM, coupling
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EMM, outer layer

EQM, inner layer

EMM, Inner layer

Figure 2.2. Schematic illustration of how the additive (top scheme) and subtractive coupling
schemes (bottom scheme) compute the energy of the chemical model.
Subtractive Scheme. In this scheme, separate QM and MM calculations are performed.
That is, the QM region is treated independently and the QM/MM coupling interaction is not
counted explicitly but considered within the MM calculation. The energy expression of the
subtractive QM/MM scheme is the sum of the MM energy of the entire system (EMM, entire
system)

and the QM energy of the active site region (EQM, inner layer), minus the MM energy of

the innery layer. The latter is done to avoid inclusion of the energy of the inner layer through
both the QM and MM calculations, Figure 2.2.
Because of this simplicity, the subtractive approach can be expanded to n number of layers
and the ONIOM approach developed by Morokuma and coworkers is an example of this
scheme.38-39 This example has been successfully applied to combine two QM methods to
represent the entire system or covering three layers. In the case of three layers there will be
an additional medium layer which can be treated, for example, using a less computationally
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expensive QM method (e.g., semiempirical) than used in the high layer. The resulting
QM/QM/MM energy expression can be represented by:
EQM/MM= EMM,entire system + EQM, inner layer + EQM, medium layer – EMM,inner layer – EMM,medium layer
At the heart of a QM/MM calculation is the treatment of the interaction between the QM
and the MM layers and should be described accurately. Two types of interactions between
these two regions are normally represented: bonded (bond stretching, bond bending and
dihedral rotation) and non-bonded (electrostatic and van der Waals) interactions. According
to the treatment of electrostatic coupling between the QM and MM regions, QM/MM
calculations are said to use either mechanical or electrostatic (or electronic) embedding.
In the case of the mechanical embedding the interaction between the two layers is treated
by a MM calculation, which is reasonable for van der Waals but not electrostatic interactions.
In particular, as a result of being treated using an MM forcefield, the charge distribution of
the outer MM layer does not directly interact with the inner QM layer, which can be a
drawback for the mechanical embedding treatment. Increasing the size of the inner layer to
account for the charge distribution is suggested to diminish the influence of this
shortcoming.40 The integrated ONIOM method is by default a mechanical embedding
method.37-38 It should be noted that the ONIOM approach can be expanded to include
multiple layers. For example, the three layer ONIOM method has been suggested as one
possible approach to enhance modeling of the polarity of the protein environment around an
enzyme’s active site.39
In the case of electrostatic embedding the electrostatic interaction between the layers is
treated using a more advanced level of computation. While this makes it more accurate it is
computationally more expensive. In particular, the change of the charge on the inner region,
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resulting from the electrostatic influence of the outer layer is represented by incorporating
an additional one-electron term in the QM Hamiltonian to represent the MM point charges.
The treatment of the QM-MM van der Waals interaction in electronic embedding is identical
to the mechanical embedding treatment.
Interestingly, the mechanical embedding approach, which avoids the overpolarization of
the QM layer caused by inclusion of the additional one-electron term in the QM Hamiltonian,
was found to be more reliable than electrostatic embedding in several enzymatic
investigations.41 However, electrostatic embedding led to faster convergence of the size of
the QM layer relative to the mechanical embedding scheme.42
Importantly, the explicit treatment of the junction area between the high and the low layer
is found to be significant only in the cases where the outer region of the protein has an
electronic influence on the inner layer. In the case of the additive QM/MM approach,
however, there is no requirement for parameters to represent the link atoms which is not
described by the force field.
In addition, the treatment of the boundary between the QM and MM layers can be largely
classified into the link atom43 (or parametrized atom44) and a localized orbitals approach.45
In the link atom approach, a link atom, usually hydrogen, is used to saturate the chemical
valence of the truncated atom in the QM layer. But this hydrogen atom is not treated by either
the QM or MM methods. However, the use of a hydrogen atom results in limitations in the
accuracy of the obtained QM/MM energy and electron density. This is because it is in a sense
artificial, as it does not exist in the original connection, and the distance between this artificial
hydrogen atom and the QM/MM boundary is only 0.5 Å, which is shorter than typical of an
X-H bond. By comparison, in the localized orbital approach a QM calculation is used to
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describe the connection between the inner and outer layers and thus, reduce errors due to
overpolarization. However, the link atom approach is more straightforward and widely used.

2.3.2.2 Technical aspects to consider when constructing a QM/MM model.
When truncating the QM-MM conjunction, the coupling boundary should be at an adequate
distance from the active site to be feasible computationally. More specifically, the boundary
should be at least three bonds away from the location of bond formation and breakage to
guarantee enough flexibility to afford dihedral rotation. It is also important to avoid placing
the boundary at any polarized or conjugated bond (either a linear bond or in a ring system).
Globally, the most appropriate place to cut at is at a single bond between non-polarized atoms
such as aliphatic C__C single bonds.

2.3.3 Comparison between QM-cluster and QM/MM approaches:
Studying the enzymatic mechanism using QM-only was found to result in a significant
change in the energy barrier compared to studies done using the QM/MM approach.32
However, absence of the protein environment does not induce significant changes in the
obtained relative energies for the chemical reaction if it is not associated with a large degree
of charge transfer.46 To examine the effect of including the protein environment on the
energy of the inner layer, (EQM), the difference in QM energy of the isolated chemical model
in the gas phase (EQM*) and the energy of inner layer inside the QM/MM model (EQM, QM/MM)
is calculated,40 EMM= EQM, QM/MM - EQM*
Convergence of energy using QM/MM models relative to the QM-cluster approach with
respect to the chosen size of the QM model has been the subject of numerous studies.47 In
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general, the QM/MM approach was found to converge faster with increasing system size
than the QM-cluster approach. For instance, benchmarking QM/MM studies on the proton
transfer from cysteine to histidine in [Ni,Fe] hydrogenase demonstrated the convergence of
the obtained energy barrier once the QM/MM junction is moved away from the active site.41
Following the same protocol, it was demonstrated that addition of more residues to the QMcluster system should not occur according to chemical intuition or to the residues’ proximity
to the active site, but rather to their contribution to the QM/MM energy.48-50 In these studies,
buried charged groups up to 20 Å away from the active site were found to significantly
contribute to the obtained energy barrier. Moreover, including additional neutral residues in
the QM region is significant only if they are located less than 4.5 Å away from the active
site. Importantly, it is also suggested that all the polarized residues located up to 10-15 Å
away from the active site should be treated at the QM level for accurate modeling of the
enzyme.41, 49 To illustrate, a recent QM/MM study declared the convergence of the QM
region when the size reached 200-300 atoms,51 while in another investigation, convergence
in the energy was achieved beyond 300 atoms.52
Another comparison between QM-cluster and QM/MM models in the study of
enzymatic reactions has been performed on the mechanism of tungsten-dependant acetylene
hydratase.36, 53 In this comparison, combining the two approaches to complementarily inform
each other was found to be a necessary step towards successful elucidation of the enzymatic
reaction. However, unlike the previous suggestions,49 the authors do not support adopting
the energy resulted from expanding the size of an optimized QM region in the QM/MM
model through the use of single point energy calculations.53 Significant differences in the
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obtained energies relative to the fully optimized QM/MM models have been observed and
were found to be independent of the chosen models.36
2.4 Density Functional Theory (DFT)
Electronic structure calculations on the QM region can be performed using a variety of
methods including ab initio, density functional theory (DFT), and semi-empirical
calculations. The central goal of these treatments is to provide an approximate solution to the
time-independent Schrödinger equation; the fundamental equation of quantum chemistry.
Solving the time-independent Hamiltonian operator for multi-electron systems is incredibly
complex, making it impossible to exactly solve the Schrödinger equation. A remarkable step
toward expanding its applicability has been achieved upon the simplification made by the
Born-Oppenheimer approximation. This allows us to assume that the atomic nuclei are
stationary relative to the electrons due to their larger mass. As a result, the Schrödinger
equation is separated into a nuclear and electronic part, simplifying the molecular
Hamiltonian to the electronic Hamiltonian. Thus, many physical and chemical properties can
be determined based on the ground state electronic structure.
The Hartree-Fock calculation (HF) is the most basic type of ab initio calculation. It is a
variational method, meaning the calculated energy is always equal to or greater than the exact
one. It solves a series of one electron equations describing how each electron moves in a
field of surrounding electrons and is built from a linear combination of basis functions
(atomic orbitals). One of the main limitations of HF calculations is that it does not account
for explicit electron correlation (repulsion), but just an average effect. Many types of
correlated calculation such as Møller-Plesset perturbation Theory (MPn), and coupled cluster
theory have been developed to correct for the lack of HF electron correlation.
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Similarly, semi-empirical (SE) methods are another approach that was developed on the
basis of the wave function to solve for the Hamiltonian operator with the inclusion of
approximations obtained from empirical data. Thus, the SE method is much faster than any
ab initio calculation, but the obtained results are not always accurate. In this approach, most
of the core electrons of the system are omitted and not treated in the calculation, extending
its application toward much larger systems. SE methods are parametrized to either
experimental data or ab initio calculations to overcome the errors of ignoring the core
electrons. This inaccuracy is a result of the fact that the molecule under study should
necessarily have structural similarities to the database used to derive the parameters. The
most commonly used SE methods are Austin Model 1 (AM1) and the parametrized method
3 (PM3).
Due to the limitations of electron correlation, the wave function theory that was globally
applied to quantum mechanics has been avoided for large systems.54 Consequently, KohnSham Density Functional Theory (DFT) is presently the most popular and powerful tool for
many applications in computational chemistry.54-55 It indicates that all the ground state
properties of any system can be derived from the electron density distribution over space.56.
The electron density is independent of the number of electrons, a substantial benefit when
examining larger chemical models(cost scales with N4).57 With comparable efficiency to HF,
DFT has an outstanding performance-to-cost ratio simultaneously being applicable to larger
chemical systems
Because the exact functional is unknown, DFT relies upon approximating the unknown
exchange-correlation (XC) functionals of the electron density58. This approximation is
known to be the main shortcoming of DFT calculations. In the scope of this approximation,
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significant progress has been achieved in approximating the XC.59 The first generation
approximations is the local spin density approximation (LSDA) in which the XC functionals
depend only upon local spin densities.55 Despite its simplicity, LSDA is known to not be
useful in studying chemical compounds as it overestimates bond lengths and underestimates
chemical barriers. The second generation includes the generalized gradient approximation
(GGA) methods which consider the gradient of the electron density in the XC functionals,
improving the accuracy of results. Thereby, introducing this generation of functionals was
the cornerstone that enabled computational chemists to use DFT. For instance, the exchange
functionals of Becke8660 (B86) and the popular Lee-Yang-Parr (LYP) correlation functionals
are pioneers of this generation.61 However, accurately describing the energy barriers is still
not fully solved.
Chemical Accuracy
Hybrid Meta GGA
Hybrid GGA
Meta GGA
GGA

(M062X)

(B3LYP)

(MPW1K)

(BP86)

LDA
HF

Figure 2.3. Representative image for the different generations of DFT functionals
according to J. Perdew62 with an example corresponding functional.
As a result, developing the hybrid density functionals (H-GGA) that mix the XC from the
GGA method with a percentage of Hartree-Fock exchange is one reason for the progress of
DFT functionals. This remarkable step upon introducing H-GGA, particularly after the
introduction of the common B3LYP functional, allowed DFT to become the most widely
used method in quantum chemistry.61, 63 In fact, the B3LYP functional became the functional
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of choice in studying numerous chemical properties, together with the hybrid meta density
functional (M-GGA) , they led to a significant improvement in the accuracy of determining
different chemical properties of molecules, Figure 2.3.64
Despite the unparalleled success in the application of DFT functionals, it is unfortunate
to know that they suffer from four major challenges.65 The largest error is the self-interaction
error which arises from the electron interacting with itself in the columbic term described by
the DFT Hamiltonian.66 This error directly influences the underestimation of barrier heights,
but can be somewhat addressed by including additional contribution from the exact HF
exchange.67 Also, another major limitation is the inability of these functionals to describe
non-covalent long-range (van der Waals) interactions.68 Presently, there is ongoing progress
towards eliminating this shortcoming through introducing empirical dispersion corrections
such as Grimme’s empirical formula.69 Interestingly, either geometry optimization of the
chemical models or single point energy calculations using B3LYP-D3 were found to be
equally successful in minimizing this error in different systems.70 One more critical
drawback of DFT functionals is that they all are ground-state methods and are unable to
provide reasonable results for excited state applications. Finally, error arises from the
inaccurate description of chemical systems containing transition metals, increasing with
increasing the %XC included contrary to a solution to self-interaction error.71 To illustrate,
M06L (with no HF exchange) led to accurate predictions in the excitation energies in some
systems.72
Quite noticeably, there is a clear conflict between the self-interaction error and inclusion
of transition metals. To overcome the latter problem, it is suggested to utilize a DFT
functional with low HF exchange; however this will lead to inappropriate estimation of the
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barrier heights.64 Currently, the meta hybrid M05, M06, and the improved M08 suites of
DFT functionals were found to be superior to other functionals in terms of diminishing the
previously mentioned errors.73 In general, however, it is well known that there is not a single
DFT functional that is suitable for all systems; the choice of the functional relies mainly on
the property under evaluation and the nature of the chemical system under study.55 For
instance, M062X outperformed the robust B3LYP functional in treating long range as well
as providing a better description of barrier heights.64 Meanwhile, the local M06-L functional,
is the most suitable for transition metal chemistry. The M06HF functional with full HF
exchange takes advantage of this XC to avoid the self-interaction error, yet it is not suitable
for transition metal chemistry.64
It is also important to mention that M062X is parametrized to approximately describe long
range interactions; however it fails to provide the same level of accuracy as dispersion
corrected DFT functionals.69 In contrast, other studies demonstrated the success of the
Minnesota functionals in describing long range interactions at a similar level to dispersioncorrected ones.74 Generally, other than the description of noncovalent interactions, M062X
was recently recommended to be the most accurate among the 14 Minnesota density
functionals.75
In conclusion, to determine which is the best DFT function to evaluate a chemical system,
one of two main tasks should be considered. The literature should be consulted as to which
functional best describes the system or perform a benchmarking study of several DFT
functionals against a known standard method such as CCSD to represent your chemical
model.49
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Chapter 3.
The Roles of Zn(II) And Active Site
Residues in Substrate Discrimination
by Threonyl-tRNA Synthetase.
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3.1 Introduction
Proteins have a diverse array of critical roles in cells and organisms. Their proper
functioning depends on the accuracy of their synthesis and thus, the process of transcription
and translation.1 Aminoacyl-tRNA synthetases (aaRS) are central enzymes in the translation
process as they charge transfer-RNA (tRNAaa) with their cognate amino acid (aa).2 This is
achieved via two half-reactions2-3 in which they activate their cognate aa through reaction
with adenosine triphosphate (ATP) to form an aminoacyl-adenylate (aa-AMP). Then, within
the same site, they catalyze transfer of the aminoacyl moiety onto the Ado76 residue of their
tRNA (tRNAaa). Using a lock-and-key specificity for their substrate, aaRS are able to achieve
an outstanding overall reaction fidelity with an error rate of ~10-4.4 Thus, in addition to their
central role in protein biosynthesis and potential as drug targets,5 they are also exemplars of
molecular recognition. As a result, they have increasingly been the subject of experimental
and computational studies.6
Structural and chemical similarities between the amino acids presents a significant
challenge to aaRS in distinguishing between cognate and non-cognate substrates. For
instance, it has been stated that amino acids that differ by only one methyl group provide no
more than 1 kcal mol-1 difference in binding energy.7 As a result, the active site of aaRS may
also bind non-cognate amino acids potentially resulting in mischarging of their tRNAaa. For
example, AlaRS may misacylate its cognate tRNAAla with the sterically larger serine as well
as the smaller glycine.8 Meanwhile, IleRS, PheRS, and ProRS may mischarge their
corresponding tRNAaa's with non-cognate valine, tyrosine, and alanine or cysteine,
respectively.9-10 In order to overcome these errors, some aaRS use a double-sieve model
wherein both the above aminoacylation site and a second editing site perform pre- and/or
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post-transfer editing.11 In the latter site, removal of the mischarged aminoacyl moiety from
aa-tRNA is achieved via a tRNA-dependent mechanism.12
In particular, the class II aminoacyl-tRNA synthetase ThrRS must discern its cognate
substrate L-threonine from multiple non-cognate amino acids including valine and serine.1314

It has also recently been the target of potential new antimicrobial drugs.15 Experimentally,

several X-ray crystal structures of ThrRS with and without various ligands bound within its
aminoacylation site have been obtained.13-14, 16 Notably, based in part on these structures the
aminoacylation active site was found to contain an essential Zn(II) ion. Indeed, mutation of
any of the three enzyme residues (a cysteinyl and two histidyl's) ligated to the Zn(II)
inactivated or inhibited the enzyme.14, 17
In general, aminoacylation as catalyzed by aaRS proceeds via a conserved substrateassisted mechanism.18 More specifically, a non-bridging phosphate oxygen of the aa-AMP
substrate acts as the required base to abstract a proton from either the Ado76-2'- (class I) or
Ado76-3'OH (class II) group of the tRNAaa.4 However, in the case of ThrRS, experimental
mutation studies concluded that the substrates non-bridging phosphate oxygens do not act as
the base.19 Recently, using molecular dynamics (MD) and DFT-cluster computational
methods we suggested that the experimentally observed bidentate ligation of the threonyl
moiety of L-Thr-AMP to the Zn(II) ensures that its α-NH2 group is neutral, and enhances the
lability of the Zn(II)…NThr bond.20-21 As a result, the substrates α-NH2 is able to act as the
required mechanistic base as shown in Scheme 3.1.
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Scheme 3.1. The mechanism of ThrRS catalyzed threonylation of the corresponding
tRNAThr where the substrate’s α-NH2 serves as the required base (based on ref. 22).

However, in addition to aiding substrate recognition, it has also been suggested that a
key role of the Zn(II) may be steric or chemical discrimination against non-cognate amino
acids.11 For example, it may facilitate discrimination against the isosteric but non-cognate
valine due to steric hindrance with the latter's side chain β-methyl group.22 Meanwhile, serine,
which differs from threonine by a single -CH2- in its side chain, is able to bind in the same
manner as threonine within the aminoacylation site of ThrRS. Thus, it has been suggested
that the Zn(II) may help ensure that only amino acids possessing a b-hydroxyl group may
bind within the aminoacylation active site.13-14 Experimentally, it has been indicated that
ThrRS catalyzed aminoacylation by the non-cognate serine occurs at a rate 1000-fold less
than for the cognate threonine.13-14 This difference in the reaction rate does mean that in
addition to pre-transfer editing, post-transfer editing of mischarged Ser-tRNAThr is
required.23-24 It has also been suggested that aaRS play a crucial role in ensuring the
homochirality of amino acid residues in proteins, which is essential to the proper folding and
thus function.25-26 The role of the Zn(II) and active site of ThrRS in discriminating against
D-Threonine

is, however, as yet unknown.

In this present study, we have used a multi-scale computational approach to investigate
substrate binding in the aminoacylation active site of threonyl-tRNA synthetase, and the
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subsequent mechanism of aminoacylation. More specifically, the role of the Zn(II) ion in the
binding and catalytic mechanism for the cognate substrate L-Thr-AMP and potential noncognate substrates L-Ser-AMP, L-Val-AMP, and D-Thr-AMP, was examined using
molecular dynamics (MD) and quantum mechanics/molecular mechanics (QM/MM)
methods.
3.2 Computational Methods
3.2.1. Molecular Dynamic (MD) Simulations
The Molecular Operating Environment (MOE) program was used to prepare all Molecular
Dynamics (MD) simulations,27 which were then performed using the NAMD program.28 We
have previously performed an MD study on the fully bound ThrRS complex.20 As then, the
Michaelis complex was constructed using several X-ray crystal structures as templates (PDB
ID: 1QF6, 1EVL, and 4EO4)13-14, 29 with the threonyl substrate being manually docked such
that both its a–NH2 and b-OH were ligated to the Zn(II) center as suggested by the
experimental structures. Furthermore, our previous MD protocol was also used herein. First,
the generated complete enzyme-substrate (ThrRS…L-Thr-AMP/tRNAThr) complex was
minimized using the AMBER99 force field until the root mean square gradient fell below
0.05 kcal/mol Å-1. Using this structure, the bound substrate was then manually modified to
generate starting structures for the corresponding ThrRS…L-Ser-/Val-AMP/tRNAThr
complexes.
All three models were then solvated by adding a 2 Å layer of water (1361 water
molecules) to generate fully solvated complexes of approximately 10971 atoms. Each
resulting solvated complex was then minimized using the AMBER99 molecular mechanics
force field until the root mean square gradient fell below 0.01 kcal/mol Å-1. The minimized
41

Chapter 3
structures were then annealed over 100 ps from 150 to 300 K at constant pressure. This was
followed by a 10 ns MD production run with a time step of 2 fs under constant pressure and
temperature and without applying any restraints. In these simulations, the default settings
implemented in the MOE software were used, including a cutoff of 10 Å for non-bonded
interactions and tether ranges from 0-100 Å applied to the heavy atoms. For each simulation,
the conformations obtained were analyzed and clustered based on the root-mean-square
deviations (RMSD) of their active site heavy atoms and substrate. An average structure of
the most dominant conformation for each ThrRS…L-aa-AMP/tRNAThr (aa = Thr, Ser, Val)
complex was then selected for analysis and to generate suitable starting models for the
QM/MM studies (see below).
Table 3.1 Average values of key distances (Angstroms) and angles (degrees) obtained from
10 ns production MD simulations of the ThrRS…aa-AMP/tRNAThr complex (aa=L-Thr, LSer, L-Val).

Geometrical

Aminoacyl substrate

Parameter

Thr

Ser

Val

3'O…Nα (Å)

3.01

2.99

2.98
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NA

3'O-C-O (º) 84.0
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77.4
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…
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An alignment analysis was performed on the three average structures obtained. No
significant differences in their bound active sites was observed as indicated by the RMSD
value obtained of just 0.26 Å. Furthermore, the average values of mechanistically important
distances and angles of all three complexes are quite similar as seen in Table 3.1. For the
aminoacylation mechanism involving D-Thr, the active site-bound L-Thr-AMP was
manually changed to its D enantiomer to generate ThrRS…D-Thr-AMP/tRNAThr.

3.2.2. QM/MM Investigations:
All QM/MM calculations were performed within the ONIOM formalism30-31 as
implemented in the Gaussian 09 program.32 This approach has been successfully applied in
the field of computational enzymology to investigate the catalytic mechanisms of other
aminoacyl-tRNA synthetases33 and related enzymes.34
A suitable chemical model was obtained by minimizing the average structure obtained
from the corresponding MD simulation using the AMBER99 forcefield. The system was
truncated to include the aa-AMP substrate and all residues and waters within ~20 Å of the
substrate. Using a two-layer ONIOM(QM/MM) approach the entire chemical system was
divided into two subsystems based on their relevance to the catalytic mechanism. The highlayer (QM-region) consisted of the aa-AMP substrate, Zn(II) ion, the side-chains of the three
residues ligated to the Zn(II) ion (His385, His511 and Cys334), the side-chains of residues
directly hydrogen bonded with the aa-AMP moiety (Gln484, Gln381, Arg363, Asp383, and
Lys465), the Ado76 ribose of the tRNAThr, and two active site water molecules. It should be
noted that based on available X-ray crystal structures the Gln381, Arg363 and Lys465
residues are thought to help stabilize the negative charge on the substrate's carbonyl oxygen
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(Ocarb) and the non-bridging phosphate oxygens during the aminoacyl transfer reaction.13-14
In total, the QM region consisted of 129 atoms. The low layer (MM region) contained all
remaining residues and waters for a total number of 2283 atoms.
For the QM-region, the density functional theory method B3LYP35-36 was chosen as it has
been shown to perform the best of several common DFT functionals for studying Zn
metalloenzymes.37 This method was used in conjunction with the 6-31G(d,p) basis set, while
the AMBER96 force field was used to describe the MM-region. All QM/MM calculations
were performed within the mechanical embedding (ME) formalism. Frequency analyses
were also obtained at the same level of theory, i.e., ONIOM(B3LYP/6-31G(d,p):AMBER96)
in order to characterize the nature of the stationary points (i.e., minima or transition structure).
Relative energies were calculated by performing single point energy calculations on the
above optimized structures at the ONIOM(B3LYP/6-311+G(2df,p):AMBER96) level of
theory. To help ensure the integrity of the enzyme model was maintained, the α-carbon's of
all low-layer amino acid residues were held fixed at their initial optimized MM positions.
3.3 Results and Discussion
3.3.1 ThrRS…L-Thr/Ser-AMP/tRNAThr Michaelis Complexes:
The QM/MM optimized structures of the L-Thr and L-Ser containing pre-reactive
Michaelis complexes (PRC), with selected distances (Angstroms), are shown in Scheme 3.2.
As the two complexes share many similarities, only the ThrRS… L-Thr-AMP/tRNAThr PRC
(ThrPRC) is discussed unless otherwise indicated.
As part of an earlier QM-cluster based computational study on ThrRS we examined the
Michaelis complex and aminoacylation mechanism of ThrRS.21 It was concluded that in the
pre-reactive Michaelis complex, the threonyl moiety of the Thr-AMP substrate was
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bidentately ligated to the Zn(II) ion via both its neutral α-NH2 and side chain β-OH groups,
giving a pentacoordinate Zn(II) center. In the corresponding reactive complex (RC),
however, the substrate's threonyl moiety was only monodentately ligated to the Zn(II) via its
side chain β-hydroxy oxygen. Notably, in this slightly higher energy complex the threonyl
side chain hydroxyl was anionic having transferred its proton to the nearby side chain
carboxylate of the Asp383 residue. Furthermore, this reactive complex lay just 7.5 kJ mol-1
higher in energy than the preceding initial PRC.
In contrast, in this present study, which uses a considerably more extensive chemical
model in conjunction with a QM/MM-based method, two pre-reactive complexes are
obtained (Scheme 3.2). In the lower energy complex, aPRCThr, the threonyl moiety is singly
ligated to the Zn(II) ion via its neutral α-NH2 group with a Zn(II)…NThr bond length of 2.11
Å. Meanwhile, its β-OH group has shifted away from the Zn(II), as indicated by the large
Zn(II)…Oβ distance of 3.31 Å, and is now strongly hydrogen bonded to the nearby side
chain carboxylate of Asp383, r(Asp383COO–…HOβThr) = 1.58 Å. Consequently, the Zn(II) ion
is tetracoordinate in its ligation. In addition, in aPRCThr the side chain amide of the active
site Gln381 forms a weak hydrogen bond with the carbonyl oxygen (Ocarb) of the Thr-AMP
substrate, r(Gln381NH2…OCarb) = 2.34 Å. Meanwhile, the side chain guanidinium of Arg363
forms a moderately strong hydrogen bond of length 1.95 Å with a non-bridging phosphate
oxygen of the Thr-AMP moiety. The same non-bridging phosphate oxygen also strongly
hydrogen bonds with the protonated side chain amine of Lys465 via an active site water with
r(OH2…OP) and r(H2O…HNLys465) distances of 1.60 Å and 1.70 Å, respectively (Scheme
3.2)
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Scheme 3.2. Optimized structures, with selected bond lengths (Angstroms) shown, of the
fully-bound active sites of the pre-reactive and reactive ThrRS…aa-AMP/tRNAThr
complexes for when the aminoacyl moieties β-hydroxyl is (a) neutral (aPRCaa, aRCaa) or (b)
deprotonated (bPRCaa, bRCaa). (aa = Thr, R = CH3 (black); aa = Ser, R = H (blue)).
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It has been observed that many Zn(II) metalloenzymes have a basic residue adjacent, but
not ligated to the Zn.38 Often, the role of this residue is to aid the activation of an R-OH
group bound to the Zn(II) ion by accepting its proton. A recent analysis determined that the
β-OH groups of threonine and Serine do have acidic character.39 This can be enhanced by
the Lewis acidity of the Zn(II) ion which often induces a decrease in the pKa value of the
ligated R-OH group.40 ThrRS exhibits a similar feature with the positioning of the Asp383
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residue adjacent, but not ligated, to the Zn(II) ion (see Scheme 3.2.). As a result, an alternate
pre-reactive complex (bPRCThr; Scheme 3.2b) was obtained in which the substrate's
threonyl moiety is bidentately ligated to the Zn(II) via both its neutral α-NH2 group and its
β-hydroxy oxygen with bond lengths of 2.18 and 2.09 Å, respectively.
Importantly, the threonyl's α-hydroxy group has now transferred its proton to the side
chain carboxylate of Asp383 with which it forms a strong Asp383COOH…Ob hydrogen bond
of just 1.67 Å. Notably, bPRCThr, which contains a pentacoordinate Zn(II), lies only 14.0 kJ
mol-1 higher in energy than aPRCThr in which the Zn(II) is tetracoordinate. In addition, the
barrier for interconversion of aPRCThr to bPRCThr is just 21.3 kJ mol-1. This suggests the
possible occurrence of either bound-active site structure in vivo and highlights the flexible
coordination of Zn(II) with tetracoordinate being the most common.41
In bPRCThr significant differences are observed in the hydrogen bonding interactions of
Ocarb and the substrates phosphate with the key active site residues (see Scheme 3.2). In
particular, the Gln381NH2…Ocarb distance has shortened from 2.34 to 1.98 Å. Furthermore, the
guanidinium of Arg363 now forms quite short and strong hydrogen bonds with non-bridging
and bridging (Ob) phosphate oxygens of the substrate's AMP moiety with lengths of 1.83 and
1.89 Å, respectively. During aminoacylation of tRNAThr the Ob centre gains significant
negative charge due to the breaking of the Ob–Ccarb bond. It should also be noted that the side
chain amine of Lys465 is now more strongly hydrogen bonded via a water bridge with the
same non-bridging phosphate oxygen as Arg363 as indicated by r(OH2…OP) and
r(H2O…HNLys465) distances of 1.46 and 1.54 Å, respectively (Scheme 3.2).
We also examined the corresponding pre-reactive complexes (aPRCSer and bPRCSer) in
which the non-cognate substrate Ser-AMP was bound within the aminoacylation active site
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of ThrRS. Overall, the binding of Ser-AMP and the hydrogen bond network is similar to that
seen in the case of the cognate substrate Thr-AMP (Scheme 3.2). In addition, key substrateenzyme distances were also generally in close agreement with differences of 0.2 Å or less,
especially for bPRCSer (i.e., when the substrate being bidentately ligated to a pentacoordinate
Zn(II)). The only exceptions occur for aPRCSer (i.e., when the substrate is monodentately
ligated to a tetracoordinate Zn(II)) and in the

Gln381NH2

…Ocarb and Arg363…Ob hydrogen

bonds which decrease by 0.29 and 1.40 Å to 2.05 and 1.97 Å, respectively. Energetically,
the same trends are observed as for when Thr-AMP is bound; aPRCSer lies lower in energy
than bPRCSer by 9.3 kJ mol-1 and can interconvert via TS1Ser at a cost of just 18.0 kJ mol-1
(see below).
These results are also in good agreement with recent X-ray crystal structures that observed
very similar Zn…Nsubstrate and Zn…Osubstrate distances for threonine and serine bound in the
active site of ThrRS.16, 42 It also supports the suggestion that size-based discrimination by the
aminoacylation active site of ThrRS is insufficient to wholly discriminate between LSerAMP and L-ThrAMP.11
3.3.2 ThrRS…L-Thr/Ser-AMP/tRNAThr Reactive Complexes
In our previous QM-cluster based computational study on the aminoacylation mechanism
of ThrRS,21 the first step of the mechanism was determined to be cleavage of the labile
Zn(II)…NThr bond so that the resulting unligated neutral α-NH2 group can act as the required
base. Notably, the threonyl moiety remained ligated to the Zn(II) via its β-hydroxy oxygen.
Based on the above pre-reactive complexes obtained, two reactive complexes are possible
(aRCThr/Ser and bRCThr/Ser) and are shown Scheme 3.2. In general, structurally, the same
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features and trends are observed in a/bRCSer as for a/bRCThr. Thus, unless otherwise indicated
only those involving bound L-ThrAMP are discussed.
The complex aRCThr can be thought of as arising from aPRCThr by a substitution. More
specifically, the threonyl's side chain hydroxyl (Thrβ-OH) shifts and ligates to the Zn(II) with
concomitant breaking of the Zn(II)…NThr bond. Notably, the Thrβ-OH group remains neutral
(i.e., not deprotonated). Alternatively, it can be thought as arising from bPRCThr by breaking
of the Zn(II)…NThr bond with concomitant proton transfer from the side chain carboxylic
group of Asp383 onto the threonyl substrates Thrβ-oxygen center.
In aRCThr the Zn(II)…NThr distance has increased from 2.11 Å (aPRCThr) to 3.16 Å.
Importantly, the -NH2 group now forms a relatively short hydrogen bond of length 1.86 Å
with the A763'-OH group of the tRNAThr (Scheme 3.2). Concomitantly, the Thrβ-OH group is
ligated to the Zn(II) ion via its oxygen at a distance of 2.29 Å and retains its strong hydrogen
bond with the adjacent Asp383COO–, though it has lengthened slightly to 1.64 Å. Meanwhile,
the mechanistically relevant

A763'-O

…Ccarb distance, which corresponds to the bond to be

formed, is 3.14 Å. In general, the rest of the substrate-enzyme hydrogen bond network
remains little altered from aPRCThr (i.e., distances differ by ≤0.12 Å). The largest change
occurs for the

Gln381NH2

…Ocarb interaction which shortens by 0.51 Å to 1.83 Å. It is also

important to note that the tetratacoordinate Zn(II) complex aRCThr lies 35.3 kJ mol-1 higher
in energy than the tetracoordinate complex aPRCThr.
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C334
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3'OHA76

C334

bPRC

Zn(II)

aPRC
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aPRC

H385
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Figure 3.1. Overlay of the substrates in the optimized structures of the bound Thr-AMP
substrates in the a) pre-reactive complexes and b) reactive complexes when the

Thr

β-

hydroxyl is either neutral (tube) or deprotonated (ball and stick) when ligated to the Zn(II)
ion.

The alternate reactive complex bRCThr also contains a tetracoordinate Zn(II) center and
lies 7.7 kJ mol-1 lower in energy than aRCThr. It can be considered as being formed from
b

PRCThr by simple cleavage of the Zn(II)…NThr bond. Indeed, the latter has lengthened from

2.18 Å (bPRCThr) to 3.17 Å with the α-NH2 group again making a strong hydrogen bond
with the Ado763'-OH moiety, though now with a shorter length of 1.78 Å (Scheme 3.2).
Meanwhile, the A763'-O…Ccarb and Thrb-O…Zn(II) distances in bRCThr are 2.77 and 1.96
Å, respectively. Notably, these latter distances are both markedly shorter than observed in
a

RCThr. The latter shorter bond reflects the fact that the

b

Thr

β-oxygen remains anionic in

RCThr, and forms only a moderately strong hydrogen bond (2.05 Å) with the neutral side

chain carboxylic of Asp383 (Scheme 3.2). Overall, the substrate-enzyme hydrogen bond
network involving Gln381, Arg363, and Lys465 is similar to that observed in aRCThr with
distances in agreement within 0.1 Å. An exception, however, occurs with the guanidinium
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of Arg363 which is now more strongly hydrogen bonded to the substrates Ob center at a
distance of just 1.92 Å compared to 3.34 Å in aRCThr.
The key cause of these differences in structure, and energy, is the protonation state of the
Thrβ-OH

group when ligated to the Zn(II) ion. The above observations suggest that when it

is deprotonated the threonyl moiety is positioned closer to the Ado76 residue of the cognate
tRNAThr. Meanwhile, the substrates phosphate Ob center is shifted towards the side chain of
Arg363. These differences in position of the substrate between the two reactive complexes
is illustrated in Figure 3.1. As can be seen, the comparatively modest differences between
a

RCThr and bRCThr in the position of the substrate's threonyl in the vicinity of the Zn(II) ion

induce larger shifts in the position of its Ccarb and Ob centers. Importantly, the ∠A763'O…Ccarb–
–

Ocarb angle in bRCThr and aRCThr is 85.5° and 58.9°, respectively. This further suggests that

the A763'O center in bRCThr is better positioned for its subsequent nucleophilic attack at Ccarb
than in aRCThr. The same trends are observed for the corresponding L-SerAMP-bound
complexes. The only difference occurs for the

Ado763'-O

…Ccarb distance, where it is

negligibly shorter in aRCSer than bRCSer by 0.02 Å.

3.3.3 Aminoacylation (Threonylation) Mechanism.
To further understand the effects of the structural and energetic differences of aRCThr and
b

RCThr, we examined the aminoacylation (threonylation) mechanism as catalyzed by ThrRS

beginning from both reactive complexes. The resulting potential energy surfaces are shown
in Figure 3.2. while the corresponding optimized structures, with selected bond lengths, are
shown in Scheme 3.3.
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Relative Energy kJ mol-1
150.9
aTSThr

123.9
108.9

aPCThr

bTSThr

35.3
aRCThr

27.6
21.3

bRCThr

TS1Thr
14.0

0.0

bPRCThr

aPRCThr

-9.8
bPCThr

Reaction Coordinate

Figure 3.2. The calculated PES surfaces for aminoacylation (threonylation) as catalyzed by
ThrRS when the threonyl moieties β-hydroxyl group ligated to the Zn(II) is neutral (blue) or
deprotonated (black) throughout the mechanism.
In ThrRS catalyzed aminoacyl transfer the substrates α-NH2 accepts a proton from the
A763'-OH

group. In addition, the

center to form the required

A763'-oxygen

A763'O—Ccarb

nucleophilically attacks the substrates Ccarb

bond, while the scissile PO—Ccarb bond must be

broken. In agreement with our previous QM-cluster based computational study21,
threonylation occurs via a concerted mechanism regardless of whether it start from aRCThr
or bRCThr.
The threonylation mechanism involving the reactive complex aRCThr (i.e., the threonyl
substrates b-OH remains neutral; pathway A), the reaction proceeds via aTSThr at a cost of
115.6 kJ mol-1 with respect to aRCThr, or 150.9 kJ mol-1 relative to aPRCThr (Figure 3.2).
The corresponding product complex aPCThr lies 88.6 kJ mol-1 higher in energy than aRCThr,
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or 123.9 kJ mol-1 higher in energy than aPRCThr. That is, threonylation is markedly
endothermic.
Scheme 3.3. Optimized structures, with selected bond lengths in Angstroms (Thr (black);
Ser (blue)), of the transition structures (TSaa) and product complexes (PCaa) for threonylation
of the cognate tRNAThr as catalyzed by ThrRS. (aa=Thr, R=-CH3; aa=Ser, R=H)
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In contrast, when threonylation follows from the alternate reactive complex bRCThr (i.e.,
the substrates b-hydroxy remains deprotonated pathway B), the reaction proceeds via
b

TSThr at a markedly lower cost of 81.3 kJ mol-1 or 108.9 kJ mol-1 relative to bRCThr or

b

PRCThr, respectively. Furthermore, the corresponding product complex bPCThr lies 37.4 kJ
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mol-1 lower in energy than bRCThr, and 9.8 kJ mol-1 lower in energy than aPRCThr. That is,
threonylation via pathway B is exothermic.
In both pathways, the hydrogen bond networks between the leaving AMP moiety and
active site residues are essentially the same and with similar interaction distances. Namely,
the side chains of Arg363 and Lys465, the latter indirectly via a water, stabilize the negative
charge of the phosphate as well as the increasing negative charge on its bridging oxygen Ob
(Scheme 3.3). The key differences between the pathways instead involve the ligands and
coordination of the Zn(II) center.
For pathway A, as can be seen in Scheme 3.3, in the transition structure aTSThr an active
site water has ligated to the Zn(II) center with a Zn(II)…OH2 distance of 2.33 Å.
Simultaneously, this water hydrogen bonds with both the side chain carboxylate of Asp383
and the substrates carbonyl oxygen Ocarb with distances of 2.12 and 1.72 Å, respectively. It
is noted that Ocarb also retains its hydrogen bond with the side chain amide of Gln381;
r(Ocarb…H2NGln381) = 1.96 Å. In the resulting product complex aPCThr the water remains
bound to the Zn(II) center, though now at a slightly longer distance of 2.58 Å. This is likely
due in part to the fact that the b-OH group remains both neutral throughout the mechanism
and hydrogen bonded to the side chain carboxylate of Asp383 in both aTSThr (2.29 Å) and
a

PCThr (2.29 Å). Consequently, the cationic Zn(II) center becomes and remains

pentacoordinate.
In contrast, in the alternate pathway B in which the substrates b-hydroxy group is
deprotonated, the Zn(II) ion remains tetracoordinate throughout. More specifically, as seen
in Scheme 3.3, in bTSThr an active site water forms a strong hydrogen bond bridge between
the b-O and Ocarb centers with distances of 1.66 and 1.94 Å, respectively, Scheme 3.3. The
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Ocarb center again retains its hydrogen bond to the amide of Gln381 with length
r(Ocarb…H2NGln381) = 1.92 Å. These shorter hydrogen bonding interactions compared to
those observed in aTSThr suggest that in bTSThr there is greater stabilization of the negative
charge buildup on Ocarb that occurs during aminoacyl transfer. It should also be noted that
despite maintaining a hydrogen bond with the neutral side chain carboxylate of Asp383
throughout the mechanism,
b

Thrβ-O

also remains strongly ligated to the Zn(II) ion in both

TSThr and bPCThr with distances of 2.02 and 2.00 Å, respectively (Scheme 3.3). The lower

energies of bTSThr and bPCThr compared to aTSThr and aPCThr is due to several factors
including that for pathway B the Zn(II) ion is tetracoordinate and forms a neutral complex,
being ligated to two histidyl's and a cysteinyl thiolate residue as well as the Thrb-O– centre. It
has been previously noted that neutral charged Zn complexes are more stable than
corresponding complexes with either positive or negative charges.43
tRNA

Zn(II)

a)

bPRCSer

tRNA

tRNA

bPRCThr

bPRCThr

bPRCThr

Zn(II)

Zn(II)
PRCVal

b)

bPRCDThr

c)

Figure 3.3. Overlay of the substrates in the optimized structures of the bound Thr-AMP
substrate (bPRCThr) and the studied substrates a) bPRCSer, b) PRCVal and c) PRCDThr.

3.3.4 Aminoacylation (Serinylation) Mechanism.
Aminoacylation using the non-cognate but viable substrate SerAMP exhibited, in general,
similar trends to that observed for ThrAMP (Figure 3.4). However, some key differences in
the structures and mechanisms were seen (see also Scheme 3.2).
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For instance, aminoacyl transfer in which the serinyl's Serβ-hydroxyl group ligated to the
Zn(II) is deprotonated (i.e., pathway B) occurs with a significantly lower barrier than the
alternate mechanism for when it is neutral (pathway A; Scheme 3.2). More specifically,
a

PRCSer can readily interconvert with bPRCSer via TS1Ser with a barrier of just 18.0 kJ mol-

1

. This step is simply proton transfer from the

SerβOH

group to Asp383. The pre-reactive

complex bPRCSer can then readily form bRCSer by breaking of the labile Zn(II)…NH2
substrate bond. Notably, bRCSer lies lower in energy than aPRCSer by 14.5 kJ mol-1. The
subsequent aminoacyl transfer occurs via bTSSer with a barrier of 128.9 kJ mol-1 with respect
to bRCSer (or 114.4 kJ mol-1 relative to aPRCSer). The final product complex lies slightly
higher in energy than aPRCSer by 7.2 kJ mol-1. Thus, the overall serinylation mechanism is
slightly endothermic.

Relative Energy kJ mol-1

153.5
aTSSer

114.4
bTSSer

18.0
TS1Ser
0.0
aPRCSer

16.0
9.3

aRCSer

bPRCSer

7.2
bPCSer

-14.5
bRCSer

Reaction Coordinate

Figure 3.4. The calculated PES surfaces for aminoacylation (serinylation) as catalyzed by
ThrRS for when the serinyl moieties b-hydroxyl group ligated to the Zn(II) is neutral (blue)
or deprotonated (black) throughout the mechanism.
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The alternate mechanism in which the Serb-OH group remains neutral while ligated to the
Zn(II) ion (pathway A), proceeds via aTSSer with a significantly higher barrier of 153.5 kJ
mol-1 relative to aPRCSer (Figure 3.4). Unlike that observed for threonylation, both possible
serinylation pathways give the same final product complex bPCSer.
That is, the product obtained is that in which the serinyl's β-hydroxy is deprotonated while
ligated to the Zn(II) ion (Scheme 3.2). Thus, unlike that observed for ThrAMP, serinylation
via either potential pathway is endothermic and hence disfavored. It is noted that the barriers
for serinylation via aTSSer (153.5 kJ mol-1) and bTSSer (128.9 kJ mol-1) both lie higher in the
relative energy than those for the analogous pathways for Thr-AMP which had barriers of
150.9 kJ mol-1 (aTSThr) and 108.9 kJ mol-1 (bTSThr), respectively (Figure 3.2).
Experimentally, both cognate Thr-AMP and non-cognate Ser-AMP are observed to be viable
substrates for aminoacylation by ThrRS, with Thr-AMP preferred.13-14, 23 The present results
suggest that in both cases aminoacylation proceeds via pathway B in which the substrates
b-hydroxy group is deprotontated when ligated to the Zn(II) center.

3.3.5 Discrimination against Val.
As noted in the Introduction, ThrRS must necessarily also discriminate against valine
due to its similar shape and volume to threonine. However, unlike threonine, and serine, it
lacks a side chain b-OH to interact with the Zn(II) ion. In addition, it does not undergo
ThrRS catalyzed aminoacylation.13 However, in order to obtain a more complete
understanding of discrimination by ThrRS we also examined binding of Val-AMP within the
active site of ThrRS and the subsequent possible mechanisms of aminoacylation. Optimized
structures obtained for the pre-reactive, reactive, transition structure and product complexes
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are shown in Scheme 3.4 along with select bond distances (Angstroms) and relative energies
(kJ/mol).
Two possible pre-reactive complexes, aPRCVal and bPRCVal, were obtained (Scheme
3.4). In both, the valinyl moiety of the substrate is bound to the Zn(II) ion by only its neutral
α-amine group. In the lower energy pre-reactive complex aPRCVal, the Zn(II)…NVal distance
is 2.19 Å. More importantly, the Zn(II) is tetracoordinate as it is also still ligated to the
enzyme via a cysteinyl thiolate and two histidyl imidazoles. In addition, the active site water
which is ligated to the Zn(II) in the apoenzyme but presumably displaced upon substrate
binding,13 forms a hydrogen bond bridge between the carboxylate of Asp383 and the
substrates carbonyl oxygen with Asp383COO–…H2O and Ocarb…H2O distances of 1.66 Å and
2.19 Å, respectively. Meanwhile, the Zn(II)…OH2 distance is 3.69 Å.
The alternate pre-reactive complex bPRCVal lies markedly higher in energy by 63.5 kJ
mol-1. Notably, the active site water is now also ligated to the Zn(II) ion with a distance of
2.19 Å and as a consequence the Zn(II) ion is pentacoordinate, Scheme 3.4. The most
significant difference in the substrate–enzyme hydrogen bonding network between the two
pre-reactive complexes involves the substrates Ob center. In aPRCVal it is hydrogen bonded
to the guanidinium of Arg363, whereas in bPRCVal the latter instead hydrogen bonds to one
of the substrate's phosphate oxygens, r(Arg363NH2…Opro-R) = 2.32 Å. It should also be noted
that unlike the orientation of the substrate in the corresponding ThrAMP analogue, bPRCThr,
the position of the substrate’s Ob center in bPRCVal is also 1.24 Å further away from the
Arg363’s guanidinium group with r(Arg363NH2…Ob) = 3.13 Å. This difference is also seen in
an overlay of the active site-bound substrate structures of bPRCVal and bPRCThr (Figure 3.3).
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We then examined possible mechanisms by which aminoacylation may proceed from
either pre-reactive complex (i.e., beginning from a tetra- or pentacoordinate Zn(II) complex).
However, a pathway could only be elucidated for the latter with a water ligated to the Zn(II)
throughout. In the reactive complex (RCV), which lies 80.1 kJ mol-1 higher in energy than
a

PRCVal, the Zn(II)…NVal bond has broken. As for the other reactive complexes considered

herein the nitrogen of the valinyl's α-NH2 now forms a strong hydrogen bond with the A763'OH group of the tRNAThr with a distance of 1.76 Å. Concomitantly, the r(Ado763'-O…Ccarb)
distance has shortened to 2.82 Å, which is 0.05 Å longer than observed in bRCThr (cf.
Scheme 3.2).
The Zn(II) center is now tetracoordinate and the ligated water has been deprotonated,
transferring one of its protons onto the carboxylate of Asp383. Consequently, the Zn…Owater
distance has shortened markedly to 1.94 Å (Scheme 3.4). Aminoacyl transfer then occurs
via TS2Val with an energy barrier of 161.2 kJ mol-1 relative to aPRCVal. This barrier is the
highest of all aminoacylation pathways elucidated in this study and is not enzymatically
feasible. The product complex PCVal, in which the valinyl moiety had been transferred onto
the

A763'-oxygen,

lies 91.6 kJ mol-1 higher in energy than aPRCVal indicating that overall

mechanism is also thermodynamically highly unfavorable.
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Scheme 3.4. Optimized structures, with selected bond lengths (Angstroms) and relative
energies (in parentheses; kJ mol-1) shown, of the pre-reactive and reactive complexes of
ThrRS…Val-AMP/tRNAThr, and the transition structure and product complex for
aminoacylation.
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3.3.6 Chiral Discrimination against D-Threonine
It has been stated that for correct protein folding it is imperative that their constituent
amino acids be homochiral.44 Indeed, amino acids in proteins occur in their L-isomer form.
It is known that D-amino acid deacylases (DTD), which show similarities to the editing site
of ThrRS, edit D-aminoacylated-tRNA formed by aaRS.45-46 However, ThrRS may also help
enforce the homochirality of the aminoacylation process by discriminating, at least partially,
between D- and L-threonine. Indeed, for AspRS and HisRS differences in the enzymesubstrate recognition network between the non-cognate D- and cognate L-substrates in their
aminoacylation sites has been suggested as the main reason for their discrimination and
60

Chapter 3
hence, stereospecificity of the aminoacylation process.47-48 Hence, the ability of the
aminoacylation site of ThrRS to discriminate against the non-cognate enantiomer Dthreonine was investigated. Key optimized structures obtained along the aminoacylation
pathway, with selected bond lengths (Angstroms) and relative energies (kJ mol-1), are shown
in Scheme 3.5.
As observed for its corresponding enantiomeric cognate substrate L-Thr-AMP, two
different pre-reactive complexes were obtained, aPRCDThr and bPRCDThr. In the former
complex the substrates threonyl moiety is ligated to the Zn(II) center via only its α-amine
nitrogen with a distance of 2.14 Å (Scheme 3.5). The Zn(II)…(H)O-βDThr distance is
considerably longer at 2.92 Å, though this is 0.39 Å shorter than observed in aPRCThr. In
contrast, in bPRCDThr, which lies 33.0 kJ mol-1 higher in energy, the substrates threonyl
component is ligated to the Zn(II) center via both its side-chain b-oxygen and α-amine
nitrogen with distances of 2.09 and 2.34 Å, respectively. The latter Zn(II)…NDThr interaction
is 0.16 Å longer than observed in the analogous complex bPRCThr. It is important to note
that all other Zn(II)…Nsubstrate and Zn(II)…O-bsubstrate interaction distances obtained in the
stationary points along the D-threonylation pathway are within 0.05 Å of those obtained for
their corresponding L-Threonyl containing complexes (cf. Scheme 3.2 and Scheme 3.3).
Furthermore, and as also observed in bPRCThr (see Scheme 3.2), the threonyl's b-hydroxy
group has transferred its proton to the carboxylate of Asp383. But, in contrast to that seen in
b

PRCThr, the side chain guanidinium of Arg363 does not form a hydrogen bond with the

mechanistically key bridging phosphate oxygen Ob as indicated by their separation of
r(Ob…H2NArg363) = 3.25 Å. Instead, as in aPRCDThr it remains hydrogen bonded to one of
the substrate's non-bridging phosphate oxygens and carbonyl oxygens with distances of 2.23
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and 1.78 Å, respectively. Comparison of the bPRCThr and bPRCDThr complexes (Figure 3.3)
suggests that the shift in position of the latter's Ob center relative to a terminal amine of the
adjacent Arg363 is one of the main differences between these two complexes.
In contrast to that observed for threonylation using L-Thr-AMP (cf. Figure 3.2), the
corresponding reactive complex RCDThr lies 6.0 kJ mol-1 lower in energy than the preceding
b

PRCDThr. However, despite this, its energy relative to aPRCDThr (27.0 kJ mol-1) is in close

agreement with that obtained when L-Thr-AMP is the substrate (Figure 3.2; 27.6 kJ mol-1).
Structurally, as observed in the reactive complex for L-Thr-AMP, the Zn(II)…NDThr bond in
RCDThr has cleaved as indicated by its distance of 3.39 Å. Again, the nitrogen of the α-NH2
group now forms a relatively short hydrogen bond to the Ado76-3'OH group of the tRNAThr
with a length of 1.86 Å. Meanwhile, the mechanistically relevant Ado763'O…Ccarb distance is
now 2.73 Å, which is 0.04 Å shorter than observed in bRCThr (Scheme 3.2) It is also notable
that the Ocarb center also now forms strong hydrogen bonds with the nearby Gln381,
r(Ocarb…H2NQ381)= 1.91 Å, and Arg363, r(carbO…H2NR363= 1.79 Å). However, the Ob center
still has not formed a hydrogen bond with Arg363, the shortest bO… HNR363 distance being
3.14 Å (Scheme 3.5).
Aminoacylation of the tRNA then proceeds via TSDThr at a cost of 116.9 kJ mol-1 relative
to aPRCDThr. This is 8.0 kJ mol-1 higher in energy than obtained for the analogous
mechanism involving L-Thr-AMP (cf. Figure 2). This may in part be due to the lack of charge
stabilization on the Ob center via hydrogen bonds with any enzyme residues, in particular
Arg363 as observed in bTSThr (cf. Scheme 3.5). It is also noted that the increasing negative
charge on the Ocarb center is stabilized by hydrogen bonds with the side chains of Gln385 and
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Arg363 with r(Ocarb…HNQ363) and r(Ocarb…HNArg363) distances of 2.0 Å and 1.69 Å,
respectively (Scheme 3.5).

Scheme 3.5. Optimized structures, with select bond lengths (Angstroms) and relative free
energy (values in brackets) shown, of the fully-bound active sites of the pre-reactive (PRC),
reactive (RC), transition structure (TS), and product (PC) complexes for aminoacylation by
D-threonine as potentially catalyzed by ThrRS.
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In the final product complex PCDThr the A763'-O–Ccarb bond has formed with a length of
1.36 Å. Aminoacylation is accompanied by concomitant release of the substrates adenosine
monophosphate moiety. However, the Ccarb…Ob bond in PCDThr has only elongated to 1.53
Å whereas in the analogous L-threonyl containing complex bPCThr the Ccarb…Ob distance is
2.98 Å. This likely reflects a lack of stabilization of the negative charge on the AMP’s Ob
center in bPCDThr by hydrogen bonding with the guanidinium of Arg363, unlike that
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observed in bPCThr. In addition, distinct from that observed in all other product complexes
examined herein, the AMP's Opro-s center remains unprotonated. In other words, the side
chain protonated amine of Lys465 and active site water have not transferred a proton onto
the Opro-S center in bPCDThr though it does retain a quite strong hydrogen bond with the
bridging water, r(Opro-S…HH2O) = 1.49 Å. Importantly, PCDThr lies significantly higher in
energy relative to aPRCDThr by 100.9 kJ mol-1, indicating that aminoacylation involving DThr-AMP is highly unfavorable (Scheme 3.5) Furthermore, the reverse reaction has a barrier
to reaction of just 16 kJ mol-1 suggesting that it is likely to occur quite readily for any product
formed.
3.4 Conclusion
The roles of the active site Zn(II) and residues in the aminoacylation mechanism catalyzed
by threonyl-tRNA Synthetase (ThrRS) has been computationally investigated. Specifically,
their role in ThrRS's ability to discriminate between its cognate substrate L-threonine and
non-cognate L-serine, L-valine, and D-threonine has been examined using molecular
dynamics (MD) and ONIOM QM/MM methods.
For both L-Thr- and L-Ser-AMP two pre-reactive complexes (PRC) were obtained. In
the lower energy complex (aPRCThr/Ser) the ligand binds to the Zn(II) only via its aminoacyl
a-NH2 nitrogen; i.e., the Zn(II) is tetracoordinate. In the alternate PRC complexes lying
higher in energy by 14.0 (bPRCThr) and 9.3 (bPRCSer) kJ mol-1, the aminoacyl is bidentately
ligated to the Zn(II) via its a-NH2 nitrogen and b-hydroxyl oxygen; i.e., the Zn is
pentacoordinate.
Similarly, for both L-Thr- and L-Ser-AMP two possible reactive complexes (RC), in
which the Zn(II)…N-asubstrate bond has been broken, were obtained. In the higher energy
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complexes, aRCThr/Ser, the Zn(II)-ligated b-OH group of the substrate's aminoacyl moiety
remains neutral. In contrast, in the lower energy reactive complexes bRCThr/Ser the
aminoacyl's Zn(II)-ligated b-hydroxyl has transferred its proton to the nearby carboxylate of
Asp383. This transfer and the substrate's b-OH group acidity is facilitated by the Lewis
acidity of the Zn(II) and the presence of the Asp383 residue. Consequently, in bRCThr/Ser a
neutral tetracoordinate Zn(II)-ligand complex is formed. Deprotonation of the b-hydroxyl
results in shorter Zn…-O-bsubstrate bond which in turn helps better position the substrate
relative to the tRNAaa and important active site residues for the subsequent aminoacyl
transfer. Notably, the substrates a-NH2 forms shorter hydrogen bonds with the

A763'-OH

moiety and, in general, the mechanistically central A763'-O…Ccarb distance is greatly reduced
in bRCThr/Ser compared to aRCThr/Ser. The substrate's non-bridging phosphate oxygen Ob
forms shorter, stronger hydrogen bonds with Arg363. The subsequent ThrRS catalyzed
aminoacyl transfer occurs in one step with barriers of 108.9 and 128.9 kJ mol-1 for L-Thrand L-Ser-AMP, respectively. From both kinetic and thermodynamic perspectives,
aminoacylation of threonine is preferred. When the substrates Zn(II)-ligated b-hydroxyl
group remains neutral, aminoacylation occurs with significantly higher barriers of 150.9 and
153.5 kJ mol-1 for L-Thr- and L-Ser-AMP, respectively. In addition, in their respective
transition structures and product complexes the Zn(II) ion is pentacoordinate as they also
bind an active site water and thus, is also not charge balanced by its ligands. Also, the
increasing negative charge on Ob during the reaction is not stabilized by hydrogen bonding
with Arg363.
L-Val-AMP, lacking a b-hydroxyl, is unable to form a Zn…O-b bond and thus help form

a neutral Zn(II) complex and facilitate cleavage of the Zn…N-a bond. Furthermore, it also
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does not form a stabilizing Ob…H2NArg363 hydrogen bond. Hence, aminoacylation by Lvaline is kinetically and thermodynamically disfavoured.
The enantiomeric D-Thr-AMP interacts with the Zn(II) center throughout the
aminoacylation process in a manner similar to that observed for L-Thr-AMP. However,
unlike L-Thr-AMP, its key non-bridging phosphate Ob center does not form and thus is not
stabilized by a hydrogen bond with Arg363. Hence, the barrier for aminoacylation (116.9 kJ
mol-1) is higher than that of its cognate L-enantiomer. Furthermore, the final product complex
is 100.9 kJ mol-1 higher in energy than the initial complex aPRCDThr and hence is not
thermodynamically favoured. This may indicate a possible role for the aminoacylation site
of ThrRS in chiral discrimination. The present results illustrate how enzymes are able to
modify the properties of their substrates and in doing so, can cause subtle but critical
positional shifts in the bound substrate that facilitate the reaction. Furthermore, it also shows
how this can be exploited by enzymes to discriminate against potential non-cognate
substrates including chiral enantiomers. The present results also provide insights for possible
future experimental studies including mutation of identified key active site residues such as
Arg363, Asp383, and Gln381.
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Chapter 4.
A Water-Mediated and SubstrateAssisted Aminoacylation Mechanism in
the Discriminating Aminoacyl-tRNA
Synthetase GlnRS and NonDiscriminating GluRS

Chapter 4
4.1 Introduction
Aminoacyl-tRNA synthetases (aaRSs) are essential enzymes with extensive roles in a
wide range of biological functions; however, protein biosynthesis remains their central
purpose.1-3 AaRSs are a family of enzymes that are well known to ligate an amino acid to
its corresponding tRNA with exceptional specificity.4 Many encoded amino acids are
structurally or chemically quite similar and consequently it can be challenging to
discriminate between them.5 Thus, to avoid any deleterious mistranslation errors, these
enzymes possess different editing functions and almost half of them incorporate a separate
proofreading domain.4, 6-7
Glutaminyl-tRNA synthetase, GlnRS, is a class I aaRS which specifically attaches
glutamine to the cognate tRNAGln yielding Gln-tRNAGln. It is able to discriminate against
the isosteric non-cognate amino acid glutamate by 107-fold.8 This high accuracy is achieved
without any free-standing editing domain.9 It has been suggested that unlike the noncognate
glutamate, glutamine adopts a catalytically favourable binding mode in the active site of
GlnRS; an arginine residue acts as a negative selectivity determinant and positions
glutamate in a less productive orientation.10
Although it is commonly thought that translation requires remarkable fidelity, it has
recently been proposed that inaccuracies in the process should be considered a “doubleedged sword”.11 Particularly, many aaRSs are found to tolerate moderate levels of
mistranslations,12 and these can be better described as adaptive translation.13 Only
eukaryote and some bacteria species have the aaRSs for all twenty canonical amino acids,
and accordingly tRNA-dependent indirect (noncanonical) pathways are needed for the
biosynthesis of different amino acids in the remaining species.14 The aaRSs involved in
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these pathways, in addition to identifying their cognate tRNAs, can also accommodate noncognate tRNA for which the corresponding aaRS is missing.
For example, most prokaryotic species lack GlnRS. Instead, they use an alternative
indirect route that involves a distinct type of non-discriminating (ND) GluRS enzyme, NDGluRS, to achieve glutamine aminoacylation.15-16 Specifically, the ND-GluRS covalently
links glutamate to the noncanonical tRNAGln to yield the misacylated Glu-tRNAGln. A
similar situation exists for the aminoacylation of tRNAAsn with aspartate, which is also
catalysed by a non-discriminating enzyme, ND-AspRS.17 These mischarged tRNAs (GlutRNAGln and Asp-tRNAAsn) are subsequently converted to Gln-tRNAGln and AsntRNAAsn by Glu-tRNAGln and Asp-tRNAAsn amidotransferase, respectively.18
The main difference between discriminating and non-discriminating GluRS is the
presence of an arginine residue in the latter; its mutation to glutamine results in a NDGluRS.19 Aside from this structural difference, both GlnRS and ND-GluRS can recognize
tRNAGln and participate in glutamine aminoacylation through direct and indirect routes.20
AaRS-catalysed aminoacylation mechanism involving glutamine occurs within the
aminoacylation site through two main steps, namely activation and acylation.21 Specifically,
the glutamine amino acid is first reacted with ATP through an inline displacement
mechanism to yield glutaminyl-AMP;22-23 in this form, the glutamine moiety is favourably
oriented for the subsequent acylation. This is initiated when a base abstracts the proton
from the Ado762′-OH group of the tRNA sugar terminal which attacks the carbonyl (Ccarb) of
the substrate, producing the glutaminylated-tRNAGln (Gln-tRNAGln), Scheme 4.1.24 It is
generally accepted that the catalytic domain of aaRSs lack a mechanistic base residue and,
accordingly, a general substrate-assisted catalytic mechanism is believed to operate.24-25 In
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particular, the aminoacylation mechanism of GlnRS has been proposed to exploit the same
general mechanism as in HisRS, TrpRS, MetRS and PheRS: one of the non-bridged
phosphate oxygens (O1p or O2p) of the glutaminyl-AMP acts as the requisite base.26-28

Scheme 4.1. The general substrate-assisted acylation mechanism in Gln-/GluRS, (X=NH2
or O), two different non-bridged oxygens (O1p and O2p) in addition to the bridged oxygen
(Ob) are available to participate.

In the case of HisRS, experimental substitution of one of the substrate's non-bridging
oxygens for sulphur diminished the rate of reaction 10000-fold which is strongly indicative
of the involvement of these oxygens in this substrate-assisted mechanism.24 More recently
our group performed a DFT-cluster study on the aminoacylation mechanism in HisRS.29 In
particular the potential for each of the substrate's phosphate oxygens to act as the catalytic
base was examined, i.e. the bridging (Ob) or non-bridging oxygens (pro-R and pro-S).
Importantly, the pro-S non-bridging oxygen was found to be the most favourable base and
lead to the only feasible activation energy.
In the case of GlnRS the catalytic mechanism is contested, being suggested to be
promoted either by the nearby Glu34 active site residue or one of the phosphate oxygens.27,
30-31

According to an early crystallographic study, Glu34 may be able to act as the required

mechanistic base, via a bridging water molecule, that deprotonates the tRNA's

Ado762′-OH

group;30 the authors disputed the previously proposed mechanism where one of the
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phosphate oxygens is the base. Furthermore, the pKa of the phosphate oxygens were
calculated to be 1.5-2.0, which suggests an inability to abstract a proton. However, more
recent mutagenesis analysis countered this hypothesis and emphasized that Glu34 plays no
role in initiating the acylation mechanism. When Glu34 was replaced by glutamine the rate
of reaction was decreased by a factor of 103-104 fold, but not completely inhibited.26 This
significant impact on the reaction rate was found to be a result of a structural change in the
conformation of the active site binding pocket upon mutation. This argument was supported
by the observation that this glutamate residue is not conserved among the other aaRS, even
in the structurally similar GluRS.26 In addition, they found that the pKa of phosphate group
rises during the reaction, meaning the basicity of the oxygen atoms is enhanced.
Our group has a long-standing interest in the mechanisms operating in aaRS
enzymes;29, 32 the principal aim of this study is to provide atomistic details regarding the
direct and indirect pathways towards the formation of Gln-tRNAGln. We have sought to
clarify the impact of the Glu34 residue within the synthetic site of GlnRS and to identify
the base in the mechanism. To further validate these findings, we have expanded our
investigation to the non-discriminating enzyme, ND-GluRS. Our results clarify the
suggested substrate-assisted scenario for this aminoacylation mechanism, which may be
common to other class I aaRSs.
4.2 Computational Methods

4.2.1. Molecular Dynamic Simulation
Suitable experimental X-ray crystal structures for GlnRS (PDB ID: 1EUQ33) and NDGluRS (PDB ID: 3AKZ34) with substrate analogues bound were used as templates for the
chemical models. Using the Molecular Operating Environment (MOE) software35 we
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prepared the two X-ray structures for Molecular Dynamics (MD) simulations. This
preparation included mutation of the substrates to the native forms, addition of missing
hydrogen atoms considering protonation states as predicted by MOE, and solvation by
adding a 2 Å layer of water. This generated solvated GlnRS…Gln-AMP/tRNAGln and NDGluRS…Glu-AMP/tRNAGln complexes, with total atom counts of 22158 and 20906
respectively. Also, the Glu34Gln mutant of GlnRS, an isostructural mutation designed to
investigate the structural role of Glu34 in the active site, was generated in silico. A recent
experimental site-directed mutagenesis study on the Glu34Gln mutant was observed to
have comparable overall kinetics to the wild-type enzyme.26
Finally, unconstrained molecular mechanics (MM) minimizations using the AMBER12
force field until the root mean square gradient fell below 0.01 kcal/mol·Å were performed
on all the studied systems. It should be noted that both GlnRS and ND-GluRS enzymes are
considered ribonucleoprotein enzymes where the tRNA is essential for the catalytic
mechanism to proceed properly.36 Thus all the MD simulations have been performed with
the tRNA bound. The minimized structures were then submitted for 100 ps annealing
equilibration from 150 to 300 K at constant pressure. The resultant structures were set up
for a 10 ns simulation run with a time step of 2 fs as per the default settings of the MOE
software. These settings include a cutoff at 10 Å for non-bonded interactions and tether
ranges from 0–100 Å applied to the heavy atoms. All MD simulations were performed
using the NAMD program.37 All sampled conformations in each MD simulation were
analysed and clustered based on their root mean square deviations (RMSD) relative to the
first structure. Notably, the equilibrium state was achieved after the first 5 ns where the
system reached a stable conformation state. A representative structure of the most
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prominent conformation was then truncated to include all atoms within 20 Å of the
substrate to generate the chemical model for the following QM/MM calculation.

4.2.2 QM-Cluster and QM/MM calculation
The Gaussian09 program package was used for all QM and ONIOM(QM/MM)
calculations.38 In order to compare between the two different possible mechanisms, we
started our investigation by performing QM-cluster-based calculations. This approach has
been successfully used to examine many catalytic mechanisms.39 The chemical cluster
models used herein for GlnRS and ND-GluRS, included the Gln-/Glu-AMP substrates and
the 3′-terminal adenosine (Ado76) nucleotide of the tRNA moiety (Figure 4.1). In addition,
they also included all residues that may participate in initiating the mechanism, stabilizing
the transition state (TS), and/or neutralizing the phosphate-leaving group. The rest of the
protein has been omitted after capping the carbon atoms.

Figure 4.1. Schematic drawing of the QM models used for the QM-cluster and the QMregion within the QM/MM models for (a) GlnRS (PDB ID: 1EUQ) and (b) ND-GluRS
(PDB ID: 3AKZ). The substrate's aminoacyl moiety in each is highlighted in red.
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More specifically, for the GlnRS model (total of 146 atoms) Asp66 has been included
due to its role in positioning the Gln-AMP substrate through salt bridge formation with the
α-NH2 group in the optimum orientation for the reactions. His43 and Lys270 are also
included since they stabilize the phosphate groups and the carbonyl oxygen (Ocarb) of the
substrate. Glu34 was also included in order to study the impact of its mutation on the
mechanism. Finally, Lys72 was included due to its direct hydrogen bond interaction with
Glu34. In the mutated Glu34Gln GlnRS model, the same residues have been represented
except the Glu34Gln mutation.
For the ND-GluRS QM-cluster model (total of 138 atoms), Arg28 and Arg216 were
included due to their direct hydrogen bond interactions with the carboxylate groups of the
Glu34 residue and the substrate (i.e.

GluCOO

−

). In addition, Lys257 and Pro31 were

included as they stabilize the developing negative charge on the phosphate group. Asp64
was also incorporated because of the salt bridge formation with the substrate's α-NH3+
group. His220 was included to stabilize the developing negative charge on the substrate’s
Ocarb centre.
The M06-2X density functional method was used throughout this study as the QM
method of choice as it is stated to provide a good description for non-covalent long-range
interactions and has previously outperformed B3LYP in representing the kinetic energy
barriers of different systems.40
For all QM-cluster studies, and in order to approximately represent the protein's polar
environment, optimizations were obtained at the M06-2X/6-31G(d,p) level of theory.
Vibrational frequencies were also obtained at this level of theory so as to identify the nature
of the stationary points and to estimate the thermal energy corrected to 298.15 K (ΔE298).
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Afterwards, single point energy calculations were performed on the above structures
using the IEFPCM solvation model with a dielectric constant (ε) of 4.0 at M06-2X/6311+G(2df,p) level of theory with inclusion of the appropriate ΔE298.41
Subsequently, the ONIOM(QM/MM) method was employed to more extensively explore
the catalytic mechanism.42-43 In this approach each enzyme-complex system was divided
into two subsystems. The QM layer (reactive region) of each included the key active site
residues (Figure 4.1) most relevant to the mechanism and was effectively identical to the
corresponding QM-cluster model (except for the capped hydrogen atoms). Meanwhile, the
surrounding protein (low-layer) was modelled using the AMBER96 forcefield.44 Optimized
geometries, frequencies, and approximate thermal energy corrected to 298.15 K (ΔE298)
were obtained at the ONIOM(M06-2X/6-31G(d,p):AMBER96) level of theory. Relative
energies were determined by single point calculations on the above optimized structures at
the ONIOM(M06-2X/6-311+G(2df,p):AMBER96) level of theory with inclusion of the
corresponding ΔE298.
4.3 Results and Discussion
4.3.1. MD simulation of wildtype/mutant GlnRS and ND-GluRS
As noted in the Introduction, in the substrate-assisted aminoacylation reaction it is
necessary for the

Ado762′-OH

proton to be abstracted by one of the oxygen atoms of the

substrate’s phosphate. For both the solvated wildtype GlnRS…Gln-AMP/tRNAGln and
mutant

Glu34Gln

GlnRS…Gln-AMP/tRNAGln complexes, a plot of

Ado762′O

…

O1p distances

obtained during the course of the MD simulations is shown in Figure 4.2a. Importantly,
their average distances were found to be 6.75 Å and 6.04 Å, respectively. These distances
are too great for there to be a direct interaction between the Ado762′O and O1p centres. This
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suggests that if the phosphate is to act as the base there needs to be a bridging water
molecule to facilitate the proton transfer process. Indeed, in the MD simulations of both
complexes, it was observed that the non-bridging phosphate oxygens (O1p and O2p) of the
substrate were typically engaged in hydrogen bonding interactions with one or more water
molecules. For GlnRS…Gln-AMP/tRNAGln and ND-GluRS…Glu-AMP/tRNAGlu the 3DRISM solvent analysis tool, as implemented in MOE, was used to further characterize the
water distribution (i.e. average positions) around the phosphate (Figure 4.3). Notably, there
is a significant localization of the water molecules around the substrates O1p and O2p
centres in both complexes. This highly hydrated environment suggests water may play a
role as a mediator in catalysis.

Figure 4.2. Plots of the variation in some key distances in Ångström along 10 ns
simulations: a)
GlnRS; b)

Ado762′-O

Ado762′-O

…

…

O1p distance for wildtype (blue lines) and mutant (red lines)

Ccarb distance for wildtype (blue lines) and mutant (red lines) GlnRS;

c) Ado762′-O…O1p distance for ND-GlnRS; d) Ado762′-O…Ccarb distance for ND-GluRS.
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For
Glu34Gln

both

the

wildtype

GlnRS…Glu/tRNAGln

and

GlnRS…Glu/tRNAGln complexes the mechanistically relevant

mutated

Ado762′O···Ccarb

distance was monitored over the course of the 10 ns MD simulation and are shown in
Figure 4.2b. Importantly, the average distances are calculated to be reasonably similar at
3.98 Å and 3.81 Å, respectively. This suggests that they are positioned reasonably close to
each other for the subsequent reaction.
For the ND-GlnRS…Glu/tRNAGln complex, analogous plots of the
(Figure 4.2c) and

Ado762′O

Ado762′O

…O1p

…Ccarb (Figure 4.2d) distances obtained over the course of the

MD simulations give average values of 4.54 and 3.25 Å, respectively. Similar to the
corresponding discriminating GluRS complexes (see above), while the average
Ado762′O

…O1p distance may seem too large for a proton transfer to occur, water may be

able to facilitate this process by acting as a bridge between the

Ado762′OH

and O1p centre

(see Figure 4.3). Thus, both GluRS and ND-GlnRS may share a common substrate-assisted
mechanism (c.f. Figure 4.2a and c).

Figure 4.3. The first solvation shell directly hydrogen bonded to the phosphate groups in
the substrates; the water oxygen density is in blue and the water hydrogen density is in grey.

81

Chapter 4

4.3.2 QM-Only and QM/MM calculation
4.3.2.1 Wildtype GlnRS Catalysed Aminoacylation with Glutamine
4.3.2.1.1 QM-Cluster: the substrate's phosphate acting as the base
If the substrate's phosphate group acts as the base there is the potential for one of its
non-bridging oxygens (O1p) or bridging (Ob) oxygen to act as the proton acceptor. Hence,
using a QM-cluster approach we examined the feasibility of either to act as the required
base in the aminoacylation process. It should be noted that given that the MD results
suggest that the phosphate may play such a role via a water bridge, an appropriate model
was used for these studies. The results obtained are given in Table 4.1.
As can be seen, the QM-cluster calculations (see Computational Methods) indicated a
clear kinetic and, in general, thermodynamic preference for O1p to act as the base through
the assistance of a bridging water molecule, rather than the Ob atom. An energy barrier of
23.5 kcal/mol is obtained when the reaction is initiated by the O1p atom compared to a
significantly higher barrier of 60.8 kcal/mol in the case of the Ob atom. The phosphate
leaving groups in the obtained intermediate complexes (IC) are in their mono-protonated
forms, since there is no participation from the nearby lysine residues. Accordingly, in the
subsequent hybrid ONIOM(QM/MM) investigations on the aminoacylation mechanism in
which the phosphate is the base, only the O1p atom was considered.
Table 4.1. Free energy values (in kcal/mol) obtained for the two different mechanisms
considered in case of the two enzymes using QM-only approach.
Enzyme

RC

TS-O1p

IC-O1p

TS-Ob

IC-Ob

GlnRS

0.0

25.6

26.2

59.7

14.0

ND-GluRS

0.0

25.0

42.0

51.1

−17.3
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4.3.2.1.2 QM/MM: the substrate's phosphate acting as the base
The QM/MM optimized (see Computational Methods) structures of the stationary
points (reaction, intermediate, product complexes, and transition structures) obtained for
the GlnRS catalysed aminoacylation of tRNAGln by Gln in which one of the substrates nonbridging phosphate oxygens acts as the base are schematically shown in Figure 4.4. The
corresponding potential energy surface obtained is shown in Figure 4.5.
In the reactive complex (GlnRC) moderately strong hydrogen bond interactions are
observed between Ado762′OH of the tRNA and a water (W1) molecule, r(Ado762′OH…OW1) =
1.82 Å, and between the same W1 and the substrate's non-bridging phosphate oxygen O1p,
r(W1H…O1p) = 1.80 Å. The other non-bridging oxygen of the phosphate, O2P, is stabilized
through hydrogen bonds with the side chains of two different residues, the cationic Lys270
residue and the nearby His43 residue at distances of 1.92 and 1.86 Å, respectively (Figure
4.4). Notably, this hydrogen bond network around O2p indicates that the O1p atom will be
the more basic one and supports the hypothesis that it is the mechanistic base. Notably,
there is no direct interaction between the Glu34 residue and the

Ado762′-OH

group. Instead,

the former is strongly hydrogen bonded to the nearby Lys72 residue at a distance of 1.67 Å.
This strong salt bridge interaction suggests that Glu34 is also unlikely to act as the
mechanistic base.
In addition, the tRNA adenosine terminal is concomitantly appropriately situated for
nucleophilic attack upon the Ccarb centre of the Gln-AMP substrate with r(Ado762′O…Ccarb)
= 3.10 Å. This geometry of the substrates in the

Gln

RC thus appears to support the

feasibility of a water-mediated substrate-assisted mechanism.
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Figure 4.4. Schematic representation of the obtained complexes along the studied
aminoacylation mechanism together with selected key distances in Ångstrom; black color
distances for the native enzymes, blue are for the Glu34Gln mutant.
Aminoacyl transfer proceeds through a concerted transition state,
More specifically, O1p has deprotonated the
bridging W1 molecule. Concomitantly, the
of the Glu-AMP substrate such that the

Ado762′OH

TS (Figure 4.4).

group through the assistance of the

Ado762′-oxygen

Ado762′-O

Gln

has approached the Ccarb centre

…Ccarb distance is now just 1.63 Å with

concurrent elongation of the Ccarb—Ob bond from 1.34 to 1.52 Å. This is found to be a late
transition state, since the proton of the W1 molecule is completely transferred to the non-
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bridged oxygen O1p of the phosphate group, r(H―O1p) = 1.01 Å (Figure 4.4).
Concomitantly, a typical single bond has been generated between the former

Ado762′-H

proton and the oxygen of W1 (OW1) with a bond length of 1.00 Å. The accumulated
negative charge on the Ocarb atom is stabilized through hydrogen bond formation to the
nearby backbone –NH– of the Glu34 residue, r(N(H)…Ocarb) = 1.81 Å), which is 0.11 Å
shorter than the corresponding distance in the reactive complex

Gln

RC. It is noted that the

hydrogen bonding interactions between the Lys270 and His43 residues and O2p are
maintained with distances of 1.72 and 2.00 Å, respectively. The energy barrier for GlnTS is
25.0 kcal/mol relative to the corresponding GlnRC, indicating an enzymatically permissible
step (Figure 4.5).
Collapse of

Gln

TS results in formation of the intermediate complex

Gln

IC1 featuring a

tetrahedral Ccarb (Figure 4.4). In this intermediate the Ado762′O―Ccarb single bond has been
formed with a length of 1.53 Å, while the Ccarb…OPO4 distance has further elongated to
1.57 Å. Similar to

Gln

RC, the developed negative charge on the Ocarb atom in

Gln

IC1 is

stabilized through hydrogen bond interaction with the backbone amide –N(H)– group of the
nearby Glu34 residue with a

…Ocarb distance of 1.81 Å. Thermodynamically

Glu34N(H)

Gln

IC1 was calculated to be 4.0 kcal/mol higher in energy than the initial reactant complex

Gln

RC ( Figure 4.5).
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Figure 4.5. The free energy surface for the aminoacylation mechanism of glutamine in the
case of the wildtype GlnRS (black color surface) and the Glu34Gln mutant GlnRS (blue
color (dashed) surface). GlnTS2 and GlnTS2′ were obtained through scan calculations.
It should be noted that in

Gln

IC1 the distance between the side chain amine of the

Lys270 residue and the substrates O2P oxygen is shortened to 1.66 Å, which is 0.05 Å
shorter than the corresponding distance in the preceding transition state (GlnTS; Figure 4.4).
This decrease in the distance better stabilizes the AMP group and facilitates the subsequent
proton transfer step from the Lys270 residue to the adjacent O2P atom via

Gln

TS2 (Figure

4.4). As shown in the calculated potential energy surface this second proton transfer occurs
without a barrier (−12.0 kcal/mol relative to the
formed

Gln

Gln

RC, Figure 4.4). That is to say, once

IC1 can react without a further barrier to give the final product complex, GlnPC.

In GlnTS2 the AMP moiety, cleaved from the initial Gln-AMP substrate, has moved 2.87 Å
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away from the glutamine moiety, which has itself now been transferred onto its cognate
tRNAGln as indicated by the typical single-bond character of the Ado762′O―Ccarb bond which
has length of 1.38 Å.
As noted, the product complex

Gln

PC, is obtained once the second proton transfer is

complete. Notably, the O2P―H bond has now formed with a length of 0.98 Å while the
glutamine and AMP moieties now lay 3.15 Å apart, Figure 4.4. Importantly, the obtained
product complex

Gln

PC lies −29.9 kcal/mol lower in energy relative to

Gln

RC and hence is

thermodynamically favourable, Figure 4.5. Taken together, the obtained potential energy
surface of this water mediated substrate-assisted mechanism implies a kinetically and
thermodynamically feasible pathway.

4.3.2.1.3 QM/MM: the substrate's α-NH2 acting as the base
It has been suggested that the substrate-assisted aminoacylation mechanism in some
aaRS enzymes exploit the aminoacyl substrate’s α-NH2 group as the base. This was initially
proposed by our group during a study on the aminoacylation of ThrRS,31 and has also
recently been proposed for the case of leucyl-tRNA synthetases (LeuRS).45 In ThrRS the αNH2 group is activated (made neutral and thus able to act as a base) by the presence of a
Zn(II) ion, while in LeuRS the protonated form of the substrate's α-NH3+ group is
deprotonated by a conserved aspartate residue.45 Due to the presence of an aspartate residue
(Asp66) proximal to the substrate α-NH2 in GlnRS, we expanded our study to explore the
possibility of the latter group being the mechanistic base. The optimized structures obtained,
with select bond distances and corresponding free energies, are summarised in Figure 4.6.
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Figure 4.6. Optimized structures for the aminoacylation mechanism in the wildtype GlnRS
where the substrate’s α-NH2 acts as the mechanistic base, together with energy values (in
kcal/mol, relative to the reactive complex) in parentheses. For clarity, the atoms that are
involved in the reaction are highlighted.
As can be seen, the relative energies of each of the stationary points (intermediate and
product complexes, and transition states) along the pathway are significantly higher in
energy compared to the values obtained for the previous case where O1p acted as the base.
For example, the corresponding first intermediate,
energy than the initial reactive complex

Gln

Gln

IC1″, is 26.8 kcal/mol higher in

RC, which is the common complex to both

possible pathways. Notably, the α-NH2 group no longer interacts with the Asp66 residue but
instead forms a moderately strong hydrogen bond to the Ado762′OH group with a distance of
r(NNH2…HO-2′Ado76) = 1.74 Å. The subsequent step is transfer of a proton from the
Ado762′OH

group to the α-NH2

moiety with concomitant formation of the

bond. Now, however, this occurs via the transition state
relative to
Gln

Gln

Gln

Ado762′O―Ccarb

TS″ at a cost of 57.8 kcal/mol

RC (Figure 4.6). This is 32.8 kcal/mol more than for aminoacyl transfer via

TS1 (c.f. Figure 4.5). Additionally, the product complex

Gln

unfavourable lying 44.4 kcal/mol higher in energy relative to

PC″ is thermodynamically
Gln

RC. Accordingly, these

findings discount the possibility of the substrate’s α-NH2 group acting as the catalytic base
in the GlnRS enzyme from both kinetic and thermodynamic perspectives.
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4.3.2.2 Aminoacylation by the Glu34Gln mutant of GlnRS.
The results reported in the above sections indicate that the Glu34 residue is not directly
involved in the aminoacylation mechanism. Instead, it participates in a salt bridge with the
protonated side chain of a nearby lysyl residue, r(Glu34COO−···+H3NLys72) = 1.67 Å.
However, as noted in the Introduction, experimental studies on the mutation of Glu34 to
glutamine observed a rate decrease in the enzyme but not inhibition. Thus, to better
understand the role of the Glu34 residue in the mechanism in silico mutagenesis was
performed in which it was substituted by the isoelectronic and isostructural residue
glutamine. Except for the Glu34Gln mutation all other active site residues are the same as
in the wildtype. The potential energy surface obtained is shown in Figure 4.5.
Significant changes are observed in the reactive complex obtained for the Glu34Gln
mutant,

Gln

RC′, compared to that obtained for the wildtype (GlnRC). In particular, the

mutation causes the substrate to shift position relative to the surrounding residues. For
instance, unlike in the case of the wildtype enzyme, there no longer is a hydrogen bond
between the Ado762′OH group and the W1 molecule. The latter W1 does retain its hydrogen
bond with a non-bridging oxygen of the phosphate group though it is slightly longer at
r(W1OH···O1p) = 1.85 Å (Figure 4.4). Moreover, the Ocarb···N(H)Gln34 hydrogen bond
distance has increased by 0.35 Å to 2.28 Å and accordingly weakened relative to the
wildtype enzyme. Similarly, the O2p···HNHis43 hydrogen bond has now been extended by
0.14 Å to 2.00 Å. These two interactions are intended to stabilize the negative charges on
the Ocarb and O2p, respectively, and the longer distances indicate less charge stabilization in
the Glu34Gln mutant. However, it is noted that the weakening of the O2p···HNHis43
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hydrogen bond is at least partially compensated for by the large decrease of 0.33 Å in the
Lys270NH3

+

···O2p hydrogen bond to 1.59 Å (Figure 4.4).

The aminoacylation pathway obtained for the Glu34Gln mutant was in general the
same as the wildtype. For instance, the first step of the mechanism proceeds through the
tetrahedral oxyanion transition state
from the analogous wildtype

Gln

Gln

TS1′. Notably, for the latter no significant changes

TS1 (c.f. Figure 4.4) are observed in the interactions

between the substrate and the surrounding residues. Thermodynamically, however, GlnTS1′
is 39.8 kcal/mol higher in energy with respect to its corresponding reactive complex,
Figure 4.4. That is, for the Glu34Gln mutant the barrier for the first step is 14.8 kcal/mol
higher in the energy. Since there is a negligible difference in the geometries of GlnTS1 and
Gln

TS1′, this energetic difference may be due to the structural influences of the Glu34Gln

mutation on the reactive complex
causes the

Ado762′OH

Gln

RC′. More specifically, in the latter the mutation

to be positioned in a less productive orientation for the subsequent

substrate-assisted mechanism and thus, larger structural changes are required for the
reaction to proceed.
Collapse of the transition state GlnTS1′ leads to the generation of intermediate complex
Gln

IC′, which is 37.2 kcal/mol higher in energy than GlnRC′, Figure 4.5. It is noted that this

is 33.2 kcal/mol higher in relative energy to the corresponding initial reactant complex than
Gln

IC. As shown in Figure 4.5 the wildtype and Glu34Gln intermediate complexes

and

Gln

Gln

IC

IC′ respectively, are geometrically analogous; the two complexes possessing the

same interactions, with similar distances, between the ligand and active site residues,
Figure 4.4. Indeed, the largest difference is just 0.04 Å in the His43NH···O2p hydrogen bond.
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Similar to the wildtype catalysed aminoacylation, the subsequent proton transfer from
the side-chain protonated amine of Lys270 to the O2p atom occurred without a barrier via
Gln

TS2′. As shown in Figure 4.4 there are no significant differences in the distances

between

Gln

TS2 and

Gln

TS2′; although the latter is 21.7 kcal/mol higher in energy. In the

resulting product complex formed,

Gln

PC′, the AMP and glutamine are 3.09 Å apart from

each other. The product GlnPC′ is thermodynamically favourable by 9.3 kcal/mol compared
to

Gln

RC′. Notably, however, it less stable than the corresponding wildtype product

Gln

PC

by 20.6 kcal/mol.

4.3.2.3 ND-GluRS Catalyzed Misacylation of tRNAGln by Glutamate
As noted in the Introduction, in most prokaryotes the aminoacylation of tRNAGln is
catalysed by the non-discriminating aaRS ND-GluRS. In particular, it binds and charges the
non-cognate tRNAGln with glutamate, yielding Glu-tRNAGln, which is then converted to
Gln-tRNAGln by a tRNA-dependent amidotransferase.18 To investigate the generality of this
water-mediated substrate-assisted aminoacylation mechanism within this class of enzymes,
we also investigated its feasibility in the ND-GluRS enzyme.
As for discriminating GlnRS initially, QM-only calculations were performed on the
two possible substrate-dependent mechanisms in which either the phosphates Ob or O1p
oxygen centres act as the base, Table 4.1. Similar to the previous findings in the case of
GlnRS, of these two when the O1p is acting as the required base leads to the most
kinetically feasible mechanism with an activation energy of 24.2 kcal/mol, compared to
50.3 kcal/mol in the case of Ob atom. It is worth noting that for the Ob mechanism, the
intermediate complex IC-Ob is lower in energy than IC-O1p due to a proton transfer from
the Lys270 residue to the O2p atom, resulting in a neutral phosphate leaving group.
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However, due to the high barrier in the case of the Ob mechanism, all subsequent hybrid
QM/MM calculations used O1p as the base.
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Figure 4.7. Schematic drawing of the complexes obtained during the O1p substrate-assisted
aminoacylation mechanism of ND-GluRS, together with selected key distances in
Ångstrom.
The QM/MM optimized structure of the

Glu

RC, derived from the previous MD

simulations, is schematically shown in Figure 4.7. As for GluRS the Glu-AMP and the
tRNA adenosine terminal (Ado762′OH) appear to be suitably positioned with respect to each
other and the active site residues for the substrate-assisted mechanism to take place. For
instance, again an active site water, W1, is positioned as a bridge between the 2′OHAdo76 of
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the tRNA and the O1p of the Glu-AMP substrate with O(H)W1···O1p and

W1O···Ado762′-

(H)O distances of 1.71 Å and 1.65 Å, respectively (Figure 4.4).
Notably, the O2p atom is more stabilized, and thus less basic than O1p, due to the
hydrogen bonding network it forms with the backbone –N(H)– group of the nearby Ser32
residue (r(O2p…HNSer32) = 2.16 Å) and two distinct water molecules with O2p…Owater
distances of 1.70 and 1.90 Å. The His220 residue, which will help stabilize the negative
charge that develops on the substrate’s Ocarb centre, directly hydrogen bonds to the latter
with r(HHis220…Ocarb) = 2.18 Å. Meanwhile, the α-NH3+ group of the Glu-AMP substrate is
stabilized through salt-bridge formation with the nearby Asp64 residue at distance of 1.77
Å. In addition, the substrate’s carboxylate group is stabilized by hydrogen bonding to the
guanidinium side chains of two arginine residues, Arg216 and Arg28. Specifically, Arg28
forms two moderately strong Arg28N(H)…OGlu hydrogen bonds at distances of 1.77 and 1.62
Å while other Arg216’s side chain forms a single hydrogen bond at 1.82 Å.
The orientation of the substrate in
deprotonation of the

Ado762′OH

Glu

RC appears to favour a W1-mediated

group by O1p. This facilitates the first step of the

aminoacylation mechanism; attack of the
occurs via

Glu

Ado762′O

−

TS1, Figure 4.7. It was noted that in

on the substrate’s Ccarb centre which
Glu

TS1 the O1p centre has effectively

fully accepted a proton from the bridging water W1. It does, however, retain a hydrogen
bond with the OW1 centre at a distance of 1.51 Å. Concomitantly, the

Ado762′O

…Ccarb

distance has significantly shortened to 1.54 Å while the Ob…Ccarb bond has elongated
slightly to 1.62 Å. Furthermore, the HHis220…Ocarb hydrogen bond distance has shortened by
0.39 Å to 1.89 Å, which is 0.2 Å shorter than the analogous interaction in GlnRS, Figure
4.4. Importantly, the energy required for this step, i.e., the energy of

Glu

TS1 relative to
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Glu

RC, is calculated to be 25.4 kcal/mol, indicating an enzymatically feasible barrier

(Figure 4.8).
The required energy for this step is 3.7 kcal/mol less than the obtained activation
barrier for the same step in GlnRS, Figure 4.8. This may be due to the presence of an extra
hydrogen bond in GluTS between the transiently charged Ado762′O and the nearby side chain
hydroxyl of Ser32, r(Ado762′-O…HSer32) = 1.91 Å, which would provide more charge
stabilization to the accumulated negative charge on the Ado762′-oxygen.

Figure 4.8. Free energy surface for the aminoacylation mechanism of glutamate by NDGluRS.
This transition state leads to the formation of the intermediate

Glu

IC, in which the

substrates glutamyl moiety is now bound to the tRNA adenosine terminal by a covalent
bond with the

Ado762′-oxygen.

Concomitantly, the covalent bond between the substrates
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glutamyl and AMP components has been cleaved as indicated by a Ccarb…Ob distance of
2.93 Å, Figure 4.7. Notably, GluIC is almost thermoneutral with GluRC, lying 0.9 kcal/mol
lower in energy, Figure 4.8.
It should be noted that there are significant structural differences between
Gln

Glu

IC and

IC. Most significantly, the latter is a tetrahedral intermediate, the Gln…AMP (Ccarb…Ob)

bond not yet being cleaved. Consequently, it lies higher in energy than the corresponding
reactant complex,

Gln

RC. In contrast,

Glu

IC more closely resembles the product complex

wherein the Glu…AMP (Ccarb…Ob) bond has been cleaved and the
bond has formed. The thermodynamic stability of

Glu

Ado762′O-Glu

covalent

IC is also due in part to the extra

charge stabilization provided to the O2p and Ob centres through the formation of strong
hydrogen bonds to the nearby water and side chain hydroxyl of Ser32 at distances of 1.52
and 1.54 Å, respectively.
Unlike the intermediate complex obtained for GlnRS (GlnIC) where a lysyl is directly
hydrogen bonded to the ligand, in GlnIC the lysyl residue (Lys257) is hydrogen bonded to a
second active site water molecule W2, r(Lys257H…OW2) = 1.52 Å. Consequently, the
subsequent proton transfer from Lys257 to a non-bridging oxygen of the AMP's phosphate
to stabilise the charge on the leaving group takes place through W2 via GluTS2, Figure 4.7.
In this transition state, the transferring proton is approximately mid-way between the side
chain amine nitrogen of lysyl257 (NLys257) and the W2 oxygen with distances of 1.28 Å and
1.23 Å, respectively. Meanwhile, the proton being concomitantly donated by W2 to the
phosphate is 1.07 and 1.41 Å from the OW2 and O2P centres, respectively, Figure 4.7. As
was the case for GlnRS, at the present level of theory this second step of the mechanism is
calculated to occur via GluTS2 without a barrier, Figure 4.8.
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Moreover, the Ob atom is now involved in hydrogen bonding interactions with the
−N(H)− and side chain hydroxyl of Ser32 with distances of 1.86 and 1.62 Å, respectively.
In the final product complex GluPC, Lys257 is now neutral having donated a proton via W2
onto the O2p atom, r(W2O…H) = 1.51 Å. Again, the overall aminoacylation process is
predicted to be thermodynamically favorable as

Glu

PC lies 3.7 kcal/mol lower in energy

than the initial reactant complex GluRC.
These results are in accord with our observations on GlnRS. The water-mediated,
substrate-assisted mechanism is kinetically and thermodynamically feasible in case of the
ND-GluRS. The first step, deprotonation of the

Ado762′-OH

group by O1p and concomitant

nucleophilic attack upon the substrate's Ccarb, is rate-limiting.
4.4 Conclusion
The aminoacylation mechanism of glutamine and glutamate amino acids to tRNAGln by
Glutaminyl- and ND-Glutamyl-tRNA synthetases was investigated computationally. Initial
MD simulations indicated that the tRNA

Ado762′OH

terminus and the Gln-/Glu-AMP

substrates are correctly orientated for a substrate-assisted mechanism with consistent
Ado762′O

…Ccarb and Ado762′O…O1p distances over the course of the simulations. Moreover,

our preliminary QM–only calculations supported the preference for the O1p atom to act as
the base, over the Ob atom. Further investigations also supported the preference of this O1p
base over the substrate’s α-NH2.
The ONIOM calculations established that this mechanism proceeds through two steps.
The first step is a water mediated substrate assisted deprotonation of the

Ado762'-OH

group

with concomitant formation of a Ccarb–O-2'Ado76 bond. This step is also the rate-limiting
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with energy barriers of 25.0 and 25.4 kcal/mol in the cases of GlnRS and ND-GluRS,
respectively.
For both GlnRS and ND-GluRS, a lysine residue was found to be positioned near the
substrate such that it is able to neutralize the phosphate leaving group through barrierless
proton transfers upon formation of a tetrahedral intermediate. The latter helps stabilize the
anionic charge on the AMP leaving group and thus contributes to the overall
thermodynamic favourability of the mechanism.
The Glu34Gln mutation of GlnRS leads to an increase in the activation energy of the
mechanism to 39.8 kcal/mol. This is likely due at least in part to the substrates not being as
favourably positioned for reaction, demonstrating at least an important structural role for
the Glu34 residue, although no direct catalytic role was discovered.
Importantly, these findings suggest the substrate-assisted mechanism elucidated for GlnRS
and ND-GluRS may occur within other class I aminoacyl-tRNA synthetases.
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5.1 Introduction
The remarkable accuracy in the translation of the genetic code of all organisms into
proteins is closely tied to the outstanding specificity of the ubiquitous aminoacyl-tRNA
synthetase (aaRS) family of enzymes.1-2 These enzymes are responsible for catalyzing the
activation of their cognate amino acid via its reaction with ATP to form aminoacyl-AMP.
Subsequently, and within the same synthetic (aminoacylation) active site they catalyze the
transfer of the activated aminoacyl group onto its corresponding tRNAaa, yielding the desired
aminoacyl-tRNAaa.3 Importantly, they are stated to be able to perform this overall process
with an exemplary fidelity of 10−4, i.e., 1 aminoacylation error per 10000 reactions.2
Consequently, this crucial class of enzymes has been the subject of many experimental and
theoretical studies seeking to gain deeper insight into their catalytic accuracy.2, 4
On the basis of size or chemical discrimination the active size pocket of an aaRS
typically accommodates the corresponding cognate substrate amino acid while excluding
non-cognate amino acids.5 However, due to electronic and/or structural similarities between
some amino acids (e.g., threonine, serine, and valine), it is challenging for almost half of the
aaRSs to correctly distinguish between cognate and non-cognate amino acids.6-7 Except for
specific cases where moderate levels of mistranslation errors can be tolerated, or may even
be necessary,8-9 any defects in the accuracy of translation can lead to protein misfolding,
which is responsible for many fatal diseases.10
In order to ensure accurate translation most aaRSs possess proofreading mechanisms.
Specifically, in the synthetic site they may use pre-transfer editing mechanisms for which the
most common is hydrolysis.11 For instance, a water molecule nucleophilically cleaves, the
labile phosphoester bond of a misactivated amino acid. This type of editing is observed in
many enzymes; e.g. LeuRS hydrolyzes misactivated Val-AMP12 and ThrRS hydrolyzes
103

Chapter 5
misactivated Ser-AMP.13 However, many aaRS may also exploit a distinct second editing
active site – the editing site – which catalyzes post-transfer editing of misacylated tRNA.11
For example, AlaRS,14 ThrRS,15 and LeuRS16 enzymes utilize this type of correcting pathway
to reject mischarged Gly-tRNAAla, Ser-tRNAThr, and Ile-tRNALeu, respectively. It has also
been noted that some enzymes have a second, free-standing editing domain; for example,
AlaRS has the AlaXp active site to correct any mislinked serine.17
Our group has a long-standing interest in the mechanisms operating in aaRS enzymes,
both regarding their synthetic activity and the pre-transfer editing functions of the synthetic
site.18-19 The principal aim of this study is to expand the understanding of the post-transfer
editing functions of threonyl-tRNA synthetase (ThrRS) enzymes. While it is thought that
yeast mitochondrial ThrRS relies only upon pre-transfer editing,20 the ThrRSs found in all
other species are suggested to also an editing site.15 This latter site is remote from the
synthetic site and is responsible for the hydrolysis of misacylated Ser-tRNAThr. Structurally,
the editing domain has been observed to be species-specific, with the two main types being
bacterial and archaeal, and accordingly there are two different editing mechanisms.21
In archaeal ThrRS, for example from Pyrococcus abyssi, the editing region is located in
the N-terminal domain and the editing mechanism proceeds by a universal tRNA-mediated
hydrolysis mechanism.5, 22-23 In contrast, in bacterial ThrRS, for instance from Escherichia
coli, the editing region has a quite distinct structure and different hydrolytic editing
mechanisms have been proposed. Unfortunately, despite experimental studies on various
possible editing pathways, the exact mechanism remains an open question.
Based on mutational and kinetic analyses it has been suggested that the binding domain’s
His73, Lys156, His186 and Cys182 residues are the most mechanistically important.15, 24
Notably, His73Ala mutation was observed to cause the most dramatic decrease in the rate of
104

Chapter 5
hydrolytic editing, followed by Cys182Ala mutation.24,25 In addition, based on experimental
X-ray crystal structures it was concluded that the His73 residue is within hydrogen bonding
distance of a water molecule (W1) thought to be positioned near the substrate.23
Subsequently, the Schimmel and co-workers also concluded that the His73 and Lys156
residues are well-positioned to partake in catalysis.25 Consequently, it was proposed that, as
shown in Scheme 5.1a the His73 residue is neutral and acts as the required mechanistic base.
Specifically, it promotes activation of W1 through proton abstraction thus enabling the
oxygen of W1 to nucleophilically attack the misacylated substrate's (Ser-tRNAThr) Ccarb
centre. This ultimately results in cleavage of the labile CCarb—O3′ ester bond. The
regenerated free Ado763′O-tRNA oxyanion is neutralized via a second proton transfer from the
nearby Lys156 residue through a bridging water molecule, W2. The enzymatic use of a
neutral histidyl as a mechanistically important base, such as in serine proteases and
flavocytochrome b2, is widely documented.26-27

Scheme 5.1. Schematic illustration of the two proposed pathways for post-transfer editing as
catalysed by bacterial E. coli ThrRS in which the mechanistic water nucleophile is activated
by either (A) His73 or (B) Cys182 acting as the required base.
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Recently, however, based on experimental oxidative stress studies on the editing domain
of ThrRS, it has alternatively been suggested that the active site Cys182 residue may instead
be the base, as shown in Scheme 5.1b.28-29 In particular, it was observed that treatment of E.
coli ThrRS by H2O2 resulted in formation of a Cys182-derived sulfenic acid (Cys182SOH). For
such a species to be formed the Cys182 must be in its thiolate form. Notably, this oxidative
modification significantly increased misincorporation mistakes, and it was concluded that
this was due to inhibition of the post-transfer editing of Ser-tRNAThr by ThrRS. Furthermore,
and in contrast to the previously proposed mechanism above, it was suggested that of the
three active site histidyl residues (His73, His77, and His186), His73 and His186 are both
protonated and help activate the thiol of Cys182 and stabilize its thiolate form.28 Hence, an
alternate post-transfer editing mechanism was proposed and is shown in Scheme 5.1b. These
studies29 also noted that the editing site of ThrRS is similar to the active site of cysteine
proteases, which are known to form sulfenic acids, and that oxidation of cysteine residues to
sulfenic acids often occurs in ROS signaling proteins.30 Moreover, it has been noted that the
editing sites of AlaRS and ThrRS share considerable sequence similarity and that their active
sites contain the same conserved residues; namely, two histidyl residues, and a cysteinyl.37
Indeed, in the editing site of AlaRS the cysteinyl (Cys666) is in a nearly identical orientation
to that of Cys182 in the editing site of ThrRS. Furthermore, mutation of Cys666 to alanine
severely inhibited the ability of the editing site of AlaRS to deacylate Ser-tRNAAla. Hence, it
has been suggested that these two aaRSs may share a common post-transfer editing
pathway.31-33
In the current study we have conducted a detailed, systematic multi-scale computational
investigation using MD simulations and ONIOM(QM/MM) methodology to gain insight into
the post-transfer editing mechanism in E. coli ThrRS. In particular, we have examined both
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the previously proposed hydrolytic editing mechanisms of ThrRS in which either His73 or
Cys182 acts as the mechanistic base, as well as possible alternate mechanisms and for a range
of different potential active site protonation states.

5.2 Computational Methods
5.2.1 Molecular Dynamics Simulations
The high-resolution experimental X-ray crystal structure of the editing domain of
threonyl-tRNA synthetase isolated from E. coli with the substrate analogue seryl-3'aminoadenosine (SerAA) bound within the active site (PDB ID: 1TKY)24 was selected as the
template structure for all chemical models used in this study. The bound analogue was
mutated back to the desired substrate (Ser-AMP) by replacing the relevant bridging –NH–
group in SerAA with an oxygen atom. Hydrogen atoms were added as appropriate and
according to their protonation states as determined from the pKa values calculated by both
PROPKA 3.134 and the default protonation tool in the Molecular Operating Environment
(MOE) software.35 Unconstrained Molecular Mechanics (MM) energy minimization using
the AMBER12 forcefield was then performed on the generated model. The model was then
solvated by adding a 2 Å layer of water around the entire complex (total 725 water molecules)
followed by a second MM energy minimization which terminated once the root mean square
gradient fell below 0.01 kJ/mol·Å2. The resulting complex was initially submitted for 100 ps
equilibration from 0 to 300 K at constant pressure using the default settings of MOE which
includes cut-offs for long range interactions of 10 Å.
The mechanisms examined in this present study can be grouped into two broad
categories; either His73- or Cys182-promoted editing. Hence, two template enzymesubstrate complexes were generated. For the former scenarios, i.e. those in which His73 acts
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as the base, the complex contained neutral His73, His186, and Cys182. These protonation
states are consistent with their predicted pKa values (see above). For the alternate scenarios
in which Cys182 acts as the base, consistent with the experimentally28 suggested ionization
states the enzyme-substrate complex instead contained protonated His73 and His186 residues
while Cys182 was deprotonated. Under constant pressure and temperature, the generated
structures were then subjected to a second simulation for 500 ps, under the same conditions
and 2 fs time steps, using the NAMD engine.36 The final conformation obtained in each 500
ps simulation was then checked to ensure it was a suitable representative structure, and then
MM minimized as above. Suitable QM/MM chemical models were then generated by
truncating the resulting complex to include all residues and waters within 10 Å of the
substrate.

5.2.2 QM/MM Investigations
A two-layer ONIOM(QM/MM)37-38 approach was used and consequently the above
derived chemical models were each divided into QM- (high-level) and MM-subsystems
(low-level) as shown in Figure 5.1. In particular, the substrate, mechanistically most relevant
residues, as well as select active site water molecules were included in the QM-region. The
surrounding protein environment, and remaining waters, were placed in the low-layer and
described using an appropriate MM method. This methodology has previously been
successfully applied to explore different catalytic mechanisms.39 All ONIOM(QM/MM)
calculations were performed using the Gaussian09 software package.40
For those chemical models used to examine mechanisms in which His73 acts as the base
the QM region contained: the substrate (Ser-Ado); the charge stabilizing residues Tyr104 and
Gly95; the proposed catalytic residues His73 and Lys156; and Asp180 due to its role in
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orienting the substrate appropriately by formation of a salt bridge with the substrate’s α-NH2.
In addition, in the appropriate MD simulations an active site water (W1) molecule was
observed to be hydrogen bonded to the His73 residue and concomitantly in close proximity
to the Ccarb of the substrate. Meanwhile, a second water (W2) molecule was hydrogen bonded
to the side-chain amine of Lys156. Hence, both of these bridging water molecules (W1 and
W2) were also included. The QM-region consisted of a total of 111 atoms and is shown in
Figure 5.1a.

Figure 5.1. The template QM-region models used to study possible catalytic mechanisms of
the ThrRS editing domain in which either (a) His73 or (b) Cys182 acts as the required base.

For the chemical models used to examine mechanisms in which Cys182 acts as the base
the QM-region was expanded to include the Cys182 and His186 residues. These QM-regions
contained a total of 121 atoms and are shown in Figure 5.1b. Moreover, for all chemical
models the α-carbon atoms of the amino acids in the low layer (at least one residue away
from the QM layer) were held fixed at their initial positions in order to ensure the structural
integrity of the model.
To obtain optimized structures, each QM layer was treated using the hybrid DFT B3LYP
method,41-43 widely applied in the study of catalytic and enzymatic mechanisms,44 in
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conjunction with the 6-31G(d,p) basis set. In order to enhance the modelling of non-covalent
and dispersion interactions, the empirical D3 dispersion correction by Grimme was applied.45
This has previously been shown to significantly improve the accuracy of kinetic barriers.46
Meanwhile, the AMBER96 force field was used for the MM region.47 Frequency calculations
were also performed at this level of theory, ONIOM(B3LYP-D3/6-31G(d,p):AMBER96), to
determine the nature of the stationary points and to calculate Gibbs free energy correction
values (ΔGcorr). Relative energies were obtained via single point energy calculations on the
above structures at the ONIOM(B3LYP-D3/6-311+G(2df,p):AMBER96) level of theory
with inclusion of the corresponding ΔGcorr. It is noted that all ONIOM calculations were
performed within a mechanical embedding formalism.

5.3 Results and discussion
As noted above it has been suggested that either His73 or Cys182 acts as the base to
facilitate and promote editing through activation of an active site water. However, this is
complicated by the existence of several acid/base residues within the editing site. In addition,
once a base has gained a proton it could, in some scenarios, potentially then act as an acid.
Consequently, in this present study the mechanisms studied can be categorized as falling into
either His73- or Cys182-promoted editing mechanisms. However, for each of these we have
examined several possible variations that differ by, for example, the protonation states of
other editing site residues. In total, 11 different possible mechanisms have been elucidated
and compared in terms of their chemistry and thermochemical feasibility.
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5.3.1 His73-promoted Editing Mechanisms
5.3.1.1 His73-promoted hydrolytic editing
The editing mechanism of archaeal ThrRS proceeds through a substrate-assisted
mechanism in which the Ado762′OH group of the tRNAThr moiety facilitates hydrolysis of the
Ccarb–O3′Ado76 bond.23 In contrast, in the presently obtained optimized structure of the reactive
complex (IRC) of the editing site of bacterial ThrRS, shown in Figure 5.2, the substrate is
positioned such that no hydrogen bonding interaction is observed between the substrate’s
Ado762′OH

group and the nucleophilic active site water (W1). Instead, W1 is in close

proximity to the catalytic His73 residue with which it forms a moderately strong hydrogen
bond, r(His73N…HW1) = 1.88 Å. In addition, W1 is positioned in good proximity to the
substrate's Ccarb center with a distance of r(W1O…Ccarb) = 3.17 Å, Figure 5.2. That is, W1
seems well positioned for the subsequently required proton transfer onto His73 and
nucleophilic attack at Ccarb. The Lys156 residue, specifically its side chain ammonium, forms
a strong hydrogen bond with a second water (W2), r(Lys156H…OW2) = 1.81 Å, which also
positions it near to the substrate. Meanwhile, the Asp180 residue helps hold the substrate in
more catalytically productive conformation through formation of an Asp180COO−…H3N+SerAA
salt bridge, r = 1.64 Å. The substrate’s Ocarb atom also forms a hydrogen bond with the
backbone –N(H)– of the Gly95 residue at a distance of 1.89 Å. Optimized structures of
stationary points (energy minima and transition states) along the mechanism, together with
selected key distances, are shown schematically in Figure 5.2. The corresponding free energy
surface (FES) for this mechanism is shown in Figure 5.3.
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Figure 5.2. Schematic illustration of the optimized structures obtained (see Computational
Methods), with select distances shown in Angstroms, for the His73 promoted mechanisms
obtained with Lys156 protonating either the (1)

Ado763′O

or (2) Ocarb centers of the Ser-

tRNAThr substrate.
The reaction is initiated by the imidazole of His73 abstracting a proton from W1 while
concomitantly, the water's OW1 center nucleophilically attacks the Ccarb center of the
substrate. This step proceeds via IaTS1 at a cost of 27.6 kcal/mol relative to IRC, suggesting
an enzymatically high-energy barrier. In IaTS1 the proton liberated from W1 has significantly
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shifted toward the His73 residue as indicated by the distances r(W1O…HW1) = 1.41 Å and
r(W1H…N H73) = 1.16 Å. Furthermore, the oxygen of the developing

W1OH

–

moiety is now

only 1.75 Å away from the substrate’s Ccarb center having formed a weak partial bond.

Figure 5.3. Free energy surfaces (kcal/mol) calculated (see Computational Methods) for the
ThrRS editing domain mechanisms in which His73 acts as a base with Lys156 acting as an
acid and protonating either the Ocarb center (blue line) or Ado763′-O (red line).

Collapse of

Ia

TS1 results in generation of the energetically stable tetrahedral

intermediate complex IaIC1, which lies 21.6 kcal/mol higher in energy than IRC, Figure 5.3.
In this complex, the His73 residue is now protonated, r(H73N–H) = 1.06 Å while the partial
Ccarb–OW1 single bond has shortened markedly to 1.54 Å. Concomitantly, the Ccarb__Ocarb and
Ccarb–O3′Ado76 bonds have lengthened by 0.06 and 0.14 Å, respectively, Figure 5.2. These
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latter increments are due to the change in the hybridization of the Ccarb toward pseudo sp3hybridization and stabilization of the increased negative charge on Ocarb by the single
moderately strong hydrogen bond of length 1.76 Å it forms with the –N(H)– of the Gly95.
The subsequent and final stage of the overall mechanism is cleavage of the Ccarb–O3′Ado76
bond and formation of the neutral

Ado76O3′H

group. An examination of IaIC1 suggests that

there are potentially three process by which this could occur. Namely, it may either occur by
proton transfer from the side chain ammonium of Lys156 through the active site water W2
directly onto Ado76O3′ or indirectly via Ocarb. Alternatively, the now protonated imidazole of
His73 may act as an acid and directly protonate

Ado763′-oxygen.

Thus, each of these

mechanisms were examined with the two most feasible being shown in Figures 5.2 and 5.3.

5.3.1.1.1 Direct water mediated protonation of Ado763′O by Lys156
The side chain ammonium of Lys156 is able to essentially directly protonate the 3′OAdo76
center of IaIC1 via a mediating water W2. This step proceeds via IaTS21 with a free energy
barrier of 33.4 kcal/mol, Figure 5.3. In this possible overall mechanism, the proton transfer
represents the rate-limiting step. In addition, the high barrier suggests that the mechanism is
unlikely to be enzymatically feasible. It is noted that IaTS21 appears to be a dissociative
transition state since the proton has essentially been transferred onto the Ado763′-oxygen while
the Ado763′O…Ccarb bond has concomitantly significantly elongated to 2.16 Å, Figure 5.2. The
resultant product complex IPC lies 4.3 kcal/mol higher in energy than IRC; that is, this
mechanism is also thermodynamically unfavorable. In IPC the Lys156 side chain amine is
now neutral while the neutral
Ado763′O–H

Ado763′OH

group has been fully formed. In addition, the

distance is that expected of a typical O–H single bond with length 0.96 Å, while
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the

carbC−3′OAdo76

ester bond has been fully cleaved as indicted by its distance of 2.8 Å,

Figure 5.3

5.3.1.1.2 Indirect water-mediated protonation of Ado763′O by Lys156
Alternatively, Lys156 may first transfer its ammonium proton via W2 onto the
oxyanionic Ocarb center in IaIC1. Subsequently, an intramolecular proton transfer can occur
from -OcarbH onto the 3′OAdo76 center of the leaving tRNA moiety, Figure 5.2. The first step
in this process proceeds via IaTS22 at a cost of 32.6 kcal/mol relative to IRC, Figure 5.3. It
is noted that while IaTS22 lies 0.8 kcal/mol lower in energy than IaTS21, it is still too high to
likely be enzymatically feasible. Furthermore, structurally, W2 has substantially transferred
its proton onto the substrates Ocarb center as indicated by the relevant distances of
r(W2H···OW2) = 1.37 Å and r(W2H···Ocarb) = 1.11 Å, Figure 5.2. The resultant subsequent
tetrahedral 1,1-diol intermediate complex (IaIC2) lies 1.1 kcal/mol higher in energy than IaIC,
being 22.7 kcal/mol higher in energy relative to IRC, Figure 5.3.
The subsequent proton transfer from the newly formed -OcarbH group onto the

Ado763′-

oxygen is found to take place via the 4-membered-ring transition state ITS3, Figure 5.2. As
noted earlier, the Ado762′OH group in the optimized chemical model herein is oriented in such
a way that it is unable to readily participate in this step to help form a 6-membered-ring
transition state. The energy required for this second step is extremely high with a barrier of
69.6 kcal/mol relative to IRC, Figure 5.3, clearly indicating that editing via this possible
mechanism is enzymatically unfeasible. It is noted that even if an alternative pathway for this
second proton transfer reaction was possible, the barrier for proton transfer via IaTS22 in
itself is higher than likely to be enzymatically feasible. The final product complex formed,
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I

PC, is the same as that obtained for the above described direct water meditated protonation

mechanism. Hence, this possible alternate mechanism is also thermodynamically
unfavorable.

5.3.1.1.3 Protonation of Ado763′O by His73-H+.
The His73 residue has also been proposed to act as an acid-base catalyst and thereby the
proton transferred to the

Ado763′-oxygen,

cleaving the Ccarb—O3′Ado76 bond, may possibly

originate from the protonated His73 residue formed in the first step of the mechanism, Figure
5.2.25 However, the relative energy of the required transition state is 45.8 kcal/mol. Moreover,
the product complex generated from this step is 24.1 kcal/mol higher in energy than IRC and
is thus significantly more thermodynamically unfavored than IPC.

5.3.1.2 His73-promoted editing through self-cyclization/lactone formation:
In the reactive complex IRC it was observed that the substrate's serinyl side-chain, and in
particular its b-OH group, could potentially undergo a conformational change. In particular,
it could rotate such that it no longer interacts with the side-chain carboxylate of Asp180 as is
common,5,

22

but instead could potentially interact with His73. Such a geometry and

interaction may facilitate an alternate editing pathway in which cleavage of the aminoacyltRNA's ester bond proceeds through formation of a 4-membered lactone ring, Figure 5.4.
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Figure 5.4 Schematic representation of the optimized complexes, with select distances
shown in Angstroms, obtained for a His73-promoted self-cyclization editing mechanism. The
relative free energies (kcal/mol) are also given in brackets.
Similar cyclizations have been suggested to play a role in editing of other misacylated
substrate's including the pre-transfer editing mechanism of MetRS previously reported by
our group.18
A scan of the potential energy surface for rotation around the substrate's serinyl side chain
C__C bond leads to formation of the intermediate complex IbIC1 lying just 5.3 kcal/mol
higher in energy than IRC. It is noted that the scan was performed as the energy surface was
very flat; that is, the rotational barrier was quite small. Indeed, after empirical free energy
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corrections were included the barrier estimated to be slightly lower than 0.0 kcal/mol,
reinforcing that in vivo this rotation can occur essentially without a barrier. In

Ib

IC1 the

substrate’s serinyl b-OH is strongly hydrogen bonded to the neutral imidazole of His73 whilst
also simultaneously in close proximity to the substrate's Ccarb center with distances of
r(H73N···HOH) = 1.76 Å and r(OHO…Ccarb) = 2.79 Å.
The oxygen of the b-OH is then able to nucleophilically attack the Ccarb center with
concomitant transfer of the hydroxyl's proton onto His73. This step proceeds through IbTS2
at a quite high cost of 31.4 kcal/mol relative to the initial reactant complex IRC. This high
barrier may again be due in part to the increasing anionic charge on the Ocarb center during
this step being stabilized by only its single hydrogen bond with the backbone -NH- of Gly95.
The resulting tetrahedral intermediate IbIC2 lies slightly lower in free energy than IRC by
−3.4 kcal/mol. Importantly, it must be noted that intermediate ligand has shifted position
slightly so that the Ocarb oxyanion center is now hydrogen bonded to the protonated imidazole
of His73 (i.e., His73-H+). This suggests that the latter residue may be able to transfer its
proton onto the Ocarb oxyanion center in order to generate a neutral lactol. And indeed, such
a proton transfer can occur essentially without a barrier via IbTS3, as indicated by the fact
that its calculated free energy after empirical corrections is lower than that of

Ib

IC2.

Importantly, this results in formation of the low energy lactol IbIC3 which lies markedly
lower in energy than IRC by 42.5 kcal/mol and is in fact the lowest energy complex along
this pathway.
Several possible reactions (not shown) were considered for the subsequent required
cleavage of the Ccarb−3′OAdo76 bond. The lowest energy pathway was found to involve an
intramolecular proton transfer from the newly formed –OcarbH group onto the Ado763′-oxygen.
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This step occurs via the four-membered ring transition state IbTS4 with a barrier of 33.3
kcal/mol relative to IbIC3. This is the rate-limiting step of the reaction and its height suggests
that at least in the editing domain of ThrRS this pathway is enzymatically unfeasible. The
final product complex formed, IbPC, while thermodynamically favoured compared to the
initial reactive complex IRC by 13.3 kcal/mol, is much higher in energy than IbIC3 by 29.2
kcal/mol, Figure 5.3.

5.3.2. Cys182-promoted editing Mechanisms:
As noted above, it has also been suggested that the active site cysteinyl Cys182 may
instead be able to act as a base to promote/catalyse the editing mechanism. Thus we
systematically examined possible mechanisms through which this may occur, with a key
difference between them being the protonation states of the conserved active site His73,
Cys182 and His186 residues. However, as for the above mechanisms, in some cases several
scenarios were considered based on for instance the source of the proton in the second stage
and/or the site of substrate to which it is initially transferred. It is noted that as for the above
His73-promoted editing mechanisms, the side chain of Lys156 was considered to be in its
protonated form.

5.3.2.1. Deprotonated Cys182 with protonated His73 and His186.
In the QM/MM optimized structure (see Computational Methods) of the reactant
complex

IIa

RC, the anionic thiolate is stabilized by hydrogen bonds with the protonated

imidazoles of His73 and His186 with distances of r(HisNH···SCys) = 2.26 Å and 1.90 Å,
respectively, Figure 5.5. In addition, it forms a moderately strong hydrogen bond with the
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nucleophilic water W1 with r(W1H…SCys182) = 1.89 Å. Similar to that observed in IaRC the
Asp180 anchors the substrate via salt bridge formation with the substrate’s α-NH3+ group at
a distance of 1.51 Å. Meanwhile, the W2 molecule is positioned close to the other side of the
substrate through hydrogen bonding to the backbone carbonyl oxygen of the nearby Ile94
residue with r(W2H…OIle94) = 1.65 Å, Figure 5.5.
Deprotonation of W1 by the Cys182 thiolate facilitates nucleophilic attack of the oxygen
of W1 on the substrate’s Ccarb center. This reaction proceeds through the transition state
IIa

TS1 at a cost of 17.4 kcal/mol relative to

IIa

RC, which is 10.2 kcal/mol less than the

corresponding step in the above described His73-promoted mechanisms, Figures 5.3 and
5.6. It is noted that it represents a late transition state as the W1 proton is substantially shifted
toward the sulfur atom and the W1 oxygen has moved quite close to the Ccarb as indicated by
their distances of r(W1H···SCys182) = 1.49 Å and r(W1O···Ccarb) = 1.73 Å, Figure 5.5. Similar
to ITS1 in the His73-promoted mechanisms, the substrate’s Ocarb center is stabilized by
formation of a strong hydrogen bond with the backbone of Gly95, r(Gly95N(H)…Ocarb ) = 1.78
Å which, due to the increased negative charge on Ocarb, is 0.26 Å shorter than the same
interaction in IIaRC, Figure 5.5. In addition, however, it also forms a strong hydrogen bond
with a nearby active site water, r(Ocarb…HW) = 1.81 Å, which is simultaneously hydrogen
bonded to the protonated imidazole of His73. The latter is made possible due to the Cys182
now being neutral and remains hydrogen bonded to His186-H+. This additional stabilizing
hydrogen bond of Ocarb may help explain the markedly lower reaction barrier obtained for
this step.
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Figure 5.5. Schematic illustration of the optimized structures obtained, with select bond
distances shown in Angstroms, for the mechanism in which Cys182 acts as a base to activate
an active water, and with Lys156 acting as acid and directly protonating the Ado763′-oxygen.

Collapse of

IIa

TS1 in leads to the formation of intermediate complex

IIa

IC1, which

possesses typical carbC−OH and RS−H bonds (r = 1.49 Å and 1.36 Å, respectively). Notably,
IIa

IC1 lies 13.7 kcal/mol higher in energy than

IIa

RC, which is markedly lower than the

relative energy (21.6 kcal/mol) than the corresponding intermediate IIC1 in the His73promoted mechanisms, Figure 5.3.
As for the above mechanisms in which His73 acted as the base, there are three possible
proton donors (Lys156, His73, and Cys182) present for the continuation of the reaction;
cleavage of the

Ado763′O—Ccarb

bond. Thus, each of the possibilities was then investigated,

the most feasible mechanism obtained for each is discussed herein.
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5.3.2.1.1. Direct protonation of Ado763′O by Lys156
In IIaIC1 the Ado763′O center is strongly hydrogen bonded to a proton of W2 at a distance
of 1.79 Å. Notably, W2 is simultaneously also positioned near the side chain ammonium of
Lys156. For the above His73 catalyzed process, proton transfer from Lys156 onto the Ado763′oxygen gave the lowest barriers. For this present scenario it is found that such proton transfer
from Lys156 onto the Ado763′O center can occur with the involvement of the bridging water
molecule, but with an high free energy barrier, via IIaTS21 of 32.5 kcal/mol relative to IIaRC
(Figure 5.6). This step also appears to share structural similarities to that described above in
the analogous His73-promoted mechanism that proceeds via IaTS21. Namely,

IIa

TS21 also

appears to be a dissociative transition state as the H···N+Lys156 distance has elongated
significantly to 1.85 Å (i.e., has been transferred onto W2) while the carbC−O3′Ado76 bond has
also been essentially wholly cleaved as indicated by its distance of 1.71 Å, Figure 5.5.
Collapse of

IIa

TS21 leads directly to formation of the product complex

IIa

PC1 in which

the tRNA's Ado76 ribose sugar and the noncognate serine amino acid are separated by a
distance of 2.84 Å. The

Ado763′O−H

single bond has been formed with a length of 0.99 Å,

Figure 5.4. Notably, this overall pathway was found to be thermodynamically favorable as
IIa

PC1 is 33.6 kcal/mol lower in energy than IIaRC, Figure 5.6.

5.3.2.1.2. Protonation of Ado763′O involving His73-H+.
In

IIa

IC it was observed that with neutralization of the Cys182 thiolate group, the

protonated imidazole of His73 (His73-H+) has switched position and now is hydrogen
bonded to a third editing site water molecule (W3). Thus, His73-H+ may in fact be able to
act as an acid and transfer its proton on the intermediate. It was found that in fact His73-H+
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is able to effectively transfer its proton via W3 onto the oxyanionic Ocarb center of

IIa

IC.

Furthermore, this effectively occurs without a barrier via IIaTS22 as suggested by its slightly
lower free energy relative to
IIa

IIa

IC (Figure 6). This low barrier also reflects the fact that

TS22 occurs early along this step; the

His73N—H

distance has lengthened only slightly to

1.15 Å and the distance to the OW3 center is still quite long at 1.36 Å. Meanwhile, the W3O…H
distance for the proton W3 concurrently donates to the substrate’s Ocarb center has increased
significantly to 1.21 Å and the corresponding HW….Ocarb distance is relatively short at 1.25
Å, Figure 5.7.

Figure 5.6. FES obtained (kcal/mol) for the three possible editing mechanisms elucidated in
which Cys182 acts as a base and His73 and His186 are protonated and the required acid for
cleavage of the Ado763′O—Ccarb bond is: Lys156 (black line and labels); His73 (red line and
labels); or Cys182 (blue line and labels).
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Indeed, the subsequently formed 1,1 diol intermediate complex IIIC22, which contains a
now tetrahedral sp3 hybridized Ccarb center, lies 11.0 kcal/mol lower in energy than the initial
reactive complex IIaRC, Figure 5.6. The next and final step is transfer of the proton from the
newly formed Ccarb–OH groups onto the 3′OAdo76 center. The lowest energy pathway for such
a transfer was found to occur involve the –OH group formed from W1 and proceeds via the
6-membered ring transition state IIaTS33. However, energetically this step has a high-energy
barrier of 33.3 kcal/mol with respect to IIaIC2 and is in fact the overall rate-limiting step for
this possible pathway, Figure 5.5 and Figure 5.6.This is likely at least partly a reflection of
the high pKa (i.e. low acidity) of the Ado762′OH group which is integrally involved in this step
(Figure 5.7). However, the resulting product complex (IIaPC2) formed, in which the
Ado763′O—Ccarb

bond is fully broken, is thermodynamically very favorable having an energy

relative to IIaRC of −50.0 kcal/mol (Figure 6).

Figure 5.7. Schematic illustration of the optimized structures, with selected bond lengths
shown in Angstroms, obtained for the IIa editing mechanism (i.e., initial active site contains
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Cys182S–/His73-H+/His186-H+) in which cleavage of the

Ado763′O—Ccarb

bond involves

proton transfer from His73 (2: red labels) or Cys182 (3: blue labels).

5.3.2.1.3. Protonation of Ado763′O involving Cys182SH.
Alternatively, the neutral thiol of Cys182formed during the first step could potentially
act as an acid to facilitate cleavage of the Ado763′O—Ccarb bond, Figure 5.7. More specifically,
Cys182SH is able to transfer its proton onto the nearby
concomitantly transfers its proton onto the
Ado763′O—Ccarb

Ado762′OH

Ado763′-oxygen,

moiety while the latter

resulting in cleavage of the

bond. However, this step proceeds through IIaTS23 with an energy barrier of

27.9 kcal/mol relative to

IIa

RC (14.2 kcal/mol relative to

IIa

IC1). Again this is the overall

rate-limiting step for this possible pathway. But, though it remains high, it is the lowest
barrier amongst the three possibilities elucidated for when the editing site initially contains a
deprotonated Cys182, and protonated His73 and His186, Figure 5.6. The resulting product
complex IIaPC3 is the thermodynamically most favored of these three related pathways with
an energy 51.0 kcal/mol lower than that of IIaRC.

5.3.2.2. Deprotonated Cys182 with neutral His73 and His186 (Cys182S–/His73/His186).
It is noted that all related AlaXps enzymes there are three residues (His9, His13 and
Cys116) that are positioned similarly to those of His73, His186 and Cys182 in the editing
site of ThrRS.7, 48 In addition, the Zn(II) binding-site in the aminoacylation site of ThrRS
contains a similarly arranged deprotonated cysteinyl and two neutral histidyl residues.15
Furthermore, the pKas predicted using PROPKA for these three residues in the editing site
of ThrRS suggested that Cys182 may be deprotonated with His73 and His186 being neutral.
Hence, we considered mechanisms in which these where their initial protonation states in the
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editing site with the optimized structures and thermochemistry of the two possible pathways
elucidated given in Figures 5.8 and 5.9.
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Figure 5.8. Schematic illustration of the optimized structures (with select bond lengths
shown in Angstroms) obtained for the editing pathways in which Cys182 acts as the base in
the presence of neutral His73 and His186, and where either Lys156 (1: black labels) or
Cys182 (2: red labels) acts as the required acid for the second proton transfer.
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In the QM/MM optimized structure of the corresponding reactive complex

IIb

RC, the

thiolate of Cys182 forms a hydrogen bond with an active site water molecule (W1) with
r(Cys182S…HW1) = 2.18 Å (Figure 5.8). Notably, this orients W1 such that its oxygen (OW1) is
positioned just 2.64 Å from the substrate's Ccarb center, a distance which is significantly
shorter by 1.40 Å than observed in

IIa

RC. This suggests that W1 is well placed for the

subsequent required nucleophilic addition, Figure 5.8. This seemingly better positioning
may also be due to the fact that unlike in

IIa

RC, the thiolate of Cys182 does not form a

hdyrogen bonding network with His73 and His186 due to their being neutral. Instead, and in
addition to its hydrogen bond with W1,

Cys182S

–

also forms a moderately strong hydrogen

bond of length 2.16 Å directly with the Ado762′OH group (Figure 5.8). This appears to help
bind and orient the substrate in a more conducive conformation for subsequent reaction.24
The analogous pathway for activation and nucleophilic attack of W1 on the substrate, as
previously obtained for IIaRC was elucidated. Again, the thiolate of Cys182 is able to abstract
a proton from W1 while the oxygen (OW1) of the latter simultaneously nucleophilically
attacks the substrate's Ccarb center, Figure 5.8. In contrast, however, this reaction proceeds
via IIbTS1 at an cost of just 9.9 kcal/mol, 8 kcal/mol lower than for the analogous reaction
via IIaTS1. (Figure 5.9). Indeed, of all the systems considered herein, this is the lowest barrier
for activation and subsequent nucleophilic attack by the active site water.
It is noted that in

IIb

TS1, the

Cys182S

…

HO2′Ado76 hydrogen bond has been maintained

though it has lengthened slightly to 2.28 Å. Meanwhile, and the developing negative charge
on the Ocarb center is again stabilized through its quite strong hydrogen bond with the
Gly95N−H

group; r(Gly95N(H)…Ocarb) = 1.67 Å. This latter distance is 0.12 Å shorter, and thus

stronger, than observed in the

IIa

TS1. As before, this step results in formation of an

oxyanionic tetrahedral intermediate complex (IIbIC), in which the r(Gly95N(H)…Ocarb)
127

Chapter 5
interaction has shortened markedly to 1.58 Å (Figure 5.8). Significantly, as shown in Figure
5.9, IIbIC is just 4.4 kcal/mol higher in energy than the initial reactive complex IIbRC. Hence,
in terms of relative free energy, it is the lowest in energy of all such intermediates IIC, IIaIC,
and IIbIC obtained herein.
As for the other systems examined, the subsequent cleavage of the Ado763′O—Ccarb bond
requires an acid to ultimately transfer its proton, directly or indirectly, onto the leaving
tRNAThr's Ado763′-oxygen. In this present scenario, the most probable proton sources are the
ammonium of Lys156 or the now neutral of Cys182. Hence, both possible pathways were
considered.

5.3.2.2.1. Protonation of Ado763′O involving Lys156.
In both

IIb

RC and, in particular,

IIb

IC, a second active water (W2) is positioned near

both the ammonium of Lys156 and the

Ado763′-oxygen.

Indeed, in

IIb

IC the water W2

simultaneously forms strong hydrogens bonds with both of these groups; r(Ado763′O…HOW2
= 1.78 Å) and r(Lys156NH…OW2 = 1.70 Å), Figure 5.8. Water-mediated transfer of a proton
from the ammonium of Lys156 onto the Ado763′-oxygen is able to proceed through IIbTS21 at
an enzymatically feasible cost of 20.8 kcal/mol relative to the initial reactive complex IIbRC,
Figure 5.9. As for all other mechanisms elucidated this barrier is the rate-limiting step of the
overall mechanism. Importantly, however, it is the lowest barrier obtained for this step of all
systems considered in this investigation.
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Figure 5.9. FES obtained (kcal/mol) for the two possible editing mechanisms elucidated in
which Cys182 acts as a base and His73 and His186 are neutral and the required acid for
cleavage of the

Ado763′O—Ccarb

bond is: Lys156 (blue line and labels); or Cys182 (red line

and labels).

In the product complex,

IIb

PC1, the noncognate serine and tRNAThr formed are now

significantly separated as illustrated by r(Ccarb…O3′Ado76 = 3.19 Å). Notably this product
complex was also thermodynamically the most favorable of all obtained being 53.6 kcal/mol
lower in energy relative to IIbRC, Figure 5.9. Collectively, the free energy values obtained
for this pathway, both kinetically and thermodynamically, support the likelihood of the
editing mechanism at least involving Cys182 as a water activating base.
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5.3.2.2.2. Protonation of Ado763′O involving Cys182.
The close proximity of the now neutral thiol of Cys182 to the Ado762′OH group suggests
the possibility that Cys182 may be able to acts as the acid, with the assistance of the Ado762′OH
group to protonated its adjacent Ado763′O center, Figure 5.8. However, such a process occurs
via IIbTS22 and requires an energy of 26.7 kcal/mol relative to IIbRC, which is higher than
obtained above for when Lys156 acted as the required acid. Furthermore, the resulting
product complex IIbPC2 is less favoured than IIbPC1 being only 16.7 kcal/mol lower in energy
than IIbRC. Thus, the Lys156 residue is kinetically and thermodynamically preferred as the
required acid.

5.3.2.3. Activation of Cys182 by His73, in the presence of a protonated or neutral His186.
It has been suggested that at least part of the role His73 may be to activate, deprotonate,
the thiol of Cys182.28 In this scenario both Cys182 and His73 would necessarily initially be
neutral, while His186 maybe either protonated or neutral. For completeness, both possible
scenarios were examined; that is, we examined possible mechanisms which being with
activation of Cys182. For the case in which initially both His73 and Cys182 are neutral but
His186 is protonated the optimized structure of the pre-reactive complex lies 10.3 kcal/mol
lower in energy than

IIa

RC; the reactive complex formed after activation. Furthermore,

proton transfer from the thiol of Cys182 onto His73 occurred with a barrier of 21.6 kcal/mol.
While this barrier is feasible, the previously described subsequent editing mechanisms that
proceed via IiaRC (Figure 5.6) all have markedly high barriers that are likely enzymatically
unfeasible. This proposal was thus discounted.
Alternatively, His73 may activate Cys182 in the presence of a neutral His186, i.e., all
three conserved residues (His73, His186 and Cys182) are initially neutral. The resulting free
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energy surface for the mechanism elucidated, along with schematic illustration of the
corresponding QM/MM optimized structures obtained, is shown in Figure 5.10. As before,
the first step is deprotonation of the catalytic Cys182 thiol by His73;28 that is, the conversion
of the pre-reactive complex

IIc

PRC into the required reactive complex

IIc

RC. This proton

transfer occurs via , IIcTS1 with a required energy of 21.7 kcal/mol. Notably, this barrier is
only 0.1 kcal/mol higher than obtained for the analogous step in the presence of a protonated
His186 suggesting that it does not exert significant influence on the activation step. In the
reactive complex IIcRC the Cys182 is now deprotonated while His73 protonated and His186
remains neutral. Importantly, it lies just 0.4 kcal/mol higher in energy than the pre-reactive
complex IIcPRC, Figure 5.10
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Figure 5.10. FES obtained (kcal/mol), together with optimized structures with select bond
distances shown (Angstroms), for the ThrRS editing domain's mechanism IIc in which
Cys182 acts as a base, but Cys182, His73 and His186 are all initially neutral.
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In

IIc

RC the Cys182 thiolate is hydrogen bonded to an active site water (W1),

r(Cys182S…HW1) = 2.04 Å. The latter moiety W1, as observed in the other mechanisms
examined herein, is also positioned in reasonable proximity to the substrate's Ccarb center with
a W1O…Ccarb distance of 3.22 Å. As in the previous scenarios, the thiolate of Cys182 facilitates
nucleophilic attack of W1 at the substrate's Ccarb center by simultaneously abstracting a
proton from W1. In this present chemical system, this step proceeds through IIcTS2 at a cost
of 27.9 kcal/mol (Figure 5.10). This is in fact the highest barrier obtained of all mechanisms
considered herein for the formation of a tetrahedral intermediate complex. Notably, it is 18.0
kcal/mol higher than that obtained for the corresponding step in the most preferred model
IIb (i.e., IIbTS1; Figure 5.9).
The oxyanionic tetrahedral intermediate formed, IIcIC, is 16.7 kcal/mol higher in energy
than the initial pre-reactive complex
Ado763′O—Ccarb

IIc

PRC. The second and final step is cleavage of the

bond. This is again found to preferentially occur simultaneously by a water-

mediated proton transfer from Lys156 onto the
IIc

Ado763′-oxygen.

This reaction proceeds via

TS3 and requires just 8.4 kcal/mol with respect to IIcIC; 25.1 kcal/mol relative to IIcPRC.

In the product complex IIcPC the now hydrolysed non-cognate serine and tRNAThr are 2.84
Å apart. In addition, it's formation is thermodynamically favoured having a relative energy
of -43.2 kcal/mol. However, while this is therefore clearly an exergonic mechanism, and
more favourable than some of the alternative pathways considered, its barrier for the ratelimiting step in this case is thermodynamically less favorable than that of the preferred
mechanism, IIb1 (see Figure 5.9).
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5.4 Conclusion
In this study we have performed an extensive systematic MD and QM/MM investigation
on the post-transfer editing mechanism catalyzed by the editing domain of ThrRS from
Escherichia coli for deaminoacylation of mischarged Ser-tRNAThr. In particular, a range of
possible scenarios have been examined in which either of the potential mechanistic bases
His73 or Cys182 deprotonate an active site water to facilitate the latter’s nucleophilic attack
on the substrate’s carbonyl center in a hydrolytic editing process. In addition, we examined
the potential of a His73-promoted pathway involving a non-hydrolytic selfcyclization/lactone formation. In total, the chemistry and feasibility of 11 different possible
mechanisms, within different possible active site protonation states, were examined and
compared.
When His73 acts as the initial base five different mechanisms were considered in which
it deprotonates either a nucleophilic water molecule (W1, resulting in hydrolytic editing) or
the Ser-AMP substrate’s serinyl β-OH, resulting in lactone formation. For those pathways in
which His73 activates W1 the mechanism essentially occurred in two stages: (i) nucleophilic
attack of W1 at the Ser-AMP's Ccarb center to form a tetrahedral intermediate; and (ii)
cleavage of the Ado763'O—Ccarb bond with protonation of the Ado763'-oxygen. The first stage
is a common one-step reaction with a free energy barrier of 27.6 kcal/mol. For the second
stage, several possible proton sources were considered. The most favorable pathway
proceeded via a one-step reaction in which Lys156 protonates the Ado763'-oxygen through a
second active site water molecule (W2) with a rate-limiting barrier of 33.4 kcal/mol. For the
His73-promoted lactone formation pathway, deprotonation of the β-OH group with
formation of the cyclic tetrahedral intermediate occurred with a barrier of 31.4 kcal/mol. The
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rate-limiting step of this pathway, however, was cleavage of the

Ado763'O—Ccarb

bond at a

cost of 32.8 kcal/mol.
For the Cys182-base scenarios, three chemical models with varying combinations of
protonation states for the conserved His73, His186 and Cys182 residues were used to
investigate the feasibility of six possible mechanisms. As with the alternate His73-promoted
hydrolytic editing mechanism, these occurred in two stages as above. Of all mechanisms
considered herein, the most kinetically and thermodynamically feasible pathway was
obtained when both His73 and His186 are in their neutral states, and Cys182 is in its thiolate
form. The first stage of the mechanism, Cys182 activation of W1 and formation of the
tetrahedral intermediate, occurs in one-step with a barrier of 9.9 kcal/mol. For the second
stage, cleavage of the

Ado763'O—Ccarb

step with Lys156 protonating the

bond, the most favorable pathway also occurs in one

Ado763'-oxygen

via W2 with a free energy barrier of 20.8

kcal/mol. The resulting product complex, with a relative free energy of −53.6 kcal/mol with
respect to its corresponding initial reactive complex, was also the most favored of all of the
mechanisms. Hence, the present results support the conserved Cys182 residue as being in its
thiolate form and acting as the required mechanistic base that initiates editing within the
editing domain of E. coli ThRS.
Importantly, given the noted similarities to the editing site of AlaRS and related enzymes
that share the same catalytic motif, this mechanism may be more generally applicable.
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6.1 Introduction
The central role of the aminoacyl-tRNA synthetase (aaRS) family of enzymes is to
catalyze the linkage of amino acids to their corresponding tRNA.1 For each existing amino
acid there is an aaRS that catalyzes its coupling onto the cognate tRNA via two half-stepscoo
all within their synthetic site: activation and acylation. First, the amino acid is activated via
reaction with adenosine triphosphate (ATP) to form an aminoacyl-adenylate intermediate
(aaAMP), followed by transfer of the aminoacyl (aa) moiety onto its cognate tRNAaa.
Impressively, this loading process occurs with a misacylation error of ~1 in every 10,000
reactions.3 Thus, aaRSs play a key role in the accurate translation of an organism's genetic
code into proteins.2 Defects in the aminoacylation process can result in misfolded and thus
incorrectly functioning proteins, which can eventually lead to disease states such as
neurodegeneration.4
Due to structural and chemical similarities between some amino acids it can be
challenging for the synthetic site of aaRSs to achieve proper discrimination. Consequently,
many exploit proof-reading (editing) mechanisms that selectively act against incorrectly
activated amino acids or aminoacylated tRNAaa to degrade them, often back to their
constituent components (Scheme 6.1).7 For example, several aaRS use a tRNA-independent
pre-transfer editing mechanism (Scheme 6.1; reaction 3) whereby the aminoacyl-adenylate
is hydrolyzed within the synthetic site.8
However, pre-transfer editing is not always solely sufficient to ensure the necessary
fidelity of aminoacylation, such as between isoelectric amino acids. Hence, an additional
post-transfer correction (editing) mechanism is often employed using a distal active site.9
Indeed, almost half of the aaRSs utilize post-transfer editing and thus behave as double sieve
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models.10 In this proofreading mechanism, misacylated tRNAaa is shuttled to the editing site
where the ester bond between the incorrect aminoacyl moiety and tRNAaa is cleaved
(Scheme 6.1). Interestingly, a triple-sieve editing mechanism is used by alanyl-tRNA and
prolyl-tRNA synthetases to ensure accurate aminoacylation.11
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Scheme 6.1. Schematic representations for the aminoacylation and editing mechanisms
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For instance, threonyl-tRNA synthetase (ThrRS) is a class II synthetase that must
necessarily discriminate between its cognate substrate threonine from the non-cognate
substrate serine. It is known to utilize a variety of editing mechanisms including pre-transfer
editing against serinyl-adenylate.7,12-13,14 Unfortunately, such editing is not sufficient to
achieve the necessary required high fidelity. With the exception of mitochondrial ThrRS,
bacterial, eukaryotic and archaeal ThrRS all possess a remote active site for post-transfer
editing.13 It is generally accepted that the editing domain sequence of ThrRS is not
evolutionarily conserved.3 Indeed, distinct from bacterial and eukaryotic versions that
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possess a universal editing domain found in both Thr- and AlaRS, archaeal ThrRS employs
a unique N-terminal post-transfer editing region.14 Accordingly, two different catalytic
scenarios have been suggested for the respective editing mechanisms in bacterial/eukaryote
and archaeal ThrRS. In the post-transfer editing mechanism of E. coli (bacterial) ThrRS,14
an active site cysteinyl15 or histidyl10 residue is thought to act as the base that deprotonates
the nucleophilic water and initiates the reaction.
In contrast, the editing mechanism of archaeal ThrRS is thought to be a paradigm for
most of the editing domains in the other aaRSs.16 Moreover, previous sequence analysis
demonstrated a substantial sequence similarity between the archaeon Pyrococcus abyssi
ThrRS (Pab-NTD) and D-amino acid deacylases (DTD).17,18 The latter domain is used by
aaRSs responsible for hydrolyzing misacylated D-aa-tRNA, thus preserving the
homochirality of proteins.19 The activity of this enzyme is extended to all the tRNAs
misacylated by a D-amino acid 46 Given their similarities, Pab-NTD ThrRS has been shown
to be capable of accommodating several D-amino acids, and thus is proposed to complement
the role of DTD in ensuring protein homochirality.3,20
For Pab-NTD, due to the apparent lack of direct involvement of the enzyme residues in a
way that could facilitate catalysis, post-transfer editing has been suggested to take place
through a substrate-assisted mechanism.3,7 In particular, based on experimentally obtained
structures, the free hydroxyl group of the adenosine ribose sugar of the tRNA (Ado762′- or 3′OH for class I and II respectively), appears to be the only potential base in close proximity
to the substrate's scissile ester bond. Furthermore, a significant inhibition in editing has been
observed upon its removal.10,21 Thus, it has been suggested that the Ado762′-OH or Ado763′-OH
group of the substrate (aa-tRNA) triggers the reaction by orienting a nucleophilic H2O
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molecule in close proximity to the aa-tRNA ester bond, i.e., the Ado762′-/3′-OH group plays a
structural or anchoring role.10 However, the precise role played by this hydroxyl group is still
debated.
The post transfer editing mechanism for different aaRSs has been the subject of several
computational studies. For example, Tateno and coworkers22 performed a Molecular
Dynamics (MD) study in order to identify essential residues in the editing mechanism of
leucinyl-tRNA synthetases for removing the noncognate valine.22 A nucleophilic H2O
molecule was observed to be consistently hydrogen bonded with the Ado763′OH group and in
close proximity to the carbonyl carbon (Ccarb) of the substrate (Val-tRNAleu). Consequently,
quantum mechanics/molecular mechanics (QM/MM) free energy simulations were
performed to explore the reaction. It was concluded that it involves a self-cleaving hydrolytic
mechanism assisted by the substrate's own

Ado763′OH

group.7,16 The hydrolytic editing

mechanism of the mislinked alanine in the freestanding editing domain (INS) of prolyl-tRNA
synthetases has also been explored using QM/MM calculations.23 Similarly, it was concluded
that the

Ado762′OH

group is crucial for positioning the nucleophilic H2O for subsequent

nucleophilic attack on the substrate's Ccarb center.
In this current study, we have complementarily used both MD simulations and QM/MM
methods to gain insights into the role played by the substrate's Ado762′OH group in the posttransfer editing mechanism of Pab-NTD ThrRS. Similarities between the fully-substrate
bound editing site and biocatalysts involving ribozymal catalysis were noted.24,25 In
particular, the function of the free RNA hydroxyl group is either to appropriately position
and anchor the nucleophilic H2O26 or to directly participate in the catalytic mechanism in the
ribosome.27 Hence, the investigations were broadened to examine the applicability and
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feasibility of analogous tRNA substrate-mediated pathways in the editing site of ThrRS
including concerted and step-wise anchoring, and single or double proton shuttle
mechanisms (Schemes 6.2 and 6.3).

6.2 Computational Methods
6.2.1 Molecular Dynamics Simulations
The Molecular Operating Environment (MOE) program28 was used to prepare all
chemical models for the MD simulations with the X-ray crystal structure of the editing
domain of ThrRS from Pyrococcus abyssi with bound seryl-3'-aminoadenosine (PDB ID:
2HL1)3 used as the initial template. The link nitrogen atom in the ester bond was replaced
with an oxygen atom and the protonation states of all the residues were assigned according
to the PropKa protonation tool implemented in MOE. All crystallographic water molecules
were removed except for two positioned near the substrate. The model was then minimized
using the molecular mechanics (MM) forcefield AMBER12. The complex was then solvated
by adding a layer of water to 6 Å around the enzyme-ligand system, resulting in a system
with total number of 11000 atoms. The generated chemical model was then submitted for a
second MM minimization using AMBER12.
The final complex was then submitted for an unconstrained 10 ns MD simulation using
the NAMD program,29 with a time step of 2 fs under constant pressure and temperature until
the system reached an equilibrium state. The generated conformations from this MD
simulation were analyzed based on their root mean square deviations (RMSD) of the heavy
atoms of their active site residues. The obtained RMSD values were then clustered and the
most representative structure (with the most prominent conformation) was chosen for the
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subsequent QM/MM calculations. This structure was then minimized using the AMBER12
forcefield. Finally, a suitable chemical model for the QM/MM calculations was then derived
by truncating the system to only include all residues and waters within 20 Å of the active
site’s substrate (2000 atoms in total).

6.2.2 QM/MM calculations
To elucidate the proofreading mechanism, we utilized the hybrid ONIOM QM/MM
approach30-31 as implemented in the Gaussian 09 suite of programs.32 This approach has been
shown to be a powerful tool for examining many related catalytic mechanisms.33-34 The entire
chemical model was divided into two subsystems based on their level of contribution to the
reaction, Figure 6.2. The active region, high layer, was described using a quantum
mechanical (QM) method while the remaining protein environment is treated using a MM
method.
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Figure 6.1. Illustration of the high layer (QM region) of the QM/MM model used in this
study.
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The QM region, consisting of 88 atoms, included the substrate 3'-seryl-adenosine
(SerAA), a model of serine bound to the A76 residue of tRNAThr, two H2O molecules and
the backbone chain of Pro116 and Ala82 as they are thought to stabilize the accumulated
negative charge on the oxygen atom (Ocarb) in the transition state. In addition, the R-group
of Lys121 was included as it is thought to be important in orienting and positioning the
nucleophilic H2O molecule in close proximity to the substrate’s ester group.7 In addition,
Lys121 is also conserved in the editing sites of other aaRSs wher it is thought to play a similar
role.35 Glu134 was also included in the QM region due to its role in positioning the substrate
through a salt bridge formation with the substrate’s α-NH2.3 Indeed, mutation of either
Glu134 or Lys121 dramatically diminishes post-transfer editing activity.3 To describe the
QM region the density functional theory methods B3LYP.36 M062X and M06HF37 in
conjunction with the 6-31G(d,p) basis set were used, while the AMBER96 forcefield38 was
used to describe the surrounding protein environment, i.e, the low (MM) layer.
Hence, optimized geometries and frequencies were obtained at the ONIOM(B3LYP/631G(d,p):AMBER96) level of theory, as were the corresponding Gibbs free energy
corrections (ΔGcorr). Relative energies were determined by performing single point energy
calculations

on

the

above

optimized

structures

at

the

ONIOM(B3LYP/6-

311+G(2df,p):AMBER96) level of theory. Only the Ca centers in the low layer were held
fixed, all other atoms being free to move during optimizations.
It is important to note that all mechanisms were studied using three different DFT
functionals; B3LYP, M062X and M06HF. In particular, we have evaluated the ability of
these functionals to reliably and accurately describe the studied mechanisms and their
thermochemistry, with the results summarized in Table 6.1. It was observed that the
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mechanism was sensitive to the % of HF exchange-correlation (XC) included. The M06HF
functional, that has the highest XC% contribution, provided a better kinetic description of
the mechanism. It is also clear from this table that, M062X gave more reasonable energy
values relative to B3LYP, in agreement with previous theoretical studies on ribozymal
catalytic mechanisms.39-40 Thus, in the following discussion we will focus only on the data
obtained using the M06HF functional to describe the QM region.

6.3 Results and Discussion
6.3.1. Concerted mechanism
Initially, the substrate Ser-AA in the optimized reactive complex (RC) was found to be
positioned in the optimal orientation required for the subsequent nucleophilic attack through
salt-bridge formation between the Glu134COO– group and the serine’s side chains (α-NH2 and
the β-OH) at r(Glu134COO–…HOβSer) = 1.89 Å and r(Glu134COO–…H2NαSer) = 1.57 Å. More
importantly, the nucleophilic H2O molecule (W) is also placed nearby the substrate in
optimal position to interact with the ester bond, r(OW…Ccarb) = 2.93 Å, and the angle of
nucleophilic attack (ÐOw…Ccarb––Ocarb) is 87.6°. The latter water molecule is held in this
position through forming a strong hydrogen bond network with the main chain Ocarb of
Pro116 residue, r(HW… OPro116) = 1.43 Å, the side chain of Lys121 residue, r(HW…NLys121)
= 1.41 Å, as well as the Ado762′OH group, r(HW…OAdo76) = 1.91 Å. Moreover, the Ocarb atom
forms a moderately strong hydrogen bond interaction with the main chain −NH− of the Ala82
residue at a distance of 2.15 Å. The hydrolytic mechanism is initiated by a nucleophilic
attack of the oxygen atom of the water molecule (Ow) on the Ccarb of the substrate, leading to
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the formation of a new Ccarb−Ow bond. This is followed by cleavage of the ester bond, where
the bridged oxygen (Ob) abstracts proton from the dissociated H2O molecule.

6.3.1.1 Anchoring Mechanism:
In this mechanism, the nucleophilic H2O molecule attacks the Ccarb atom and its proton is
instantly shifted toward Ob atom of the ester bond through a 4-membered ring transition state
(ITS4), Scheme 6.1. The obtained free energy barrier for this step is found to be 32.7
kcal/mol, which is quite a high barrier enzymatically, as a result of the geometrically
constrained 4-membered ring. In this transition state, the substrate is positioned in a less
productive hydrogen bond orientation relative to the main chain −NH− of Ala82 residue,
which is required to stabilize the generated negative charge on the oxyanion. In this position,
the Ocarb…HNAla82 interaction is now weaken at distances of 2.30 Å with 0.15 Å further
relative to RC, Table 6.2
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Scheme 6.2. Schematic illustration of the concerted mechanisms studied for: (a) the
anchoring mechanism (4-membered ring); (b) proton Shuttle (6-membered ring); and (c)
double-proton shuttle (8-membered ring).

I

TS4 is followed by the formation of the product complex (PC1) where the Ccarb…Ob

distance is drastically elongated to 3.07 Å. Obviously, the Ado762′O of the adenosine-leaving
group is stabilized by forming a new (Ob––H) single bond with a length of 0.97 Å, whereas
the departure of serine amino acid is facilitated by forming a new Ccarb––OHw1 bond with
length of 1.32 Å. Relative to the initial reactive complex RC, the product complex PC1 lies
5.6 kcal/mol lower in energy suggesting a thermodynamically favorable product complex.
The free energy surface for this concerted scenario is shown in Figure 6.1.
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Figure 6.2. The optimized molecular structures for the obtained transition states (TSs) with
selected bond lengths in Angstroms (Å).
Moreover, to better clarify the precise role for

Ado762′OH

group following the current

anchoring pathway, we investigated the mechanism in the presence of the deoxy substrate
Ado762′H

group instead of

Ado762′OH.

molecule and the substrate’s

Ado762′OH

Notably, the missing hydrogen bond between W
led to a negligible change in the position of the W

molecule to the Ccarb by an increase of just 0.07 Å relative to the distance obtained in the
wildtype RC. Identical to the RC, the W1 molecule is tightly held in this place by forming
a strong hydrogen bond with the main chain Ocarb of P116 with a distance of 1.40 Å in
addition to the presence of the conserved Lys121 residue (Ow1…HLys121) at a distance of 1.41
Å. Also, the angle of the nucleophilic attack (ÐOw…Ccarb___Ocarb) is now 90.14°. Thereby,
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the previously proposed role of the

Ado762′OH

group to align the nucleophilic W in

appropriate orientation might be possible inaccurate. More interestingly, the obtained energy
barrier for the 4-membered concerted mechanism was found to be even more favorable than
the one obtained in the presence of the Ado762′OH group with energy value of 25.4 kcal/mole
(data not shown).

Free energy in kcal/mol
32.7
I TS4

31.5
ITS8

26.1
ITS6

0.0
RC
-5.6
PC1

Figure 6.3. The calculated free energy surface in kcal/mol for the concerted mechanisms to
cleave the ester bond of the mischarged Ser-tRNAThr using M06HF functional.
In order to fill this gap of understanding, an alternative mechanism that might provide a
complete picture regarding the actual role of the Ado762′OH group in the mechanism has been
explored.
6.3.1.2 Proton-Shuttle Mechanism
In this pathway, the proton transfer to the leaving Ob atom is shuttled through the
assistance of the bridging

Ado762′OH

group, see Scheme 6.1, and subsequently we rather
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obtained a 6-membered cycle transition state, Scheme 6.1B. In fact, the 6-membered cycle
formation/breaking mechanism in the ribosome studies is found to proceed with a lower
energy barrier relative to 4-membered one.37 This preference is due in part to the presence of
more hydrogen bonds and more productive angles for the protons transfer process.
Importantly, the driving force for this kind of mechanisms is the development of low barrier
hydrogen bond (LBHB), which is known to significantly contribute in facilitating many
enzymatic catalysis.38 This type of LBHB interaction takes place when two atoms or more
with similar pKa values form strong hydrogen bonds and thus can share a proton matching
the geometry of our system. The optimized transition states with the important bond lengths
for this mechanism (ITS6) are shown in Figure 6.2. The energy barrier for this step was
found to be 26.1 kcal/mol, approximately 6.7 kcal lower than the value obtained in the 4membered one (ITS4) and hence enzymatically more feasible (Figure 6.3). In this ITS6, the
developed negative charge on the oxyanion atom is stabilized through hydrogen bond
formation with the amide linkage −NH− of the Ala82 residue at a distance of 2.05 Å which
is 0.10 Å shorter and thus stronger interaction than the corresponding one in ITS4.

Table 6.1. Calculated energy barriers in kcal/mol for the various mechanisms (represented
by

their

transition

state

label)

obtained

at

the

ONIOM(DFT

method/(6-

31G(d,p):AMBER96).

DFT
Method

Transition State
I

TS4

I

TS6

I

TS8

II41

II

TS14

II

TS24

II

TS16

II

TS26

II

TS26`

B3LYP

31.1

34.8

48.5

49.3

41.9

45.6

40.3

43.1

36.2

M062X

34.9

33.1

38.1

39.7

36.0

39.8

30.6

29.0

40.7

M06HF 32.7

26.1

31.5

36.9

32.3

36.0

25.9

30.45

25.9
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In an effort to identify a lower energy barrier via better stabilization of the oxyanion in
I

TS6, we attempted to provide extra hydrogen bond interaction as suggested before.39

Specifically, we expanded our chemical model in the QM layer to comprise more residues
(main side chain of His83 residue and an extra bridged H2O molecule), offering more
hydrogen bond to the Ocarb atom, r(Ocarb…HH2O) = 1.80 Å. Reoptimization of the new
complexes along the same concerted proton shuttling pathway did not lead to a considerable
change in the energy barrier relative to the smaller QM model (data not shown). Thus, charge
stabilization on the Ocarb atom does not contribute significantly in the obtained energy barrier
in the system studied herein.

6.3.1.3 Double–Proton shuttle Mechanism
Notably, there are two water molecules trapped near the critical Ado762′OH group in our
chemical model. Thereby, an 8-membered ring concerted mechanism is also explored in our
investigation. Specifically, the proton transfer process from the nucleophilic W molecule to
the

Ado762′OH

group takes place through a second bridged water molecule (double-proton

shuttle mechanism), ITS8 in Scheme 6.2c.
In contrast to ITS6, ITS8 costs a higher energy barrier with a value of 31.47 kcal/mol, Figure
6.3 and Table 6.1 However, regardless of the increased number of hydrogen bonds involved
in the proton transfer process in ITS8, it is less energetically favorable due in part to its
geometric distortion, suffers from steric hindrance, Figure 6.2 Moreover, ITS6 has a quite
strong hydrogen bond with more planar ÐOcarb__Ocarb…NHAla82 bond angle of 156.2° for the
oxyanion stabilization; while the same angle in the case of ITS8 is found to be less productive
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with value of 116.2°, (although r(Ocarb…NHAla82) = 1.87 Å), indicating a deviation of the
substrate from the most productive orientation in the active site.
The optimized molecular structures with selected bond lengths for places where bond
formation and bond breaking take place are shown in Figure 6.2. Comparing between the
key bond distances in these three transition states, (ITS4, ITS6 and ITS8) it was noticed that,
the most significant change in the geometry of the models corresponds to locations where
bond forming and breaking takes place. Specifically, the Ccarb__Ob bond distance (r1) is
mostly cleaved in case of ITS4 and ITS6 complexes with values of 1.79 and 1.65 Å
demonstrating a late transition state while in the ITS8 the same bond is slightly cleaved at a
distance of 1.48 Å. In agreement with this observation, we noticed the newly forming bond
OW__Ccarb (r2) is more advanced in the case of ITS4 and ITS6 with distances of 1.53 and 1.48
Å than its value of 1.61 Å in ITS8, Figure 6.2.

6.3.2. Two-step Mechanisms
6.3.2.1. Anchoring Mechanism
The accumulated negative charge on the oxyanion group in the transition states was thought
to be the main reason for the overestimated barriers. As a result, an alternative step-wise
mechanism was proposed through two subsequent steps with two 4-membered ring transition
states along the pathway, Scheme 6.3, pathway a.35, 40-41
In the first step of this mechanism, a 4-membered ring (IITS14) is formed through a
concurrent step of a nucleophilic attack on Ccarb and the proton of the W molecule is instead
transferred to Ocarb atom. The latter proton transfer might provide more charge neutralization
to the developed negative charge on the Ocarb atom, Scheme 6.3. This transition state leads
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to a formation of diol intermediate complex (IC) where Ccarb atom forms two single bonds
with two different OH groups (OHW or OHcarb). This intermediate complex is followed by a
second proton transfer from one of the new hydroxyl groups to the Ob, stabilizing the leaving
group in the product complex (PC1 or PC2) through another 4-membered transition states
(IITS24 or IITS24′), Scheme 6.3.
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After exploring all these possibilities, the obtained barriers are found to be quite high,
Table 6.1. Accordingly, the two-step anchoring mechanism is also kinetically inappropriate.
Overall, the generated oxyanion is not the only factor that influences the obtained energy
barriers; the constrained 4-membered ring transition state has a significant impact on the
energy costs as noticed previously in similar chemical systems.36, 42 Subsequently, another
two-step proton shuttle mechanism through a 6-membered cycle transition state has been
considered, Scheme 6.3.

6.3.2.2 Proton-Shuttle Mechanism
This proton shuttle mechanism is initiated by a proton shift from the Ado762′OH group to
the Ocarb atom. Though IITS16, an advanced Ow…Ccarb distance (r2) at 1.31 Å is observed to
represent a new bond formation. Importantly, the negatively charged Ocarb atom is further
counterbalanced via the shuttled proton from the Ado762′OH group at Ocarb__H bond length of
1.42 Å (r2), Figure 6.2. However, the energy barrier for this step is found to be 25.9
kcal/mol, which is just 0.17 kcal lower in energy than the concerted one (ITS6). Indeed, the
latter transition state is considered the most feasible step among the other transition states.
The next step is the formation of the diol IC, which is identical to the previous one mentioned
in the 4-membered step-wise mechanism. Afterwards, a second proton transfer process
occurs from one of the newly generated hydroxyls of the IC to the Ob atom and then
formation of product complex where the labile ester bond is cleaved and the serine is
released, Scheme 6.3, pathway b. As we discussed earlier in the step-wise anchoring
mechanism, there are two different possibilities for the reactions to move from the
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intermediate IC into one of the product complexes PC1 or PC2. In the first possibility, the
second proton shuttle step will take place from OHw hydroxyl group to the Ob atom though
a cyclic 6-membered transition state (IITS26). A higher energy barrier than the first one with
value of 30.5 kcal/mol is needed for this IITS26 to proceed. Alternatively, the second step
proton transfer (IITS26′) occurred through a proton shuttle from the OHcarb atom to the Ob
atom at a lower energy barrier with value of 25.9 kcal/mol, Figure 6.4. The obtained key
distances for these two transition states are shown in Figure 6.2. Notably, the facile Ocarb__Ob
bond (r5) is slightly cleaved to a distance of 1.58 Å in case of IITS6. Meanwhile the same
bond is observed to be 1.87 Å in case of IITS26, indicating a late transition state. This
significant difference in the bond lengths induces a geometric change in the surrounding
residues; the negatively charged Ob center in IITS26′ is counterbalanced by forming a quite
stronger hydrogen bond with the nearby Lys121 residue with the assistance of a bridged
water molecule, r(Ob…HW1) = 1.46 Å. This hydrogen bond is not observed in the IITS26,
which might be the reason for its higher energy barrier with respect to IITS26`. In addition,
the accumulated negative charge on Ocarb atom, that is neutral in IITS26, is neutralized by the
amide chain –NH– of Ala82 at distance of 2.42 Å in IITS26′.
The following step will be the generation of different product complexes according to
the source of the offered proton to the leaving group as well as the position of the OH group
in the releasing serine, Scheme 6.3. Both product complexes are thermodynamically
favorable and lie at -5.8 and -2.3 kcal/mol in energy for PC1 and PC2 respectively. The
obtained free energy surface for the optimized complexes along these pathways is shown in
Figure 6.4.
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Figure 6.4. The obtained free energy surface in kcal/mol for the most favorable step-wise
mechanism occurring through a 6-membered ring transition state.

Collectively, the post transfer editing pathway is believed to be more favored through a stepwise proton shuttle mechanism from a kinetic perspective. Additionally, the two-step
mechanism gave a slightly more stable transition state (IITS26) than the concerted one (ITS6),
Table 6.1.
6.3.3 D-amino acid deacylase function
AaRSs play a central role in preserving the overall homochirality of the protein by
discriminating between the enantiomeric species of the cognate L-amino acid against the
noncognate D-amino acid.43 This homochirality is maintained by using another freestanding
checkpoint called D-amino acid deacylases (DTD) responsible for hydrolyzing the
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misacylated D-aa-tRNA.44,45 The activity of this enzyme is not restricted for specific tRNA,
but is extended to all the tRNAs misacylated by a D-amino acid. Interestingly, previous
sequence analysis demonstrated a substantial sequence similarity between the N-terminus
motif in Pab-NTD ThrRS and DTD.44,45 As a result, Pab-NTD ThrRS was found to be
capable of accommodating several D-amino acids, and thus is proposed to complement the
role of DTD in perpetuating the homochirality.3, 46 To study the ability of the current editing
model to hydrolyze the D-Thr–tRNAThr and function as a deacylase, we investigated the
proton shuttle editing mechanism with D-Thr-AA as the substrate.

Free energy in kcal/mol

29.2
III TS6

0.0
III RC

-5.4
III PC

Figure 6.5. The obtained free energy surface for the deaminoacylation of D-threonine by
the editing site of ThrRS.

Notably, the optimized

III

RC for this new complex shows that the nucleophilic W

molecule is held in the optimal position required for nucleophilic attack, r(Ow…Ccarb) = 2.92
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Å. Similar to the obtained geometry in RC in which serine is the substrate, W is oriented
productively as a result of forming strong hydrogen bonds with Ado762′OH, the side chain of
Lys121 and the main chain Ocarb of Pro116 with distances of 1.93, 1.41 and 1.43 Å,
respectively. Following the concerted proton-shuttle mechanism where the rate limiting step
is a 6-membered cycle transition state (IIITS6), we observed a kinetically favorable barrier
with 29.2 kcal/mol with respect to IIIRC. The obtained bond distances for this transition state
indicates a late transition state where the carbO__Ow bond is more advanced toward a typical
single bond (1.48 Å) and the Ccarb…Ob bond is mostly cleaved at a distance of 1.65 Å. The
substrate’s oxyanion group is stabilized through forming a moderately strong hydrogen bond
with the main chain of Ala82 residue, r(Ala82NH…Ocarb) = 2.02 Å. Later, IIITS6 is followed
by the formation of

III

PC where the ester bond of D-threonine-AA substrate is entirely

cleaved, r(Ccarb…Ocarb) = 2.45 Å, and a new single OH bond is formed in the leaving group.
The free energy surface for the correcting mechanism of D-threonine is shown in Figure 6.5
Accordingly, the elucidated editing mechanism takes place through a kinetically feasible
barrier if D-threonine is the substrate. This barrier is a strong precursor suggesting the
possibility of the Pab-NTD editing model to employ the extra DTD function. Importantly,
this editing pathway for eliminating the attached D-amino acid might be universal for the
other DTD enzymes, which has substantial similarity to the one studied here.
6.4 Conclusion
To explore the post-transfer proofreading mechanism of the archaeal ThrRS editing site,
we applied molecular dynamics (MD) and quantum mechanics/molecular mechanics
(QM/MM) methodologies. Assessing three different DFT functionals; B3LYP, M062X and
M06HF indicated the sensitivity of the computational models to the amount of XC%
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included and the M06HF functional with a full-HF exchange functional resulted in the lowest
energy barriers.
After exploring different editing mechanisms, the obtained energy barriers of either the
concerted or the stepwise mechanisms via the geometrically constrained 4-membered ring
transition state are kinetically less favorable compared to the 6-membered ones.
Interestingly, the role played by the Ado762′OH group to align the nucleophilic H2O molecule
in close vicinity to the ester group is suggested experimentally, removing it during the 4membered ring mechanisms showed negligible differences in the calculated energy barriers.
Significantly, the contribution of the

Ado762′OH

group in the proton shuttle from the

nucleophilic water molecule to either the Ob (concerted) or Ocarb (two-step) dramatically
decreases the energy barrier to 26.1 and 25.9 kcal/mol, respectively. Importantly, in a good
match with the experimental results, the Ado762′OH group is found to necessarily trigger the
correction mechanism. Additionally, using this elucidated mechanism, an extra deacylase
activity of the editing site of archaeal ThrRS has been confirmed.
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QM/QM Investigation on The Pretransfer Editing Mechanism in SeryltRNA and Isoleucyl-tRNA Synthetases

Ser-/IleRS
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Chapter 7
7.1 Introduction
The accuracy of the genetic translation of RNA is of central importance for the proper
functioning of the coded proteins and cell survival. This process is carried out by the
fundamental aminoacyl-tRNA synthetases (aaRSs), enzymes that are noted for their
remarkable precision.1 Importantly, any limitation in the fidelity of translation can result in
fatal diseases including cancer.2-3 The entire family of enzymes is split into two main
subclasses, class I and class II, according to structural differences in their catalytic sites.5
Each of the twenty aaRSs is only responsible for the transfer of its native amino acid to the
cognate tRNA. Therefore, a deeper understanding of the accuracy of the catalytic function
of the aaRSs is a matter of growing interest.4
The active site of the aaRS catalyzes a two-step process, namely amino acid activation
and tRNA acylation. Initially, it juxtaposes both the amino acids and the ATP in a
productive orientation for the activation step to occur. In this step, the carboxylate group’s
oxygen atom of the amino acid nucleophilically attacks the phosphorous atom of the ATP
molecule leading to the formation of aminoacyl-AMP and releases the inorganic
diphosphate group (Scheme 7.1).6 The acylation step then takes place, whereby the amino
acid is covalently attached to the terminal adenosine of the cognate tRNA, resulting in
aminoacyl-tRNA.
In fact, aaRSs perform their functions with a translation error rate of 1:10000, which is
remarkable enough for aaRS to be known as the paradigm of molecular specificity.7 In
order for the aaRS to achieve this outstanding specificity, their active sites recognize the
corresponding amino acids and reject any larger or similar ones. However, it is a complex
task for some of these enzymes to correctly distinguish their native amino acids and reject
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the isosteric and isoelectronic noncognate ones.8 To ensure the high fidelity of the
translation process, aaRS utilize numerous proofreading mechanisms including pre-transfer
(removing the misactivated adenylate) or post-transfer (excluding the misacylated-tRNA)
editing mechanisms.9-10
The location for post-transfer editing to take place is a separate active site known as
the editing domain.7 Meanwhile, the hydrolysis of the undesired aa-AMP intermediate can
occur in several different places places.12 Firstly, the synthetic site might eject the
misactivated aa-AMP substrate into the cytoplasm which then undergoes uncatalyzed
hydrolysis.13 Alternatively, this hydrolysis might take place in the synthetic site by a
tRNA-independent pre-transfer editing process. However, within the synthetic site is the
most common location for pre-transfer editing pathway in aaRSs.
Unusually, IleRS, a class I aaRS, seldom utilizes a tRNA-dependant pre-transfer editing
mechanism.14-15 This atypical reaction contributes almost one-third to the entire editing
mechanism employed by Escherichia coli IleRS. In fact, IleRS’s exclusion of the
structurally similar valine takes place by employing both pre- and post-transfer hydrolysis
processes.16-17
In the pre-transfer tRNA-dependant mechanism, the misactivated Val-AMP is
transferred from the synthetic site to the remote editing region and then the pre-transfer
proofreading takes place. This suggestion was supported by a recent X-ray crystal structure
of the misactivated Val-AMP substrate in the editing region of E.coli IleRS.18 Accordingly,
it is suggested that the editing domain is the dedicated location that hosts all the different
types of editing mechanism employed by IleRS in contrast to most of the aaRS.19
Furthermore, it has been argued that IleRS is able to accommodate the homocysteine and
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edit it before its incorporation to the tRNA to help prevent, for instance, cardiovascular
diseases.20 In response, we explored the pre-transfer editing mechanism against
homocysteine in the editing region of IleRS using a suitable X-ray structure (PDB ID:
1WK8).18
The class II aaRS seryl-tRNA synthetase (SerRS), which is responsible for the ligation
of serine to the corresponding tRNASer, relies only on pre-transfer editing to discriminate
against the misactivation of the noncognate and structurally similar cysteine and threonine
aminoacids.21 Despite the lack of a separate editing region, the pretransfer editing in SerRS
is sufficiently efficient as to achieve an outstanding level of discrimination.22 In particular,
methanogenic archaeal SerRS contains a Zn(II) metal ion in its active site that is essential
for substrate recognition.23 Moreover, SerRS is also responsible for charging the tRNASec
with serine for the indirect biosynthesis of selenocysteine (Sec).24
It is generally accepted that the active site of most aaRSs do not have a catalytic
residue that can promote the reactions, and as a result a substrate-assisted mechanism is the
most common scenario,25-28 although there are suggested exceptions.29 Importantly, a selfcyclization mechanism has been suggested in the active sites of many enzymes to edit
against the toxic homocysteine (Hcy).11 In this mechanism, one of the nonbridging oxygens
of the phosphate group (O1p) of the aa-AMP substrate acts as the base that deprotonates the
substrate's thiol. The resulting thiolate sulfur then attacks the sp2 carbonyl carbon of the
substrate (Ccarb) and the resultant thiolactone is released, Scheme 7.1.30 Similarly, LysRS
excludes misactivated ornithine-AMP in the form of ornithine-δ-lactam, by which the
terminal ammonium group of the substrate was deprotonated and the resultant R-NH2 is the
nucleophile.31 Consequently, the pre-transfer editing mechanism by IleRS against the
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unnatural amino acid Hcy, and SerRS against the non-cognates cysteine and threonine
might follow the same pathway through self-cyclization mechanism.
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Scheme 7.1. The generally proposed self-cyclization mechanism in the pre-transfer editing
against Hcy.11
AaRSs are widely recognized as novel drug targets for different infectious diseases.32
IleRS in particular has been identified as the target for the antimicrobial compound
mupirocin, which is currently being used for treatment of both bacterial skin infections and
the fatal parasitic infection African Trypanosomiasis.33-34 Essential to the development of
new and more potent therapeutic drugs is a more complete understanding of how such
enzymes may act against them.35-36
In this study, we have computationally investigated the pre-transfer editing
mechanisms of IleRS and SerRS against possible noncognate amino acids. In particular, the
applicability of the common substrate-assisted self-cyclization mechanism for such
reactions was examined.
7.2 Computational Methods
2.1 Molecular Dynamics Simulations
We started our simulation by considering X-ray structures of each enzyme with bound
substrate analogues, PDB ID: 1WK818 and 2CJ923, respectively. Using the Molecular
Operating Environment (MOE) software37 we performed the required chemical
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modification for each enzyme to mutate the substrate to its native form. The Val-adenosine
monosulfate (AMS) analogue substrate in 1WK8 was changed to Hcy-AMP; the sulfur
atom in sulphate group was mutated to the native phosphorous atom HcyAMP…IleRS/tRNAIle. Moreover, in case of 2CJ9, the sulfur atom in the sulfate group of
the Cys-AMS was mutated to phosphorous atom and three different models containing
three different substrates naming Ser-AMP….SerRS/tRNASer and the noncognate CysAMP…CysRS/tRNACys and Thr-AMP….SerRS/tRNASer have been prepared. The
ionization states of all the residues have been identified based on the predicted pKa using
the available tool in MOE. In each generated model, we have performed solvation using 2
Å layer followed by MM minimization using AMBER12 forcefield. Later, the minimized
systems were initially submitted for 100 ps equilibration from 0 to 300 K temperatures at
constant pressure where tether ranges from 0 to 100 Å have been applied on heavy atoms.
N345

D328
R336
Hcys-AMP

C306
Zn(II)

Cys-AMP

P324
C461
E355

R353
G325

SerRS (PDB ID: 2CJ9)

IleRS (PDB ID: 1WK8)

Figure 7.1. The selected residues treated in the QM layer in SerRS (left model) and in
IleRS (right model).
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Then, under constant pressure and temperature, each generated model was submitted
for 10 ns MD simulation with a time step of 10 ps using the NAMD engine.38 The
conformations generated from the MD simulations were then analyzed based on their root
mean square deviation (rmsd) values which then clustered and the average structure with
the most prominent conformation has been selected to be the representative model. Starting
from this structure we derived our QM/QM chemical models after truncating it to include
the first shell of the residues around the substrates. (Total number of atoms is 744 atoms in
IleRS and 656 atoms in SerRS).
7.2.2 QM cluster and QM/QM calculations
To investige the validity of self-cyclization mechanism in the pre-transfer editing
pathway in the studied models, the alternative hybrid ONIOM (QM/SE) scheme was
used.39-40 In this approach, each system has been divided into two main subsystems
according to their importance into the catalytic mechanism. The active site residues are
considered in the high layer that is represented by DFT using the hybrid functional
B3LYP41-42 as implemented in Gaussian 0943, Figure 7.1. Meanwhile, the surrounding
protein environment is treated by semiemperical (SE) PM3 method instead of the standard
QM/MM to improve the description of the coupling interaction.44 Indeed, this methodology
has been noticed to be successful in exploring different catalytic mechanisms and Znmetalloenzymes in aprticular.45-47 In the case of IleRS, the QM layer comprises the HcyAMP substrate, Asp328 residue that form a salt-bridge interaction with the amino group of
the substrate as well as the backbones of Pro324 and Gly325 residues. In addition to four
water molecules were added to stabilize the accumulated negative charges on the Ocarb and
O2p during the progress of the reaction, total number of atoms in this layer is 84 atoms.
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Meanwhile, the QM layer in SerRS contained the substrate, Arg353, Arg336 and
Asn345 residues and two water molecules to help neutralizing the phosphate oxygens as
well as Ocarb atom. Moreover, the tetracoordinated Zn(II) with its binding residues (Glu355,
Cys461 and Cys306) have been added to the high layer due to the direct coordination
between the substrate-NH2 group and the Zn(II) metal ion, total number of atoms in this
QM layer is 107 atoms, Figure 7.1. Later, frequency analyses were also computed at
ONIOM (B3LYP/6-31G(d,p):SE), which is the optimized level of theory, in order to
ensure the nature of the stationary points and also to calculate Gibbs free energy (ΔGcorr).
Relative energies were calculated by performing single point energy calculations at the
ONIOM (B3LYP /6-311+G (2df,p): PM3) level of theory.
To gain further details regarding the impact of protein environment on the behavior of
the catalytic mechanism and the overall geometry of the active site, we have explored the
mechanism using Quantum Mechanics cluster calculations.48 The QM cluster approach is
known to be a successful tool for studying enzymatic reactions.49 In this approach, only the
active site’s significant residues (which is identical to high layer of QM/SE system used
herein) are considered in the cluster calculation. As described in the methods section, only
the active site residues are excised and the remaining protein is omitted. Each residue was
capped by adding a hydrogen atom to the respective carbon (143 atoms). Afterwards,
single point energy calculations were performed using B3LYP/6-311+G(2df,p). Meanwhile,
the frequency calculations were also performed at the optimization level of theory
(B3LYP/6-31G(d)) to estimate the Gibbs free energy corrections (ΔGcorr).
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7.3 Results and discussion
7.3.1 MD results
According to our MD simulation on both IleRS and SerRS, the substrates were
noticed to adopt a unique bent conformation in the active site. The aminoacyl-adenylates
functional groups, i.e., the R–SH terminal of Hcy and Cys or the R–OH of Thr and Ser
amino acids are in an optimum orientation for a proton transfer reaction to take place with
the assistance of O1p of the AMP group. Figure 7.2 indicates the change in these distances
along the 10 ns MD simulation as well as the adopted conformation for both Cys and Hcy
in SerRS and IleRS, respectively. During 10 ns simulation run the average SHcy…O1p
distances are found to be 3.58 Å, 5.53 Å and 5.39 Å for Cys-AMP, Thr -AMP and SerAMP, respectively in the active site of SerRS, Figure 7.2A. In addition, the intramolecular
distance between the R-S(O) group and the Ccarb atom is noticed to be 3.27, 2.87 and 2.86
Å for Cys-AMP, Thr-AMP and Ser-AMP, respectively. Similarly, in the active site of
IleRS, the average
while the

HcyS

HcyS

…O1p distance during the simulation run was found to be 4.54 Å

…Ccarb is found to be 4.57 Å, Figure 7.2B. Accordingly, the active site

pockets of IleRS and SerRS recognize all the substrates in a specific conformation required
for the self-cyclization mechanism.
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Figure 7.2. The conformation adopted by the substrate as well as a plot indicating the
change in selected key distances resulted from the MD simulation; A) for the Cys-AMP in
SerRS and B) for Hcy-AMP in IleRS.
7.3.2 QM/SE Investigations
7.3.2.1 Pre-transfer editing against Hcy-AMP by IleRS
The first optimized model using QM/SE calculations for Hcy-AMP in the active site of
IleRS suggested a less favorable orientation of the substrate, IRCHcy. In this state, the aH3N+ is hydrogen bonded to the nearby Asp328 residue with

Asp328COO

-… +

N H3 distance

of 1.85 Å, Figure 7.3. Interestingly, the R–SH terminal of the Hcy-AMP substrate is not
positioned nearby the O1p atom which is required for initiation of the reaction.
Consequently, we performed a dihedral scan calculation around Cb__Cg bond to obtain a
better conformation of the substrate for the pre-transfer editing mechanism to proceed. This
dihedral scan cost a free energy barrier of 24.3 kcal/mol (ITS1Hcy) and lead to the formation
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of IICHcy where the R-SH group of the Hcy substrate is tilted down to form hydrogen bond
with the O1p atom, Figure 7.3. This hydrogen bond interaction is formed with the
assistance of a bridging water molecule (W1) at HcyS(H) …OW1 and O1p…HW1 distances of
2.15 and 1.69 Å, respectively, Figure 7.3.
In this intermediate complex, the substrate is positioned productively for the
subsequent concerted mechanism through a cyclic transition state ITS2Hcy. The O1P atom
deprotonates the R-SH of the Hcy-AMP with the assistance of the mediating W1 and the
thiolate group attacks the Ccarb atom of the substrate to complete the substrate-assisted
mechanism with an energy barrier of 23.2 kcal/mol. Relative to the energy barrier required
for ITS1Hcy, ITS2Hcy is more kinetically favorable and therefore the first transition state (of
the dihedral scan) is the rate-limiting step. In ITS2Hcy the

HcyS

…Ccarb distance has

shortened to 2.22 Å and concomitantly the Ccarb___Ob bond has significantly lengthened to
1.72 Å. Moreover, in this late transition state the O1p atom becomes protonated by forming
typical O1p__H single bond with a length of 1.01 Å. Also, it should be noted that the
transient thiolate ion in this step is stabilized via the formation of moderately strong
hydrogen bonds to the bridged W1 and another water molecule with distances of 2.17 and
2.59 Å, respectively. Moreover, the negative charge on the O2P atom is also stabilized
through hydrogen bond formation with a nearby water molecule with distance of 1.71 Å.
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23.2
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Figure 7.3. Optimized molecular structures during the studied substrate-assisted selfcyclization mechanism in IleRS with selected key distances as well as free energy
differences. The values in blue color obtained using QM-cluster calculations.
In the product complex the homocysteine has formed a thiolactone, IPCHcy, which can
then be released from the active site, Figure 7.3. Notably, this step is found to be exergonic
as the IPCHcy lies lower in energy than IRCHcy at −24.6 kcal/mol. In this step, the
HcyS

__

Ccarb distance is 1.78 Å, indicating a typical C__S single bond. Meanwhile, the

Ccarb…Ob bond is entirely cleaved at 3.11 Å. The

Asp328COO

…H3NHcy salt bridge

interaction is maintained during the reaction, demonstrating the importance of the Asp328
residue in positioning the substrate for the reaction to proceed. After studying the same
mechanism using QM methodology, the overall scenario is found to be kinetically feasible
following the same two-step mechanism obtained in the QM/SE calculations, with
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insignificant changes to the bond distances. This reasonable change in the interactions may
be a result of the flexible geometry of the models when studied in the gas phase. We also
explored the possibility that the bridged oxygen (Ob) could be the base that initiates the
reaction. According to our QM calculations, the rate-limiting step is now the second
transition state with an energy barrier of 45.9 kcal/mol, indicating an enzymatically
unacceptable barrier (data not shown). Thus, the O1p atom is the initiator of the reaction.

7.3.2.2 Pre-transfer editing against Cys-AMP by SerRS
The model generated from the initial MD simulation of the Cys-AMP…SerRS
structure was submitted for QM/SE simulation. In the first optimized reactive complex,
II

RCCys, the Cys-AMP substrate adopts a more linear conformation, unlike its orientation in

the previous MD simulation. In this orientation, the Ocarb atom is hydrogen bonded to the
amide NH2 of Asn345, r(NH2…Ocarb) = 2.41 Å. The O1p atom is stabilized by the
formation of hydrogen bonds to the guanidine groups of two nearby arginine residues,
Arg336 and Arg353; Arg363 provides two moderately strong hydrogen bonds with
distances of 2.44 Å and 1.85 Å while a single hydrogen bond with distance of 1.75 Å is
provided by Arg353, Figure 7.4. Considering the charge stabilization around the O2P atom,
the O1p is relatively less susceptible to hydrogen bonding interactions except for the
formation of two hydrogen bonds with two different water molecules, r =1.85 and 1.75 Å.
The O1p atom is thus more basic and hence more likely to act as the base. The Zn(II) ion
adopts a tetracoordinate geometry where the N atom of the substrate’s a-NH2 occupies the
fourth coordinated ligand with distance of 2.15 Å. Notably, this geometry is maintained
during the progress of the reaction. Similar to the self-cyclization mechanism of Hcy-AMP
in the editing site of IleRS, the overall mechanism occurs through two main steps. Initially,
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a dihedral scan was performed around the Cb__Cg bond to obtain a more favorable
orientation of the

CysSH

group for the substrate-assisted mechanism. Then, the

deprotonation/nucleophilic attack of thiolate group onto the Ccarb to form the cysteine
thiolactone, Figure 7.4.

N345
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R336
R336
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2.89
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2.44
1.85
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1.89

1.75

Cys-AMP

R336

R336

1.84
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1.79

2.13

R353

IIICCys

R353

IIRCCys

2.12
1.60
2.03

1.96

1.74

R353
IIPCCys

R353
IITS2Cys

Figure 7.4. Optimized molecular structures along the studied substrate assisted mechanism with
selected key distances when Cys-AMP is the substrate in IleRS.

Owing to obtain more favorable position for the nucleophilic attack to take place, the
II

RCCys complex is then submitted for dihedral scan calculation which noticed to be barrier-

lees with an energy of −8.1 kcal/mol, IITS1Cys in Figure 7.5. This remarkable low barrier
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demonstrated the strong preference of the Cys-AMP to adopt the telted conformation for
the pre-transfer editing mechanism to occur.
Later, is the formation of the intermediate complex IIIC1Cys where the substrate is in
more reactant-like orientation, Figure 7.4. This intermediate complex lies at −5.7 kcal/mol
relative to IIRCCys supporting the feasibility of this intermediate, Figure 7.5.
The binding orientation of the Cys-AMP enables the Cys-SH group to be in direct
interaction with the O1P atom of the substrate, r(CysS-H…O1p) = 2.89 Å, while maintaining
the other hydrogen bond interactions with the substrate, Figure 7.4. This

II

ICCys is

followed by a concerted transition state, IITS2Cys, where an intramolecular deprotonation of
the thiol group by the O1p atom is accompanied by nucleophilic attack on the Ccarb atom,
Figure 7.4. This step was found to be rate limiting with an energy barrier of 14.6 and 20.4
kcal/mol relative to

II

RCCys and

II

IC1Cys, respectively, Figure 7.5. Accordingly, the

proposed pre-transfer editing in SerRS against the noncognate Cys takes place through a
kinetically feasible self-cyclization mechanism. In this transition state, the Ccarb…Ob bond
is partially cleaved at 1.60 Å, while the S…Ccarb is partially formed at 2.12 Å, Figure 7.4.
Moreover, the hydrogen atom of the substrate’s R-SH group is entirely shifted towards
the O1p atom, r = 0.98 Å, indicating a late transition sate. Arg336 and Arg353 are found to
play essential roles in stabilizing the developing negative charge on the Ocarb and O1p
atoms. Arg336 forms two hydrogen bonds with distances of 2.05 and 1.84 Å, while Arg353
provides further charge stabilization to the Ocarb atom with a hydrogen bond distance of
1.96 Å, Figure 7.4. All these factors may contribute to the obtained enzymatically feasible
barrier. From this transition state is formed the product complex IIPCCys where the Cys
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thiolactone is completely established and Ccarb has moved 2.97 Å away from the Ob atom.
Notably, the Arg336 and Arg353 residues maintain their hydrogen bond interaction with
the Ccarb and O2p atoms. Arg336 forms two moderately strong hydrogen bonds with
distances of 2.13 and 1.79 Å to the Ocarb and O1p atoms, respectively. Similarly, the
guanidine group of Arg353 forms hydrogen bond interactions at 2.03 and 1.74 Å, Figure
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Figure 7.5. The free energy surface of the self-cyclization mechanism in SerRS; the black,
red and blue colored surface is for Cys-AMP substrate, Thr-AMP and Ser-AMP substrates,
respectively.
This IIPCCys is found to be thermodynamically favorable with an energy 3.6 kcal/mol
lower than IIRCCys, Figure 7.5. The formation of this 4-membered cysteine thiolactone is
thermodynamically less favorable than the formation of the 5-membered homocysteine
thiolactone, which is likely to be a result of the geometrically constrained 4-memered ring
versus the more favorable 5-memberd one obtained in the IPCHcy.
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7.3.2.3 Pre-transfer editing against Thr-AMP by SerRS
As mentioned in the Section 7.1, the aminoacylation site of SerRS accommodates the
native serine amino acid and edits against the structurally similar cysteine (Section 7.3.2.2)
and threonine. Accordingly, we expanded our study to examine the validity of a selfcyclization mechanism in the pre-transfer editing against the non-cognate Thr-AMP.
Overall, the mechanism is noticed to be identical to the case of Cys-AMP and takes place
through two main steps, Figure 7.6. The Thr-AMP is in the linear conformation in the first
optimized structure, IIRCThr, similar to our observation of IIRCCys. Notably, the type of
interaction between Thr-AMP substrate and surrounding residues is almost identical to the
analogous Cys-AMP, Figure 7.6. The only significant difference between the two
substrates is the absence of a hydrogen bond between substrate’s Ocarb with the nearby
Asn345. The Zn(II) ion adopts a tetracoordinate, tetrahedral geometry with the substrate
being the fourth ligand through its amino group, r(a-NH2…Zn) = 2.10 Å.
The first step in the mechanism is the dihedral scan which was found to be kinetically
accessible with an energy barrier of just 0.7 kcal/mol relative to IIRCThr, Figure 7.5. This
scan process lead to the generation of a thermodynamically favored (−0.6 kcal/mol lower in
energy than IIRCThr intermediate complex IIIC1Thr, where the Thr-AMP substrate adopts a
bent conformation, Figure 7.6. In this conformation, the OH group of the substrate is
directly hydrogen bonded to the O1p atom with distance of 2.26 Å. The following
cyclisation step is initiated by intramolecular proton abstraction from the alcohol group by
the substrate’s O1p atom and concomitant nucleophilic attack onto Ccarb to form a cyclic
tetrahedral intermediate. The energy barrier for this step is 26.6 kcal/mol relative to
II

IC1Thr indicating an enzymatically acceptable rate-limiting step, Figure 7.5.
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In the product complex, IIPCThr, the Ob___Ccarb bond is cleaved entirely at 3.08 Å and a
cyclic lactone derivative is formed, Figure 7.6. However, the formation of IIPCThr is
thermodynamically unfavorable at 2.6 kcal/mol higher than IIRCThr which is 6.1 kcal/mol
more than the IIPCCys, Figure 7.5.
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Figure 7.6. Optimized molecular structures of the studied substrate-assisted editing
mechanism of SerRS with selected key distances in Å when Thr-AMP is the substrate.

7.3.2.4 The validity of pre-transfer editing against the cognate Ser-AMP
Our calculation was further extended to include the native Ser-AMP substrate to
investigate the difference between the cognate and the noncognate substrates in the selfcyclization mechanism. Initially, the information obtained from our MD simulation did not
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highlight any significant difference between them. Using the QM/SE approach, the first
optimized model, IIRCSer indicates an identical binding geometry of Ser-AMP to the other
non-cognate Cys-AMP and Thr-AMP substrates. The Ser-AMP substrate is positioned
linearly in the active site and its a-NH2 group coordinates to the tetrahedral Zn(II) metal
ion with distance of 2.11 Å. Moreover, careful investigation of the type and distances of
interaction between Ser-AMP substrate and the surrounding environment indicates a
negligible change during the progress of the reaction relative to the Cys-AMP and ThrAMP cases.
Following the two-step substrate assisted mechanism, we have successfully identified
all the structures along the pathway, Figure 7.7. The dihedral scan results in an energy
barrier of 4.3 kcal/mol which is 12.5 and 3.6 kcal/mol higher than the required energy for
the corresponding step in Cys-AMP and Thr-AMP, respectively, Figure 7.5.
This IITS1Ser is followed by the formation of the IIIC1Ser where the serine’s OH group
forms a hydrogen bond with the O1p atom of the substrate with distance of 2.12 Å, Figure
7.7. Unlike the corresponding complex in the case of the non-cognate substrates, the IIICSer
is thermodynamically higher in energy than IIRCSer by 7.4 kcal/mol indicating that this is a
less favorable orientation for the Ser-AMP substrate relative to the linear one, Figure 7.5.
Next is the deprotonation of the OH group of the substrate by the adjacent O1p atom
and simultaneous nucleophilic attack of the incipient alkoxide on the sp2 Ccarb of the
substrate, Figure 7.7. This step was observed to have a high-energy barrier at 31.5 and 24.1
kcal/mol relative to its corresponding IIRCSer and IIIC1Ser, Figure 7.5.
In fact, this is the highest energy barrier obtained among all the studied substrates,
indicating the infeasibility of SerRS to edit out the cognate serinyl substrate. We tried to
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explore any geometrical change which might be the reason for this significant difference in
the energy barrier between

Cys

TS and

Ser

TS. Our careful investigations on the transition

states demonstrate the identical binding of the substrates in both cases. Particularly, the
exact same types of interaction with negligible change in the distances have been noticed,
Figure 7.4 and Figure 7.7. Considering the difference in the pKa value between the Cys
and Ser amino acids with the former being more likely to give its proton, this may be a
considerable factor indicating the lower cost in energy to obtain IITSCys, Figure 7.5.
In the product complex IIPCSer the cyclic serine intermediate is formed 2.97 Å away
from the monoprotonated AMP. Interestingly, unlike our finding for the other substrates,
the formation of IIPCSer is found to be energetically unfavorable and lies 17.7 kcal/mol
higher in energy than the corresponding IIRCSer, Figure 7.5.
Notably, relative to IIPCCys there is a significant change in the geometry of IIPCSer.
Specifically, Arg353, which is known to have a stabilizing interaction with the Ocarb atom
in both IIPCCys and IIPCThr, shows no interaction in IIPCSer, Figure 7.7. Instead, it forms a
single hydrogen bond interaction with O2p atom with a distance of 2.18 Å. Accordingly,
the pre-transfer editing against Ser-AMP is not enzymatically feasible from both a kinetic
and thermodynamic perspective.
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Figure 7.7. Optimized molecular structures along the studied substrate-assisted mechanism
with selected key distances when Ser-AMP is the substrate.

7.3.3. Self-cyclization mechanism using QM-only approach
To study the impact of treating the protein environment implicitly, we have utilized
QM-only approach to study the same mechanism. Except for Asn345, similar models to the
QM layer in the QM/SE model have been prepared with total number of 65 atoms. We
successfully characterized all the intermediates and transition state along the pathways for
the different substrates Cys-AMP Thr-AMP and Ser-AMP. Notably, due to the gas phase
optimization utilized in this case, considerable change in the types of interaction between
each substrate and the surrounding amino acids (data not shown).
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Figure 7.8. The relative free energy surface of the self-cyclization mechanism in SerRS
utilizing QM-only approach; the black, red and blue colored surface is for Cys-AMP
substrate, Thr-AMP and Ser-AMP substrates, respectively.

Despite these structural changes the obtained free energy surfaces (Figure 7.8) is
quite similar to the ones obtained utilizing the more accurate QM/SE approach. The rate
limiting step is found to be IITS2′ prior to the formation of the final product complex IIPC′.
As for the QM/SE findings, the rate-limiting step for the self-cyclization of Ser-AMP is
noticed to have the highest energy cost. Furthermore, the obtained intermediate complex
for the Ser-AMP substrate is less thermodynamically stable relative the cases for the other
non-cognate substrates. In all the studies cases, the product complex was found to be
energetically favorable yet it is the least stable in the case of the cognate Ser-AMP
substrate. Overall, the QM-only methodology could provide satisfactory estimations of the
free energy surface in less time.
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7.4 Conclusion
The pre-transfer editing mechanism in IleRS and SerRS has been extensively explored
utilizing Molecular Dynamics, Quantum Mechanics/Semiempirical (QM/SE) and QM
approaches. Our findings indicated that both enzymes employ self-cyclization mechanism
to prevent the incorporation of the misactivated Hcy, Cys and Thr substrates. Our MD
simulation demonstrated the tendency of all the studied substrates to adopt bent
conformations in their corresponding active sites. Furthermore, in case of the editing of
IleRS against Hcy-AMP, the rate limiting step is found to be the first transition state that
involves a dihedral scan and costs relative free energy of 24.3 kcal/mol. However, in the
case of the pre-transfer editing in SerRS, the rate limiting step is the second transition state
with a concerted step of intramolecular proton shift from the R-SH/-OH group of the
substrate to the substrate’s O1p atom and a concomitant nucleophilic attack on the sp2 Ccarb
atom. This step has energy barriers of 26.0 and 14.6 kcal/mol for the non-cognate CysAMP and Thr-AMP substrates, respectively.
Meanwhile the same step is found to enzymatically infeasible if Ser-AMP is the
substrate and a kinetic barrier of 31.5 kcal/mol was obtained. Additionally, the following
intermediate complex in the studied substrate-assisted mechanism for IleRS (with the HcyAMP substrate) and SerRS showed a relatively stable complex where the substrates adopt
tented conformations suitable for the editing mechanism to proceed through selfcyclization. Lastly, the generation of the cyclic product complex where the non-cognate
amino acids and AMP are moved apart are found to energetically favorable except the case
for the native Ser-AMP. Interestingly, omitting the impact of the protein environment
during the QM only approach lead to a successful treatment of the mechanism and the
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obtained free energy surface shows significant homology with the corresponding ones from
the more accurate QM/SE methodology.
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Synthetase.
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8.1 Introduction
Due to increasing resistance against current antibacterial drugs, an urgent need to develop
new antimicrobial agents for novel targets has arisen.1 Among the various enzymes used as
antibiotic targets, aminoacyl tRNA synthetases (aaRS) have been widely validated as novel
antimicrobial agents.1-3 AaRS are a ubiquitous family of enzymes that play a crucial rule in
protein biosynthesis. Based on some differences in structural characteristics, this family of
enzymes is divided into two main classes: class I and class II.4 AaRS catalyze the attachment
of the cognate amino acid onto its respective tRNA through two main half-steps. Initially,
the amino acid is activated by reacting with adenosine triphosphate (ATP), forming an
aminoacyl-adenylate (aa-AMP), Scheme 8.1. Then, the activated amino acid is covalently
attached to either the 2′- or 3′-OH group (based on the class) of the 3′-terminal adenosine
(Ado76) of the corresponding tRNAaa.
Insertion of a noncognate amino acid into a protein sequence will lead to abnormally
folded proteins6 that directly trigger serious diseases such as neurodegeneration,
tumorgenesis, and eventually cell death.7-9 Hence, for each amino acid there is a specific
aaRS which must be able to discriminate between the structurally similar amino acids in the
cellular pool to guarantee faithful translation; employing different proofreading functions in
either their catalytic sites (pre-transfer editing) and/or in a separate editing region (posttransfer editing).5, 10 Consequently, they are able to perform their task of aminoacylating their
corresponding tRNA with outstanding fidelity; the mistranslation error is on the order of 1045

. Since there are known structural differences between bacterial and human aaRS,

inhibition of aaRS function in bacteria can be exploited to cause selective prevention of their
growth and thus elimination of the infection.11 In particular, bacterial threonyl-tRNA
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synthetase (ThrRS) is a primary antibiotic target that has been considered recently through
the uncompetitive inhibitor Borriledin which inhibits the catalytic function of ThrRS through
binding to a hydrophobic region near the active site.12 More specifically, upon binding it
induces a conformational change in the adjacent active site and, as a result, obstructs the
optimal binding of the substrate to the cofactor. In addition, ThrRS has been proven to have
a significant function related to angiogenesis as antiangiogenesis action is observed upon its
inhibition by Borriledin.13 However, the binding site of Borriledin is conserved in both
bacterial and human ThrRS, and thus it lacks selectivity for the bacterial enzyme.14
O
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Scheme 8.1. Schematic representation of the general two-step aminoacylation mechanism
catalyzed by aaRS.
In contrast, the aminoacylation (catalytic) site does exhibit structural differences between
the bacterial and human species. Hence, the alternative use of competitive inhibitors that
bind in the catalytic site may display better selectivity for the bacterial enzyme.15 In such
cases, binding of the inhibitor would render the cognate threonine unable to bind and hence
the rate of aminoacylation would be significantly diminished. Most of these types of

195

Chapter 8
inhibitors are naturally occurring compounds; for instance, the most clinically widely used
aaRS inhibitor is mupirocin, a bacterial isoleucyl-tRNA (IleRS) synthetase inhibitor.16 Other
naturally occurring inhibitors include indolmycin17 that acts against tryptophanyl-tRNA
synthetase, cispentacin2,

18

that functions against IleRS and prolyl-tRNA synthetase,

ascamycin2 that inhibits phenylalanyl-tRNA synthetase, and albomycin19 which represses
serinyl-tRNA synthetase function. Another competitive inhibitor is β-Hydroxynorvaline
(βHNV), an unnatural amino acid that differs by a single –CH2- group from threonine, has
been experimentally shown to readily bind to the catalytic site of ThrRS.20-21
A number of experimental studies have been performed to understand the catalytic
activity of ThrRS as well as the main features of its active site.20, 22-25 It is well-known that
its catalytic site contains an essential Zn(II) that adopts a penta-coordinated structure:20, 23
binding to three enzyme residues (His385, His351 and Cys334) in addition to the threonine
substrate's a-NH2 and β-OH groups. The noncognate substrate serine, also having a β-OH
group, can bind in a similar manner to the Zn(II) metal atom and thus can be activated by
ThrRS while valine cannot.26 Importantly, ThrRS appears to only recognize and activate
amino acids that can form a Zn(II)-O-β interaction. The non-natural amino acid βHNV
contains just such a substituent OH group and does bind within the active site Zn(II) in a
manner similar to that of the threonine. As a result, ThrRS is unable to discriminate against
it with high fidelty, and instead catalyses its activation and subsequent aminoacylation at a
high rate; only 30-fold less than the cognate threonine.20 Moreover, ThrRS appears to possess
no ability to edit against βHNV in either its aminoacylation site nor editing sites. As a result
it is incorporated into the protein sequence, acting as inhibitor for its growth.21
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Herein, we have performed detailed computational studies to gain deeper insights into the
aminoacylation of βHNV within the synthetic site of ThrRS in order to more fully understand
the required chemical characteristics to achieve proper inhibition. We have followed the
same substrate-assisted concerted scenario elucidated by our group previously and shown in
Scheme 8.1,27 using MD simulations in combination with detailed ONIOM(QM/MM)
calculations.28 Furthermore, we investigated the active site-bound βHNV which may be
helpful for designing potentially more potent analogues. To determine the most effective
chemical conformation, we have considered the acylation mechanism for a systematic
isomeric series of substrates, based on the position of the substituted ethyl relative to the
substrate’s α-NH2 group. Moreover, since protein biosynthesis is a homochiral process, we
have also investigated enantioselective translation of βHNV.29 Additionally, we have also
performed an assessment on the performance of a variety of GGA density functionals to
obtained reliable results. Finally, we performed further calculations to verify the critical role
played by the Zn(II) in the active site by mutation with the structurally similar but larger and
toxic Cd(II) which also has a closed shell. We then recalculated the relative free energy of
the aminoacylation pathway in the presence of Cd(II).
8.2 Computational Methods
To prepare the βHNV chemical model with the right conformation, we compared between
the chemical stability of three different possibility according to the orientation of the –C2H5
group as in Figure 8.1. Notably, isomer b was found to have the lowest energy accordingly,
the most stable amongst the other isomers followed by conformer c., Figure 8.1. Therefore,
we mainly considered these two conformers for subsequent MD and QM/MM calculations.
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a)

b)

c)

Figure 8.1. Optimized structures of the different βHNV isomers with different orientations
of the terminal methyl using the B3LYP/6-31++G(d,p) level of theory.
8.2.1 Molecular Dynamics simulation:
Based on recent X-ray crystal structures (PDB ID: 1QF6) for the cognate threonine in
ThrRS active site22 and previous studies done by our group, we adjusted the βHNV ligand
orientation mimicking the Thr-AMP….ThrRS/tRNAThr template to obtain the βHNVAMP….ThrRS/tRNAThr Michaelis complex for the two conformers, a and b, Figure 8.1,
using the Molecular Operating Environment (MOE)30 software package. The protonation
states of the residues were assigned according to the protonation tool implemented in MOE.
The two obtained models were solvated by adding a 2 Å layer of water molecules followed
by molecular mechanics (MM) minimization using the AMBER12 forcefield until the root
mean square gradient fell below 0.01 kcal/mol·Å. Under constant pressure, the generated
structures were then submitted for 100 ps annealing equilibration from 150 to 300 K. Finally,
the generated complexes were then submitted for 10 ns MD simulation with a time step of 2
fs using NAMD engine.31 All simulations were carried out under unconstrained pressure and
temperature and at a cutoff of 10 Å for non-bonded interactions and tether ranges from 0–
100 Å applied to the heavy atoms. Latter, we analyzed the generated trajectories based on
their root mean square deviation (RMSD) differences. Clustering analyses were then carried
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out and a representative structure with the most dominant conformation for each complex
was chosen for the subsequent analysis. Notably, after performing alignment analysis
between these two representative models, we did not observe any considerable changes in
the average distances for the most important interactions between the ligand and the
surrounding active site residues. After superimposing the two active sites, an RMSD value
of 0.31 Å was noticed, Figure 8.2. Thereafter, we minimized the representative models using
the AMBER12 forcefield and then truncated them to generate our chemical models for the
subsequent QM/MM analyses (see below).

C334%

A76%
R363%

H385%
Zn(II)%
H351%
D383%

aaAMP%

Figure 8.2. Overlay of the representative active site structures for the two substrate isomers
(H atoms are omitted for clarity).
8.2.2 QM/MM Investigations
The overall chemical structure is divided into two main subgroups within the active site
based on their importance to the catalytic mechanism applying the ONIOM formalism32-34
as implemented in Gaussian 09.35 The first subsystem is the chemically reactive region
consisting of 129 atoms and described at a QM level. This region include the βHNV-AMP
substrate, the Zn2+ atom and its three ligating residues, His385, His511, and Cys334, two
glutamine residues (Gln484, Gln381), three positively charged residues, Arg363, Arg383,
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Lys465, the adenosine76 of the cognate tRNAThr, and two water molecules. The second
subsystem is the remaining environment and was modeled using MM (total number of atoms
is 2283). The density functional theory B3LYP method,36-38 that has been previously
demonstrated to give the best performance in the description of Zn mettalloenzymes,39 with
the 6-31G(d,p) basis set was used to treat the QM region within the mechanical embedding
(ME) formalism, while the AMBER96 force field40 was used to describe the MM layer.
Furthermore, to estimate the sensitivity of the QM region to the amount of Hartree-Fock (HF)
exchange-correlation included, we performed an assessment on the kinetic performance of a
variety of GGA density functional (B3LYP* (15% HF contribution), B3LYP± (10% HF),
BP86 (0% HF), and M06L (0% HF)). Moreover, in order to address the major limitation of
the B3LYP functional in the description of vdW effects,41 we included Grimme’s DFT-D3
empirical dispersion corrections.42-43 It has been found that including dispersion corrections
enhances the reliability of the calculated energy barriers to better replicate experimental
results.44 Thus, we reoptimized our complexes after including such dispersion corrections..
For all the ONIOM calculations studied herein, relative energies were calculated by
performing single point energy calculations at the ONIOM (X/6-311+G (2df,p):Amber96)
level of theory where X is the different functionals used for the optimization. To characterize
the nature of the stationary point as well as to calculate Gibb’s free energy (ΔGcorr) and zeropoint vibrational energy (ZPVE) correction values, frequency analyses were computed at the
optimization level of theory, i.e., ONIOM (X/6-31G(d,p):Amber96)-ME.
8.3 Results and Discussion
8.3.1 Exploring the most enzymatically feasible isomer
In agreement with our previous calculations for the most dominant coordination state of
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Zn(II),28 the first structure we obtained from our QM/MM optimization on the first substrate
(case b in Figure 8.1) contains a tetrahedral coordinated Zn(II) metal ion where the βHNVAMP ligand is monoligated to it only through its α-NH2 group (bPRC). A high-energy barrier
of 183.8 kJ mol-1 was obtained for the rate-limiting step; too high to be considered
enzymatically feasible (data not shown). Alternatively, the Lewis acidity character of Zn(II)
with the assistance of the unbounded Asp383 residue allows the substrate to be in its
deprotonated form, a common behavior in many Zn-metalloenzymes.45-47 More specifically,
we obtained alternative pre-reactive complex inside this active site which differs in the
protonation state of βHNV-AMP’s hydroxyl group, Scheme 8.1.28 This enables the βHNVAMP substrate to be bidentately ligated to the Zn with both α-NH2 and the β-O- groups. The
latter observation is facilitated by the known flexibility of Zn(II) which can switch between
coordination states.39, 48-49 Notably, the difference in energy between these two prereactive
complexes (bPRC and PRC) is obtained to be just 0.74 kJ/mol and with a barrierless proton
transfer process at -22.6 kJ/mol, Figure 8.3. In this starting from the structure of βHNVAMP with deprotonated hydroxyl group, we followed the same suggested scenario, where
the subsequent step is the cleavage of the Zn(II)…NβHNV bond to form the reactive complex,
RC. In this RC, the NβHNV atom forms a moderately strong hydrogen bond with the hydrogen
atom of the Ado763'-OH group, r(βHNVN…H3'O)= 1.74 Å, and the Zn(II) atom is then switched
from pentacoordinated to tetracoordinate geometry whereas the βHNV substrate is
monoligated to the Z(II) through only its deprotonated β-OH group, r(βHNVOZn)= 1.99 Å,
Scheme 8.2. The optimized structures for the obtained transition states and product
complexes with selected bond lengths are shown in Scheme 8.2. The free energy surface for
the aminoacylation mechanism of βHNV-AMP is shown in Scheme 8.3.
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aPRC%
bPRC%

TS1%
20.8%
!22.6%

PRC%
14.9%

RC%
34.5%

TS2%
159.6%
90.2%

1.2%

PC%
21.6%

0.7%
!28.8%

Figure 8.3. The calculated free energy surface obtained at the ONIOM(B3LYP/6311G+(2df,p):AMBER96)+ΔGcorr level of theory for the overall acylation mechanism for the
neutral form (red surface) and deprotonated form (black surface) of βHNV-AMP substrate.

Following this reactive complex, the reaction takes place through a concerted step where
the Ado763'-OH is deprotonated, r(Ado763'O…H)= 1.52 Å, by the α-NH2 group of the substrate
concomitant with nucleophilic attack of the

Ado763'-oxygen

on the Ccarb center,

r(Ado763'O…Ccarb) = 1.88 Å, with an enzymatically feasible energy barrier of 90.2 kJ/mol. The
next step is formation of the product complex, PC in which a single bond between the Ccarb
and the now deprotonated

Ado763'-O

of the ribose sugar is formed, r(Ado763'-O…Ccarb)= 1.37

Å. As part of the concerted step, this is synchronous with cleavage of bO…Ccarb bond as
indicated by the 3.15 Å separation.
Indeed, because of the complete proton transfer from the nearby Lys468 residue through
a bridging H2O molecule to form a typical

pro-RO-H

single bond, the accumulated negative

charge on the Opro-R atom has been partially neutralized, facilitating the release of the
phosphate group as in the product complex PC, Scheme 8.2. This product complex lies 28.8
kJ mol-1 lower in energy with respect to bPRC.
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Scheme 8.2. The optimized molecular structures with selected bond lengths for the obtained
complexes in case of two different isomers. Blue colored values are for isomer (B) and the
black text for isomer (A).
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Collectively, βHNV can be easily acylated in the catalytic site of ThrRS matching the
experimental results.21 Moreover, we tested the possibility of acylation of the other
conformations of βHNV-AMP (isomer a Figure 8.1). The optimized molecular structures
with selected bond lengths for this conformation are shown in Figure 8.2. It is clear from
this scheme that the types of interaction of these two isomers with the surrounding residues
are almost identical in all the obtained complexes along the aminoacylation pathway. For
clarity, an overlay of the active sites of the reactive complexes for the two conformations is
shown in Figure 8.4. However, following the same aminoacylation mechanism, the energy
barrier for the proton transfer step where the neutral substrate (aPRC) is converted to its
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deprotonated form (PRC) proceeded with a higher energy barrier than the first case with a
value of 20.8 kJ/mol (TS1). In comparison with conformation b, this value is approximately
45.5 kJ/mol higher in energy. More importantly, the rate limiting-step was obtained to occur
through transition state with an enzymatically unfavorable energy barrier of 159.6 kJ/mol
(TS2). The product complex (PC) lies 21.6 kJ/mol higher in energy with respect to aPRC; a
relative energy difference of 50.4 kJ/mol, supporting the preference of only the first isomer
to be acylated which might guide the experimentalists for developing more potent inhibitors.

K465
H351

H334
Zn
R363

H385

D383

D381

Figure 8.4. Overlay of the two QM layers of the reactive complexes for the two different
conformations (a and b) of βHNV-AMP (H atoms are omitted for clarity).
8.3.2. An assessment on the performance of HF-XC:
Furthermore, we performed an assessment of a wide range of functionals to describe the free
energy surface of aminoacylation given the b conformation of unnatural amino acid βHNV.
Full reoptimizations were carried out using the functionals described in the methods section.
Notably, the mechanisms underwent through a similar trend displaying negligible changes
in the geometry; the bidentate substrate is more stabilized than the monodentate one.
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Specifically, the prereactive complex (PRC) with the deprotonated βHNV-AMP substrate
lies lower in energy than the corresponding neutral one by -5.47, -6.77, -6.62 kJ mol-1 for
B3LYP*, B3LYP± and BP86, respectively. Continuing the calculation starting from PRC,
we obtained the free energy surface for each functional, Figure 8.5.

TS

M06-L (0% HF)
B3LYP* (15% HF)
B3LYP/LanL2DZ
B3LYP± (10% HF)
BP86 (0% HF)

bPRC

PC

RC

8.3
8.9
8.8
5.3
6.6

128.1
101.7
87.6
77.8
61.8

-25.2
-27.5
-26.9
-25.1
-24.9

Figure 8.5. Free energy surface for the aminoacylation mechanism of βHNV using variety
of DFT functionals.
Notably, there is a good correlation between the amount of HF-XC included in each
method and the respective energy barrier. The smaller the portion of %XC, the lower the
energy barrier. Specifically, with respect to PRC (deprotonated substrate and thus
pentacoordinate Zn(II) ion), the calculated free energy barriers are found to be 87.6, 77.8,
61.8 kJ/mol, for B3LYP*, B3LYP± and BP86, respectively with BP86 to be most suitable
functional to describe such systems kinetically. Although varying the functionals shows a
dramatic impact on the energy barriers, the thermodynamic aspect is relatively unaffected
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since the calculated energy differences of the product complex for each method are quite
similar; -27.5, -26.8 and -25.1 kJ/mol for B3LYP*, B3LYP± and BP86, respectively.
Overall, the coordination geometry of the Zn(II) ion in the all studied functionals changed
typically from pentacoordinated in the case of a bidentate ligand (PRC) to tetracoordinated
in RC and the obtained bond lengths in PRCs are almost identical, Table 8.1. The latter
geometry was found to be consistent until formation of the product complex, PC. The
significant improvement in the obtained barrier was not a result of the representation of the
Zn(II) binding environment.

Table 8.1. The calculated bond lengths, in Å, for Zn(II) binding environment using different
DFT functionals.
Functional

Zn-C334

Zn-H351

Zn-H385

Zn-NH2

Zn-OH

B3LYP

2.47

2.02

2.13

2.14

2.14

B3LYP-D3

2.46

2.10

2.00

2.14

2.15

B3LYP*

2.46

2.12

2.00

2.14

2.15

B3LYP±

2.46

2.11

2.00

2.12

2.17

BP86

2.45

2.09

1.99

2.19

2.19

M06L

2.37

2.14

2.01

2.19

2.09

B3LYP/LANL2DZ

2.49a

2.19a

2.09a

2.22a

2.09a

8.3.3. The impact of including dispersion correction on the PES:
Adding dispersion correction to the GGA functionals has been widely shown to reduce
their limitations of describing long range interactions.50-51 The geometry of the obtained
complexes were reoptimized using Grimme’s dispersion corrected B3LYP-D3 and BP86-
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D3. Although there are slight differences in the interaction distances in the overall complexes,
the calculated energy barrier for the acylation mechanism treated by B3LYP-D3 functional
was found to be 93.3 kJ/mol relative to the PRC, Figure 8.6. Moreover, the energy of the
formed PC was thermodynamically favored with value of -51.1 kJ/mol with respect to PRC.
Therefore, the B3LYP-D3 method better represents our transition metal complexes and gives
results that are more suitable kinetically as well as thermodynamically than B3LYP. Also,
we performed the same calculation using BP86-D3. Typically, in comparison with BP86,
including long range interaction correction greatly improves the description of the energy
barrier to be 54.4 kJ/mol relative to the corresponding aPRC, Figure 8.6.
Consequently, our system is found to be very sensitive to both the dispersion correction
as well as the amount of XC% contribution in the utilized functional. Thus, we decided to
investigate the behavior of the hybrid meta exchange-correlation functional M06-L. As one
of Minnesota functionals, it was originally developed to approximately account for long
range interactions through empirical parameterization.52-53 In addition, it has 0% HF
contribution which was found to be reliable for describing systems containing transition
metals.54 Using this functional to describe the mechanism under study, the resulting barrier
was not as good as the one obtained using BP86, 128.1 kJ/mol relative to PRC.
TS&

Black&B3LYP+D3&
Red&BP86+D3!

PRC&

RC&
1.9&
+0.7&

93.3&
54.5&

PC&
+51.1&
+54.1&

Figure 8.6. The obtained free energy surface for the acylation mechanism using dispersion
corrected functionals.
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However, the obtained product complex, PC, lies 25.2 kJ/mol lower in energy relative
to PRC, Figure 8.5. The description of this functional for the Zn(II) complex interactions in
PRC does not possess any marked difference in the distances relative to the other functionals,
Table 8.1. To expand our study, we also assessed the performance of the effective core
potential LANL2DZ basis set for the description of Zn(II), while the remaining atoms were
represented by 6-31G(d,p). After reoptimizing the complexes, the obtained free energy
surface for the acylation of βHNV-AMP is shown in Figure 8.5 and the energy barrier for
the rate-limiting step increased slightly by to 101.7 kJ/mol with respect to bPRC which was
described with a normal basis set. The generated PC is 24.9 kJ/mol lower in energy than
b

PRC. Although this basis set gave slightly less reliable kinetic energy in comparison with

the common 6-31G(d,p) basis set, it provided us with a considerable barrier, supporting our
mechanism at less expense computational time, certainly an advantage for TM complexes.
In addition, by measuring the interaction distances between Zn(II) and the bound ligands,
Table 8.1, the obtained values are very similar; more evidence supporting the use of
LANL2DZ to describe this system.
8.3.4. Mutation of the active site’s Zn(II) to Cd(II):
To investigate whether the Zn(II) ion is essential, we determined the free energy surface
for aminoacylation of βHNV replacing Zn(II) with the chemically similar Cd(II).
Replacement with Cd(II) is expected to exhibit a great impact on proceeding with the
proposed mechanism. Indeed, we used the GenECP methodology to treat the metal with the
LANL2DZ ECP and the remaining atoms with the 6-31G(d,p) basis set, similar to the
investigations above. Unlike the Zn(II) complexes, the ligand binds differently to the Cd(II),
forming a unique prereactive complex, PRCCd, in an octahedral coordination geometry. In
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this structure, the interaction distances with the other protein residues (His383, His351 and
Cys334) are elongated and weakened, Table 8.1. Also, the β-OH group of the substrate
remains neutral and forms a quite strong hydrogen bond with the nearby Asp383 residue,
r(AspCOO–…HOβHNV) = 1.49 Å. However, this β-OH group is coordinated to the Cd(II),
r(Cd…OHβHNV = 2.21 Å), Scheme 8.3. In addition to an active site H2O molecule that binds
to Cd(II), r(Cd…OH2) = 2.34 Å, and becoming the sixth ligand in the octahedral geometry,
PRCCd.
Interestingly, in case of the reactive complex where r(βHNVN…HOAdo76) = 1.86 Å, the βOH group is deprotonated and it is now firmly binds to the Cd (II) atom, r(Cd…OHβHNV) =
2.44 Å) and the Cd…OH2 bond is lengthened to 2.94 Å. For the rest of the obtained complexes
along the reaction pathway, the Cd(II) is in a tetracoordinated geometry and the H2O
molecule no longer binds to Cd(II). Following the same acylation mechanism, the energy
barrier for the rate-limiting step of the mutant complex (TSCd) is observed to be 172.63
kJ/mol, much higher than the one observed for the native Zn(II) complex, Scheme 8.3.
To investigate the reasons for this high barrier, we superimposed the geometry of the two
transition states (for the mutant and wild type enzymes) and there are no considerable
differences; however, a distinct agreement in the obtained types of interactions was observed.
The obtained high-energy barrier may be due in part to the change in the coordination
geometry of Cd(II) from the 6-coordinate PRCCd to the 4-coordinate TSCd.
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Scheme 8.3. Optimized molecular structures with selected bond lengths in Angstroms and
relative energies (in parentheses; kJ/mol) for the obtained complexes in case of the Cd(II)mutant complexes.
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Similarly, the resulting PCCd is thermodynamically unfavorable, lying 59.7 kJ/mol higher
in energy than PRCCd. Based on these results, we argue that the single mutation of Zn(II) to
Cd(II) results in a drastic kinetic and thermodynamic changes in the free energy surface.
Thereby, we have unveiled the pivotal role played by Zn(II) its presence is mandatory for
the mechanism to proceed. Relative to Cd(II), the size of Zn(II) is small enough to bind only
three residues, Cys334, His351 and His385, in addition to the substrate. Except for the
substrate-binding mode, the tetracoordinated geometry obtained in the wildtype ThrRS
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between the Zn and the protein residues was consistent during the overall mechanism,
Scheme 8.3.
8.4 Conclusion
Using MD simulations followed by ONIOM(QM/MM) calculations, we elucidated the
aminoacylation mechanism of βHNV in the active site of ThrRS. In agreement with our
previous studies, the substrate should be in its ionized form for the reaction to occur.
Although two different conformations of βHNV-AMP bind in a similar manner to Zn(II) and
interact similarly with the other residues in the active site of ThrRS, a specific conformation
was found to be more kinetically favorable. This information is valuable in terms of
understanding the chemical features of the unnatural βHNV that could compete with the
cognate threonine for aminoacylation.
Moreover, the accuracy of different GGA density functionals, namely; B3LYP (20%
HF), B3LYP*(15%HF), B3LYP± (10%HF), BP86 (0%HF), and M06L have been assessed
in terms of their reliability in providing reasonable energy barriers for our system. The BP86
functional was found to be the most reliable kinetically and including dispersion correction
(BP86-D3) improve its accuracy in description of the pathway kinetically. The less
computationally expensive LANL2DZ was successful in representing the chemical reaction
kinetically without any considerable changes in the Zn(II) coordination geometry. The
importance of Zn(II) to promote the catalytic mechanism has been further verified by
performing our calculations in a mutated complex (Zn(II) to Cd(II)). The calculated energies
of the transition state as well as the product complex of the mutant are drastically increased,
preventing progress of the reaction.
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Library of Potential Competitive
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9.1 Introduction
The fundamental aminoacyl-tRNA synthetase (aaRS) family of enzymes are well known
by their vital role in protein biosynthesis1 in which they display exceptional catalytic
fidelity.2 For each amino acid, there is a particular enzyme responsible for its
aminoacylation to its corresponding tRNA.3-4 This family of enzymes is divided into two
classes, class I and class II, which are based on the distinct architecture of the protein. Each
class is comprised of ten amino acids.5 AaRSs catalyze aminoacylation processes in two
steps, namely, activation and acylation. In the activation step, the amino acid reacts with
adenosine triphosphate (ATP) forming an aminoacyl-adenylate intermediate (aa-AMP).6
This step is followed by an acylation step in which the amino acid is covalently linked to
its cognate tRNA through either the 2'- or 3'- OHAdo76 of the tRNA terminal adenosine,
depending on the enzyme class, forming the aminoacyl-tRNA product.7
In fact, it is well established that the accurate translation of amino acids is crucial for
proteins to function properly. A high number of mistranslation errors can lead to misfolded
proteins that promote many fatal diseases including neurodegeneration.8-9 Importantly, in
order to perform this outstanding task, aaRS employ editing functions by pre- and/or posttransfer proofreading pathways either in the synthetic site or in a remote editing domain.1011

Mitochondrial ThrRS harbors a pre-transfer editing mechanism to correct misactivated

serine before it is linked to tRNAThr.12 However, archaeal and bacterial enzymes employ
post-transfer correcting mechanisms in the editing domain to hydrolyze misacylated SertRNAThr.13-14
On the other hand, due to growing antibiotic resistance towards present antibacterial
drugs, it has become essential to expand pharmaceutical research toward discovering novel
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antimicrobial targets.15 The inhibition of the bacterial aaRS activity results in restricting
bacterial growth and thus eliminating microbial infection.16-17 Accordingly, aaRSs are
accepted as targets in antimicrobial therapy.18 One of the most common pathways exploited
to inhibit the function of bacterial aaRS is through competitive inhibitors that are able to
bind firmly inside the corresponding active sites. These competitive inhibitors are
analogues to the native substrates with similar or even stronger binding affinities and
thereby diminish the natural activity of the enzyme.
ThrRS is one of the primary antibiotic targets and a number of competitive inhibitors
have been synthesized and experimentally identified.19 In this study, many of the
synthesized inhibitors that exhibited potent binding affinity are able to chelate to the Zn(II)
in a bidentate fashion, similar to the native threonine. This Zn(II) ion is a unique feature of
the active site of ThrRS and adopts a pentacoordinate geometry with the remaining three
sites being occupied by three protein ligands (His351, His385 and Cys334).20 Intriguingly,
the Zn(II) ion has a central role in recognizing threonine and serine as well as rejecting the
isosteric valine.21 Moreover, the unnatural β-hydroxynorvaline (βHNV), differing from the
cognate threonine by an ethyl group instead of methyl, was experimentally shown to be a
substrate for ThrRS.22 βHNV shares the same side chain groups as the cognate threonine
which enables it to bind identically to the Zn(II) ion, preventing ThrRS from being able to
discriminate against it.23
Zn(II) is the second most abundant metal in enzymes and Zn(II) metalloenzymes are
encoded by approximately 10% of the human genome.24 Among other characteristics, its
ability to adopt a range of coordination geometries contributes to its remarkable ubiquity in
biological systems. Most commonly, a tetracoordinate Zn(II) is observed.25. The role of
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Zn(II) as a cofactor can vary from structural, where it stabilizes protein conformation, to a
catalytic one where it is directly involved in the mechanism.26
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Scheme 9.1. The equation used to estimate the B.E, X and Y represent the chelating
groups while K and M represent the Push-Pull substituents.
Our main objective in this study was to suggest competitive binders in the active site of
bacterial ThrRS by conducting hybrid DFT calculations on numerous proposed ligands.
Based on our knowledge of the required criteria for an excellent chelating group to Zn(II),
we attempted to identify potential ligands. Initially, we focused on elucidating the specific
role of Zn(II) in the discrimination mechanism performed by this active site. This
understanding then enabled us to tune a variety of ligand sets looking for ideal chemical
reactivity. This protocol is widely used in drug discovery for similar Zn-containing
systems.27-29 In these studies, the main factor representing potency was the value of the
binding energy (B.E) of the proposed ligand which is derived from the previous equation,
Scheme 9.1.
9.2 Computational Methodology
We performed our calculations utilizing the M05-2X functioal30 and 6-31+G(d) basis
set as implemented in Gaussian0931 for the optimizations of the complexes, except for
Zn(II) where 6-311G(d) is used. Based on a recent benchmark study, M05-2X
outperformed a list of other DFT functionals in describing Zn-ligand compounds.32 Also,
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the overall optimization method was used successfully in similar calculations.28 Frequency
analysis was conducted at the optimization level of theory to ensure the nature of the
stationary points. The considered Zn(II) geometry included the first coordination sphere in
which two imidazole rings and methanethiol were used to represent two histidine (His351,
His385) and cysteine (Cys334) protein residues Scheme 9.1, respectively. Moreover, a
library of ligands with terminal heteroatoms were constructed, Scheme 9.2.

9.2.1 Docking Analysis
For the initial model, the X-ray structure of Escherichia coli ThrRS (PDB code:
1QF6)20 was docked with the ligand. Docking calculations were performed using the
Molecular Operating Environment (MOE) software.33 Then the entire complex was
prepared for the investigation through protonation and solvation (adding a 2 Å layer of
water solvent molecules). The considered ligands were also minimized using molecular
mechanics (MM) minimization utilizing the AMBER12 force field available in MOE.
Using the induced fit protocol, the receptor is kept rigid in the native conformation with
the studied ligands free to move. The most favorable binding modes were selected
Thereafter, the generated series of poses were rescored using the London dG protocol
where the most favorable scores, determined by estimating the corresponding binding free
energy values, indicate the conformation that has the most favorable hydrophobic,
hydrophilic, and hydrogen bond interactions.
We modified the second rescoring step to retain 100 different poses, the maximum
value available in MOE. This is followed by conducting forcefield refinements through
energy minimization on the resulting poses from the previous placement stage. During this
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energy minimization stage, a cut-off distance of 6 Å in combination with fixation of the
side chains of the receptor was applied to speed up the calculation. A dielectric constant of
4 was used to represent the electrostatics of solvation and the final energy is then estimated
using the generalized Born solvation model. Lastly, the second rescoring has been
performed using the GBV1/WSA dG forcefield-based scoring function which evaluates the
binding free energy of the ligand in each pose. Notably, during the two rescoring stages,
any duplication in the produced binding (H-bonding or hydrophobic interactions) pattern
has been eliminated.
9.3 Results and Discussion
9.3.1 DFT calculations
A small model to represent the ThrRS Zn-binding site was constructed for the
subsequent calculations. It has been demonstrated that the presence of a Zn(II) metal ion
with its Lewis acidic character in most Zn-metalloenzymes imposes a change in the pKa
values of the binding ligands.34-35 Specifically, the pKa of the ligand decreases followed by
a relative increase in the pKa of neighboring bases, facilitating the proton transfer from the
ligand’s β-OH group to this base. Consistent with this hypothesis, the active site of ThrRS
has an adjacent base residue (Asp383) not ligated to the Zn(II) and strongly hydrogen
bonded to the β-OH group of the substrate. Thus, we initially performed our calculations
considering two different analogues, 1-amino-2-propanol and 1-amino-2-propoxide to
represent the native L-threonine in the neutral and deprotonated OH group forms,
respectively.
Notably, the neutral ligand is observed to bind in a monodentate fashion to the Zn(II)
through its amine group, and thereby the overall Zn(II) is tetracoordinate. Meanwhile,
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deprotonation of the OH group in the ionized threonine analogue enhances its Lewis
basicity and thus enables the substrate to bind in a bidentate fashion to the metal ion to give
a pentacoordinated Zn(II). Indeed, the latter coordination is consistent with the native
threonine’s binding mode in the ThrRS active site, according to a recent X-ray structure.21
Notably, the estimated B.E. for the ionized ligand (1a) is markedly larger (-507.1 kJ/mol)
than the corresponding value of the neutral one (1g), only -59.2 kJ/mol, Scheme 9.2.
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Similar to other Zn complexes, ThrRS is energetically favored to have an overall
neutral charge for the complexation.25 One of the reasons for the preference of the
pentacoordinate Zn over the tetracoordinated one is that the overall charge of the complex
is neutral only in the pentacoordinate form. Subsequently, the proposed library of ligands
in this study contains ionized heteroatoms allowing for the formation of a pentacoordinated
metal ion, Scheme 9.2. On the other hand, it is well established that aaRSs play a critical
role in preserving the homochirality of the synthesized protein.36 It is possible that the
active site has editing activity against D-amino acids and accommodates only the L-form.
Moreover, ThrRS maintains this enantioselectivity by harboring a separate editing
domain called amino acid deacylases (DTD). Its role is to hydrolyze any misacylated Dthreonyl-tRNAThr.37 Accordingly, we considered two different enantiomers of the threonine
analogue in the studied model (1a and 1b) and the B.E. for each model has been calculated.
Notably, the B.E. values vary according to the studied enantiomer and the most preferred
configuration that gave the highest B.E. is (R)-1-amino-2-propoxide (1a) with value of 35.5
kJ/mol higher than the other conformation (1b), Scheme 9.2. In order to better describe
this phenomenon, two additional ligands, with chirality α to the amine rather than the
alcohol, have been examined (1c and 1d). Importantly, various B.E. values have been
observed with preference of the S-enantiomer, 1c in Scheme 9.2.
As previously discussed, the synthetic active site of ThrRS cannot adequately
distinguish between threonine and the structurally similar serine even with the presence of
Zn(II) as a cofactor. Consistent with this observation, we also investigated the binding of a
serine analogue (2-aminoethanol), 1e, to the Zn(II) complex. The resulting B.E. is found to
be slightly lower than the corresponding value of the threonine analogue with a small
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difference of 2.4 kJ/mol. In fact, it is documented that the difference in B.E. between the
two amino acids is only 4.2 kJ/mol.38 Arguably, the subtle added donating ability of the
extra methyl group in the threonine analogue enriches the electron density on the chelating
oxygen atom and subsequently strengthens its ability to bind to the Zn(II) atom.
Importantly, a comparison between 1c and 1a complexes showed that the methyl group
attached to an α-NH2 group has less impact on the obtained B.E. unlike when it is
positioned next to the O– atom. In agreement with that, inserting an extra methyl group on
to 1a close to the α-NH2 group, ligand 2a, does not enhance the binding capability, and thus
has nearly no influence on the estimated B.E. (-515.6 and -514.3 kJ/mol for 1a and 2a).
However, adding an NH2 group to the chiral atom in ligand 2d, with it inductive ability as a
donor group, greatly improved the biding efficacy and resulted in a B.E. of -524.1 kJ/mol,
Scheme 9.2. Generally, tuning the binding potency has been achieved by changing the
electronic properties of the attached substituents and electron donating substituents are
energetically favored. Furthermore, the binding of a β-HNV analogue has been studied, 2b,
and the observed B.E is considerable with a value of -513.5 kJ/mol. This B.E. value is 2.1
kJ/mol less than the cognate threonine analogue, reasonably indicating β-HNV can be
recognized in the active site of ThrRS.22
Meanwhile, valine can be rejected easily from this active site due to its inability to
bind to the Zn(II) in a similar fashion to the cognate threonine.39 Based on our analysis on
the binding of valine, it coordinates only through its α-NH2 and this results in
tetracoordinated Zn(II) ion. Importantly, it exhibits extremely low B.E. with value of just
−44.0 kJ/mol indicating an exceptionally weak binding affinity to the Zn(II) atom,
matching experimental observations.23, 39 According to a previous related study,28 another
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set of asymmetric conjugated ligands have been analyzed, 2e, 2f and 2g. The B.E.
increased by increasing the electron donating capability of the substituent group, the ligand
2g giving the most favorable B.E. with value of -498.6 kJ/mol. However, all three ligands
displayed a weaker binding ability relative to the B.E. of the threonine analogues.
In light of these findings, different sets of ligands have been studied, 3a-3g in Scheme
9.2. Overall, unlike the previous study that demonstrated the remarkable binding ability of
aromatic ligands, our work showed aliphatic cyclic rings have a better binding ability. By
comparing between 3b and 3e, both 6-membered ring ligands, we obtained a difference of
87.3 kJ/mol in the estimated B.E. with the aliphatic ligand much preferred. The reason for
the weak interaction of aromatic ligands is partially due to the involvement of the lone
pairs of the bonded heteroatoms in the conjugated system. Also, the binding strength of 3b
improved by 16.9 kJ/mol to -431.8 kJ/mol after inserting a N atom close to the bonded
oxygen atom, ligand 3a in Scheme 9.2. Importantly, we also considered the two aromatic
ligands that gave the highest B.E. to histone deacylase,28 3c and 3d. According to our
calculations, the proposed aliphatic rings (3e, 3f and 3g) exceeded these ligands in terms of
their binding capability, Scheme 9.2.
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Figure 9.1. Optimized complexes with key bond lengths in Å of the binding geometries of
selected ligands to the Zn(II) coordination sphere.
Furthermore, among the three different sizes of the aliphatic cyclic ligands studied, 6membered cyclic ligands have the most favorable B.E., probably due to their less strained
geometry. Globally, aliphatic chains are still energetically preferred with respect to the
values of the B.E.. The optimized complexes for selected ligands together with some key
distances are shown in Figure 9.1.
Two additional sets of compounds were also examined, 4a-4g and 5a-5f. Our goal was
to determine which atom has the strongest binding affinity. In this series of ligands,
Scheme 9.2, comparisons between the type of electron donors in the dative bond (amine,
alkoxide, sulfoxide) and the electron donating/withdrawing ability of the substituents
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(hydrogen, amine, cyano) were performed. These compounds were run as neutral and
dianionic ligands. In case of the neutral ligands, 4a, 4b and 4c, ligand 4b with two oxygen
atoms showed the highest binding affinity followed by 4c with terminal sulfur atoms.
Interestingly, relative to the neutral forms, the B.E. of the corresponding ionized ligands,
4d, 4e and 4g, increased drastically due to having two anionic terminal atoms. The
dianionic species in general showed extraordinary binding ability (almost twice the B.E.
value of the threonine analogue). Notably, the most favorable binding ability was found in
the dianionic species with two oxygen donors, ligand 4g, Scheme 9.2.
In agreement with the former findings, push-pull substituents induce a change in the
value of the estimated B.E.. Furthermore, when the strong electron withdrawing cyano
group (–CN) was placed on the two main carbons in different combinations, a considerable
reduction in the B.E. has been noticed. Placing two CN groups has a greater impact on
decreasing the value of the B.E. than a single CN group, as it is explicit in 5d and 5a. Also,
a comparison between 5a and 4b demonstrates the influence of single CN group on the
chelating ability. In case of 4b, the B.E. is slightly diminished relative to 5a due to the
presence of the NH2 group with the latter energetically favored. It is also interesting to note
the higher B.E. values for the ligands with no EWGs, 4d, 4e and 4f, compared to the
structures with one or more EWGs 5a-5e, Scheme 9.2.

9.3.2 Docking Results
We performed this investigation considering only the most favored warheads based on
DFT calculations. The phosphate group in Thr-AMP is replaced by a sulfamoyl group to
link the ligand to the adenosine moiety. The ligand is surrounded by a net of hydrogen
bonds with Arg363 residue as well as the adenosine fragment is replaced by indazole. All
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four ligands studied, 1a, 4c, 4e and 4d bound properly in the active site. More specifically,
the adenosine analogue is sandwiched through different hydrogen bond interactions, the
most conserved one with the carboxylic group of Glu365.

1a!

4d!

4e!

5c!

-18.4!

-20.7!

-18.9!

-19.9!

Figure 9.2. Cocrystal structures of selected ligands docked in the active site of E. coli
ThrRS. The estimated values of the B.E. in kJ/mol are shown in blue.
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Importantly, all the ligands chelate to the Zn(II) ion in a similar fashion to the cognate
threonine, Figure 9.2. The calculated binding free energy indicated that the proposed
ligands are more potent than the native threonine. Furthermore, in agreement with our DFT
calculations, 4d is the most potent ligand having the highest binding energy of -20.7 kJ.
9.3.3 QM/MM calculation
In previous work by our group40, we performed a detailed QM/MM investigation on
the aminoacylation mechanism of threonine in ThrRS using the same DFT functional and
basis set. Using the same chemical model, we expanded the current work to explore the
binding efficiency of three suggested candidates using a QM/MM model. Specifically, we
replaced the native substrate threonine with the three ligands that showed the best binding
energies, 4c, 4f and 4g. After performing full optimization of the new QM/MM models, we
noticed that the three ligands chelate to Zn(II) through the two heteroatoms, Figure 9.3.
Similar to the native threonine, Zn(II) is pentacoordinate and the two systems showed
remarkable stability.

4g!

4c!

4f!

Figure 9.3. Optimized QM/MM models for the catalytic site of ThrRS with the bound
substrates, threonine(1a-2), key residues considered in the QM layer have been hided for
clarity.
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9.4 Conclusion
Based on our DFT calculations, it was observed that the B.E. is a notable indicator of
the discrimination mechanism that takes place in the synthetic site of ThrRS against the
structurally related serine, valine, and βHNV amino acids. Moreover, the binding capability
is strongly related to the chirality and the basicity of the ligated atoms. Relative to the
neutral ligands, the deprotonated ligands display a remarkable binding ability as
demonstrated by their corresponding B.E. values. Furthermore, the B.E. of the ligands with
two deprotonated heteroatom terminals dramatically increased, with the symmetric one
preferred. This understanding guided us to propose a series of potent ligands that could
bind more efficiently to Zn(II) relative to the native threonine.
Additionally, to verify the reliability of the proposed potent ligands, we performed
molecular docking as well as QM/MM investigations on the selected ligands, further
supporting our preliminary results. Overall, our findings inform about the essential
characteristics required for competitive inhibition against bacterial ThrRS and will
hopefully inspire development of novel inhibitors.
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Conclusions and Further Work

Chapter 10
10.1 Conclusions
Using a variety of computational enzymology protocols, we have successfully clarified
the mechanisms of the aminoacylation and editing reactions catalyzed by the fundamental
aminoacyl-tRNA synthetases and valuable atomistic details regarding their chemistry have
been identified.
In chapter 3, we used MD and QM/MM methods to examine the role played by the
Zn(II) ion and active site residues in ThrRS's ability to discriminate between its cognate
substrate L-threonine, and the non-cognate L-serine, L-valine and D-threonine. The present
results suggest that a role of the Zn(II) ion, with its Lewis acidity, is to facilitate
deprotonation of the side chain hydroxyl groups of the aminoacyl moieties of cognate ThrAMP and non-cognate Ser-AMP substrates. In their deprotonated forms these substrates
are able to adopt a conformation preferable for aminoacyl transfer from aa-AMP onto the
Ado-3'OH of the tRNAThr cosubstrate. Relative to the neutral substrates, when the
substrates are deprotonated with the assistance of the Zn(II) ion the barrier for the ratelimiting step is decreased significantly by 42.0 and 39.2 kJ/mol for L-Thr-AMP and L-SerAMP, respectively. An active site arginyl residue also plays a key role in stabilizing the
build-up of negative charge on the substrate's bridging phosphate oxygen during the
mechanism. For the enantiomeric substrate, D-Thr-AMP, product formation is highly
disfavoured and as a result, the reverse reaction has a very low barrier of 16.0 kJ/mol.
In chapter 4, the aminoacylation mechanisms of glutaminyl-tRNA synthetase (GlnRS)
and the non-discriminating glutamyl-tRNA synthetase (ND-GluRS) have been investigated
by employing MD simulation, QM-cluster and QM/MM calculations. Our investigations
demonstrated the feasibility of a water-mediated, substrate-assisted catalysis pathway with
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rate limiting steps occurring at energy barriers of 25.0 and 25.4 kcal/mol for GlnRS and
ND-GluRS, respectively. A conserved lysine residue participates in a second proton
transfer to facilitate the departure of the adenosine monophosphate (AMP) group.
Thermodynamically stable (−29.9 and −9.3 kcal/mol for GlnRS and ND-GluRS) product
complexes are obtained only when the AMP group is neutral. This substrate-assisted
mechanism may be common to the structurally similar aspartyl-tRNA synthetase (AspRS)
and asparginyl-tRNA synthetase (AsnRS).
In chapter 5, we have explored multiple possible post-transfer editing mechanisms
for ThrRS from Escherichia coli. The editing site is known to contain two conserved
histidyl's (His73 and His186) and a cysteinyl (Cys182), all of which could act as the
required mechanistic base. We have performed detailed molecular dynamics (MD) and
quantum mechanics/molecular mechanics (QM/MM) studies in which the protonation
states of each of these residues was varied. Furthermore, using the various substrate-bound
active site models obtained, we have examined previously proposed and alternative
possible mechanisms for deaminoacylation of Ser-tRNAThr by ThrRS in which His73 or
Cys182 act as the base; 11 mechanisms in total. The present results suggest that the most
feasible mechanism is obtained when both His73 and His186 are neutral, while the thiol of
Cys182 is deprotonated and acts as a base. The resulting reaction was found to proceed in
two steps. First, deprotonation of an active site water by the thiolate of Cys182 with its
concomitant nucleophilic attack at the substrate's Ccarb center occurs with a calculated free
energy barrier of 9.9 kcal/mol. The subsequent, and overall rate-limiting step, is a watermeditated proton transfer from Lys156 to the

Ado763′-oxygen

resulting in simultaneous

cleavage of the Ado763′O—Ccarb bond with a free energy barrier of 20.8 kcal/mol.
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In contrast to bacterial ThRS’s editing site, discussed in chapter 5, in archaeal
ThrRS, it has been suggested that the substrate’s 2′OHAdo76 is the only available
mechanistic base, which is the focus of the investigations reported in chapter 6. The
suggested role of this 2′OH group was to promote the reaction by orienting a nucleophilic
water molecule close to the scissile Ser-tRNAThr ester bond. In this study, we performed an
extensive computational investigation, using both Molecular Dynamics (MD) and hybrid
ONIOM Quantum Mechanics/Molecular Mechanics (QM/MM) methods, to consider all
possible editing mechanisms. The results of our investigation show that the 2′OHAdo76
group plays a crucial role; the editing mechanism was found to proceed step-wise via the
formation of 6-membered ring transition structure. Moreover, the elucidated mechanism
was found to be applicable for the D-amino acid deacylase activity that is exhibited by the
same editing domain. Three different functionals were considered in this study and the
M06-HF functional was found to give the most enzymatically feasible energy barriers.
In chapter 7, we used MD, QM/SE and QM methodologies to provide atomistic details
regarding the pre-transfer editing against the non-cognate homocysteine (Hcys) by
isoleucyl-tRNA synthetase (IleRS) as well as cysteine (Cys) and threonine (Thr) by seryltRNA synthetase (SerRS). Notably, in the two enzymes considered herein, pre-transfer
editing follows a substrate-assisted self-cyclization mechanism. This mechanism is found
to take place via two main steps, a dihedral scan around the substrate’s Cb__Cg bond
followed by a concerted R-S(O)H deprotonation and nucleophilic attack on the substrate’s
carbonyl carbon. Notably, the rate limiting step to edit against Hcy-AMP by IleRS is the
first step with an activation barrier of 24.3 kcal/mol. Meanwhile, the highest energy barrier
obtained during the editing against Cys and Thr by SerRS resulted from the second step
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with values of 20.4 and 26.6 kcal/mol, respectively. Interestingly, following the same
pathway to investigate the possibility of pre-transfer editing against the native Ser-AMP by
SerRS, an energy barrier of 31.4 kcal/mol was obtained indicating an enzymatically
infeasible process. Additionally, an agreement between the relative free energy obtained
by QM/SE with the corresponding values obtained by QM-cluster one was observed.
In chapter 8, using MD and QM/MM methodologies we elucidated the escape from
the fidelity by the unnatural β-Hydroxynorvaline (βHNV), in the aminoacylation site of
ThrRS. Due to the presence of Zn(II) with its Lewis acidity character, only the ionized
form of βHNV results in an enzymatically feasible barrier. Furthermore, consisten with the
homochiral behavior of this active site, we observed that there is a specific conformation of
βHNV that could be aminoacylated. Benchmarking analysis was performed and our system
was found to be responsive to the %HF as well as the dispersion correction included in the
used density functional theory. Importantly, the BP86-D3 functional was found to be
superior to all the studied functionals in representing the rate-limiting step kinetically. The
importance of Zn(II) in the aminoacylation mechanism was further emphasized when its
substitution with the chemically similar Cd(II) led to a dramatic increase in the energy
values and thus, less feasible from both thermodynamic and kinetic perspectives.
In chapter 9, detailed DFT quantum chemical study was conducted to examine the
binding ability of various ligands to Zn(II) in ThrRS by comparing the value of the binding
energy (B.E) for each ligand relative to the native substrate, threonine. Our screening
investigation showed that the native threonine should ligate in a bidentate fashion to this
Zn(II) which lead to the highest B.E. Thereby, the synthetic site of ThrRS rejects
noncognate amino acids that cannot perform this type of interaction. Moreover, based on
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their ligation to the Zn(II) and the obtained B.E values compared to the cognate threonine,
many potent ligands have been suggested. Importantly, ligands with deprotonated warheads
showed the highest binding ability. Further investigation on the selected ligands using
molecular docking and QM/MM confirmed our initial findings of the suggested
competitive ligands being able to bind efficiently in the active site of ThrRS. The suggested
ligands from this study are potential candidates for competitive inhibitors against bacterial
ThrRS.
This research should enable mechanistic investigations on the rest of the crucial family
of aminoacyl-tRNA synthetases. Several of the elucidated catalytic mechanisms can be
generalized to other members of this family, and thereby future work will be to explore
applicability of such mechanisms. Moreover, many other questions need further analysis,
including the first step of activation mechanism as well how each enzyme recognizes its
cognate tRNA. Eventually, these findings should provide significant insights into the
outstanding chemical fidelity of these enzymes. Consequently, this understanding should
open many novel routes to approach our long-term goal in establishing collaboration with
many experimental leaders who are currently working on the biochemical analysis of
aminoacyl-tRNA synthases.
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